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Background: While animal-assisted intervention (AAI) programs have shown 
significant benefits to patients, there are concerns regarding their use in healthcare 
settings limiting utilization. This works aims to enhance the adoption and use of hospital 
AAI programs and understand the positive and negative outcomes of implemented 
control measures. We hypothesize that a One Health framework will aid in the 
understanding and improvement of hospital AAI infection control concerns. This 
dissertation will 1) collect perspectives on concerns and control measures to understand 
perceived risks, and 2) examine microbial dynamics to understand actual risks.  
Methods: The first two chapters are literature reviews to identify knowledge gaps and 
provide rationale for the thesis research. The next two chapters are based on a qualitative 
study interviewing key stakeholders in hospital AAI programs. The last two chapters 
describe research that sampled for both hospital pathogens and whole microbial 
communities to pilot test a canine decolonization approach as an infection control 
intervention.      
Results: The literature reviews revealed a lack of data on the risks associated with 
hospital AAI, and a One Health approach can be used to address this knowledge gap. The 
qualitative findings indicated occupational health benefits are limited by administrative 
and infection risk barriers, but these could be overcome through collaboration and 
leadership. Microbial findings suggest the canine decolonization intervention blocked 
the microbial contribution from the therapy dog and reduced rare microbiota on the dog, 
yet did not prevent all microbial sharing, indicating the dog as only one possible pathway 
for transmission. 
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Conclusions: The results from this thesis support the hypothesis that a holistic One 
Health approach can assist in understanding and designing interventions to improve 
hospital AAI programs. The qualitative findings stress the importance of understanding 
practical considerations for program implementation. In the quantitative study, 
allocation of the relative contribution for all potential microbial transmission pathways, 
and the determination of potentially negative unintended consequences of infection 
control policies, can inform the design of appropriate and effective control measures. 
This thesis suggests that a One Health framework should be used for future research in 
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Chapter 1: Introduction 
1.1 Background 
 
Holistic systems-thinking is needed to solve complex public health problems. The One 
Health framework is an example of such an approach, as it examines the 
interconnections between humans, animals, and the environment. The goal of this 
research is to delve into the positives and negatives of human-animal-environment 
interactions within a healthcare setting, particularly the use of animals as an adjunctive 
therapy modality, with the objective to support, protect, and enhance these programs.  
The One Health Concept 
One Health recognizes the inextricable linkage of humans, animals, and their shared 
environment (Destoumieux-Garzon et al., 2018). It is defined as any added value in 
human and animal health and wellbeing, environmental sustainability and protection, or 
economic incentive, that can be achieved by closer cooperation of various disciplines, 
including human, animal, and environmental health, which could not be accomplished if 
the sectors work separately (AVMA, 2008). It involves collaborative problem solving—
locally, nationally, and globally. Previous research, ranging from vaccination campaigns 
to early emerging disease detection, shows that a One Health approach provides a clear 
benefit for the health of humans and animals alike (Rabinowitz et al., 2013; Zinsstag et 
al., 2011). Public health problems are frequently complex, transboundary, multifactorial, 
and across species, and if approached from a purely medical, veterinary, or ecological 
standpoint, it is unlikely that sustainable mitigation strategies will be produced. 
Therefore, a One Health framework is critical to address many current public health 
issues.  
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This concept has never been more evident than now, as this dissertation is written 
during a worldwide coronavirus pandemic (SARS-CoV-2, COVID-19). The One Health 
concept first grew in popularity when the Wildlife Conservation Society used the term in 
their guiding principles, linking the health of humans and domestic animals with the 
health of ecosystems, issued to address public health challenges during the first SARs 
outbreak of 2003-2004 (Mackenzie & Jeggo, 2019; Wildlife Conservation Society, 2004). 
The roots of One Health are in nineteenth-century comparative medicine, which used 
animal models to advance human medicine. In 1984, Calvin Schwabe identified ‘One 
Medicine’ as considering “the close systematic interaction of humans and animals for 
nutrition, livelihood, and health” (Zinsstag et al., 2011). While most One Health research 
has centered on zoonosis, or the spread of disease from animals (either wildlife or 
domestic) to humans, Hodgson and Darling introduced the concept of “zooeyia” to the 
One Health field in 2011 as “the positive inverse of zoonosis”, the multiple benefits to 
human health from interacting and bonding with animals, which provided the evidence 
base for the philosophical construct of the human-animal bond (Hodgson & Darling, 
2011). The human-animal bond is a mutually beneficial and dynamic relationship 
between people and animals that is influenced by behaviors essential to the health and 
wellbeing of both. This includes, but is not limited to, emotional, psychological, and 
physical interactions of people, animals, and the environment (Hines, 2003). 
Animal-Assisted Interventions 
The strength of the human-animal bond and its potential implications for human health 
and wellness is the fundamental premise of animal-assisted interventions (AAI). AAI is 
an umbrella term that is any intervention that intentionally includes or incorporates 
animals in health, education, and human services for therapeutic or ameliorative process 
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in humans (Dudzik, 2018). It includes animal-assisted activities, programs for 
motivational, educational, and recreational purposes such as classroom reading animals 
and animals for trauma support. It also includes animal-assisted therapy, structured 
therapeutic programs with a targeted clinical outcome or goal delivered by health 
professionals, such as animal use in physical therapy. Both forms of AAI are used in 
healthcare settings, either for the purpose of positive distraction to patients or as a 
targeted therapy modality in patient care.     
AAI is a perfect example of a One Health approach. It incorporates the health of humans 
as a direct result of animal exposure and interaction. The environmental impact on 
human-animal interactions within AAI incorporates the hospital’s social, cultural, 
political, and economic factors. In fact, the One Health framework previously has been 
recommended as a beneficial application to AAI research (Chalmers & Dell, 2016; 
Hediger et al., 2019), specifically to understand the synergistic or antagonist effect on the 
health of humans and the health of the therapy animals.  
However, the One Health concept can also be used to examine the dynamic balance of 
positive and negative impacts of AAI programs. While numerous health outcomes have 
been reported in patients experiencing AAI (Kamioka et al., 2014; Maujean et al., 2015), 
there are potential challenges to incorporating animals into a hospital setting, which can 
include children with poor immune function. AAI programs may enhance the exchange 
of pathogens between therapy animals and people. Hospitals can be incubators for 
infectious disease agents, such as methicillin-resistant Staphylococcus aureus (MRSA), 
Clostridioides (Clostridium) difficile, and Pseudomonas aeruginosa. While these 
hospital-acquired pathogens are enhanced by the close contact and antimicrobial 
selective pressure inherent to a healthcare setting, therapy animals may unwittingly 
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serve as disease recipients and mechanical vectors, or an interactive fomite. It is possible 
that contact between therapy animals and individuals may lead to subsequent infection 
in both. While research on this potential negative outcome is lacking, research has 
shown that dogs can carry hospital-associated pathogens, which could potentially be 
transmitted to patients with whom they interact (Dalton et al., 2020). 
The “Hygiene Hypothesis” and Microbial Interactions between People and 
Animals 
An additional dimension to this dynamic process is the idea that microbes, including 
pathogens, function in the context of their holistic microbial community. A better 
understanding of that microbial community, and shifts within that community, will 
better elucidate pathways and mechanisms of the potential pathogenic risk of AAI 
programs. This is important as our total microbial communities, or microbiome, plays a 
critical role in health homeostasis. Previous microbiome work has shown that 
transmission of non-native microbes could alter hosts’ microbial species diversity and 
community structure, which could positively or negatively influence the risk of pathogen 
colonization, and ultimately could be associated with disease (Grice & Segre, 2011). 
Conversely, a high level of microbial diversity within a host niche may confer protection 
against the acquisition of pathogen bacterial species and ultimately improve health 
outcomes (Chehoud et al., 2013; Rosenthal et al., 2011). This leads into the concept of the 
hygiene hypothesis or germ theory, which imparts that a broad range of exposures 
“train” developing immune systems to tolerate a variety of environmental allergens, 
reducing risk for inflammatory conditions, such as atopy, hypersensitivity disorders, and 
obesity (Strachan, 1989; Wold, 1998). 
The hygiene hypothesis applies to the One Health concept, and AAI specifically, when 
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examining research surrounding the microbial shifts as a result of pet ownership. In 
addition to the mental and physical benefits of pet ownership described earlier as a 
rationale for AAI, there are also benefits of pet ownership through the mechanism of the 
microbiome. Pet ownership is associated with a composition of more unique microbiota 
that are more frequently shared between owners (Misic et al., 2015; Song et al., 2013). 
Following the hygiene hypothesis, early life pet exposure is associated a decreased 
incidence of these immune conditions and is best demonstrated where exposure to 
diverse microbes from farming environments, including animals, is protective against 
the development of asthma (Azad et al., 2013; Carlsen et al., 2012; Fall et al., 2015; Stein 
et al., 2016). 
Qualitative Methods for One Health and AAI Studies 
A key component of One Health research is the need to take a systems-thinking holistic 
approach to understand and address wicked problems. On the micro-scale, this relates to 
our broad understanding of microbial communities. On the macro-scale, this conveys the 
need to understand perspectives and opinions from multiple stakeholders. Collaboration 
and diversity are key components of the One Health framework (refer to the CDC image 
below). Understanding problems of a complex nature necessitates involving a diverse 
group of individuals, communities, organizations, and professional bodies. The use of 
qualitative research methods best embodies this multi-stakeholder engagement.  
Qualitative research is the collection and analysis of unstructured and non-numerical 
data to examine events in their natural settings, attempting to interpret phenomena in 
terms of the meanings, experiences, and views of affected and effected populations. 
When performed well, qualitative methodologies can help One Health researchers 
develop impactful research questions, create more accurate and contextually relevant 
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parameters for quantitative studies, and produce policy recommendations and 
interventions attuned to the political and socio-cultural context of their implementation. 
Qualitative methods have already been successfully integrated into One Health-based 
studies, such as pet owners’ vaccination reluctance and parasitic control programs 
(Bardosh et al., 2014; Wera et al., 2016), as well as the field of AAI to better understand 






























1.2 Research Hypothesis and Specific Aims 
 
The dynamic process of potential positive and negative consequences resulting from AAI 
necessitates a harmonized approach to understand the balance of zoonosis and microbial 
transmission, what could be considered a negative, and the positives associated with the 
human-animal bond. This is achieved through the utilization of the One Health 
framework. The goal of this dissertation is to take a systems-thinking approach to begin 
to understand the complex subtleties that occur during an AAI session by considering all 
potential pathways and stakeholders. This understanding is critical in order to identify 
best practices to improve AAI programs and enhance their utilization, the objective of 
this and future research.  
Working towards this objective, we hypothesize that the application of the One Health 
framework, both on the micro- and macro- scale, will increase understanding of AAI 
programs in healthcare settings in order to identify potential targets for improved 
program implementation. We will test our hypothesis through two independent aims.  
Aim 1: Identify Occupational Health Benefits and Concerns of Key 
Stakeholders Regarding Hospital-Based Animal-Assisted Intervention 
Programs 
Aim 1 will address an urgent need to evaluate opinions of program safety and infection 
control policies from various occupational key stakeholder groups, as infection control 
concerns could challenge not only use but the effectiveness of AAI programs. This aim 
also seeks to understand the effectiveness of hospital-based AAI programs to reduce 
healthcare worker (HCW) stress, a leading occupational hazard in this cohort. To date, 
no research has evaluated the efficacy of AAI as a valid therapy to reduce stress in this 
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vulnerable yet essential worker population, as well as assess infection control beliefs and 
practices for professional personnel who work with hospital-based AAI programs. We 
will collect qualitative data on the knowledge, beliefs, and practices regarding 
occupational stress reduction and infectious disease risk mitigation strategies for AAI 
programs, from HCWs and therapy animal handlers. This work will inform future 
research efforts and contribute valuable knowledge to the appropriate and safe 
implementation of hospital-based AAI programs to ensure their sustainability as a 
beneficial resource in holistic health for occupational groups and patients.  
Aim 1 Research Question: 
Focusing on key stakeholders involved in hospital-based AAI programs, we identified 
knowledge, beliefs, and practices of 1) AAI program benefits for HCW occupational 
stress reduction and 2) concerns and control strategies for infectious disease 
transmission during AAI.  
Aim 1 Objectives: 
1. Characterize opinions of hospital-based AAI programs as an efficacious and 
effective occupational stress reduction intervention.   
2. Elucidate concerns and current practices of infection control during AAI 
programs, and thoughts on novel interventions. 
This work will contribute foundational evidence regarding the risk and benefits of AAI 
programs as a method to promote the health and well-being of patients and HCW. 
Results generated by this research project will begin to address a critical knowledge gap 
in the benefit and risk of increasingly frequent hospital AAI programs and raise 
awareness of AAI hazards and previously undescribed benefits. The disseminated results 
of this study will contribute rigorous scientific evidence to inform guidelines in the 
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utilization of AAI for stress management in an occupational setting. These guidelines will 
focus on improving the positive aspects of AAI, while considering interventions or 
strategies to minimize the potential risk from pathogens. This work will have important 
applications for AAI programs within a hospital setting and may even be extended for 
AAI in other occupational settings. 
Aim 2: Characterize Microbiome Alterations of Patients and Therapy Dogs 
during Hospital Animal-Assisted Intervention Programs  
Therapy animals may contribute both general non-native microbes and hospital-
associated pathogenic ones to patients with whom they interact, both of which can alter 
human host microbiome. To date, no published studies have evaluated whether 
interactions among therapy dogs and patients in an AAI program can alter microbial 
communities in either. Understanding microbial sharing between pediatric populations 
and therapy animals, as well as associated factors that drive microbial transmission, has 
implications for both infection control measures and potential beneficial outcomes 
related to hospital AAI programs. For this aim, we collected microbial samples from 
pediatric patients, therapy animals, and the hospital environment, as part of a pilot study 
to understand the effectiveness of a canine decolonization as an infection control 
intervention. 
Aim 2 Research Question:  
Within the context of an infection control pilot study, we examined if the microbiome of 
patients and therapy animals will be altered after interaction during a hospital AAI 
session. 
Aim 2 Objectives: 
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1. Quantify the degree of microbial sharing between therapy dogs and patients, and 
determine factors that modify this microbial sharing, namely contact level 
between the patients and therapy dogs. 
2. Explore the effect of a therapy dog decolonization protocol on the therapy dog’s 
microbiome.  
3. Explore the effect of a therapy dog decolonization protocol on microbial sharing 
between therapy dogs and patients. 
Understanding both the beneficial and detrimental aspects of microbial sharing between 
humans and therapy animals, and risk factors for altered sharing, will address safety 
concerns of hospital use of AAI programs. If we identify modifiable risk factors in 
patients or therapy dogs for negative microbial outcomes, these could be targets to 
address in order to improve the safety and sustainability of AAI programs and increase 
its utilization as a valid alternative patient therapy in the healthcare field. Findings will 
inform future research into whether exposure to animal microbes may benefit human 
microbiota or contribute to the correction of disease-state dysbiosis. This work will have 
implications for other studies that assess microbial sharing in the context of the human-
animal bond and contribute to a foundational understanding of the dynamics of 
microbial profiles, which may be useful in the prevention and treatment of diseases in 
individuals in the future.  
Dissertation Chapters that Address Each Aim 
Chapters 2 and 3 are literature reviews and commentaries that provide further 
background and scope to this research field and highlight specific knowledge gaps as a 
rationale for this dissertation. 
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Chapter 4 describes stakeholder perspectives on AAI program barriers and facilitators 
for our qualitative Aim 1. 
Chapter 5 is a targeted commentary, translating the qualitative results in Aim 1 to 
hospital administrators and infection control audiences.  
Chapter 6 portrays microbial community shifts in the therapy dog as a result of the 
decolonization intervention (Aim 2.2). 
Chapter 7 focuses on microbial sharing between patients and the therapy dogs, both of 
hospital pathogens and entire microbial communities, and explores factors that modifies 
this sharing in Aim 2.      
Chapter 8, the conclusion, ties together all the original research within this dissertation 
as it relates to the set hypothesis and research goal. Each chapter uniquely and 
independently moves forward the state of knowledge on the positives and negatives of 
hospital AAI programs through the application of the One Health framework, with the 
purpose of preserving these beneficial programs. 
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Despite improvements in hospital infection prevention and control, healthcare 
associated infections (HAIs) remain a challenge with significant patient morbidity, 
mortality, and cost for the healthcare system. In this review, we use a One Health 
framework (human, animal, and environmental health) to explain the epidemiology, 
demonstrate key knowledge gaps in infection prevention policy, and explore 
improvements to control Gram-positive pathogens in the healthcare environment. We 
discuss patient and healthcare worker interactions with the hospital environment that 
can lead to transmission of the most common Gram-positive hospital pathogens – 
methicillin-resistant Staphylococcus aureus, Clostridioides (Clostridium) difficile, and 
vancomycin-resistant Enterococcus – and detail interventions that target these two One 
Health domains. We discuss the role of animals in the healthcare settings, knowledge 
gaps regarding their role in pathogen transmission, and the absence of infection risk 
mitigation strategies targeting animals. We advocate for novel infection prevention and 
control programs, founded on the pillars of One Health, to reduce Gram-positive 
hospital-associated pathogen transmission.   
 
Keywords 
Infection prevention, infection control, hospital-associated infections, hospital 





One Health approaches are based on the belief that we cannot truly understand human, 
animal, and environmental health by addressing each in isolation. In order to address 
complex public health challenges, we must understand the interconnectedness of these 
domains with a holistic methodology. Similar to other systems-thinking models, One 
Health focuses equally or more on the relationships between the factors in the system, 
rather than on the individual-level factors themselves.   
The One Health paradigm has origins in the recognition that diseases often emerge from 
interactions of humans and animals, termed initially as “one medicine”, and 
incorporated preventative and public health. It has since grown to include environmental 
science and eco-health to encompass the shared environment role (Destoumieux-Garzon 
et al., 2018). The combined assessment of health risks across the three domains; 
humans, animals, and the environment; involves design and implementation of 
intervention strategies that address all three sectors with a goal to produce assimilated 
knowledge. The One Health concept has been successfully applied to fields such as 
emerging zoonotic disease outbreak investigation and biosecurity risk across humans 
and animals (Destoumieux-Garzon et al., 2018; Okello et al., 2014). 
But how does One Health impact our healthcare system? Hospitals serve as an incubator 
that incorporates dynamic microbial inputs from the community from both people and 
animals, as illustrated in Figure 1. Antimicrobial use exerts selective pressure on these 
incoming microbial ecosystems, shifting to a higher prevalence of resistant organisms. 
Microbial ecosystems are defined for this paper as the composition, and the networks, of 
the entire microorganism population within a single niche or site. Individuals in the 
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hospital (both patients and employees) may become colonized with hospital-associated 
multidrug-resistant organisms (MDRO) and then are discharged back to the community, 
creating a cyclic feedback loop (Dulon et al., 2014; Patel et al., 2017; Xue & Gyi, 2012). 
Finally, MDRO acquisition and infection is more likely diagnosed in the hospital setting, 
resulting in the hospital serving as both a surveillance point and multiplier for resistant 
organisms and infections, which underscores the need to describe community and 
hospital-based risk factors that influence the hospital environment.  
The application of One Health principles to hospital infection prevention and control has 
not been described previously. In the clinical setting, One Health can provide practical 
ways to incorporate environmental and animal contact considerations into patient care. 
While the concept has been endorsed by major medical and public health organizations, 
studies of physicians reveal limited awareness to the environmental health aspects of 
medical problems in the patient care settings, as well as low awareness levels about 
prevention or treatment of zoonotic diseases from animals (Allen, 2015; Hamilton et al., 
2005). Therefore, the purpose of this review is to use a One Health lens to describe the 
relationship between the hospital environment and patient care specifically for Gram-
positive hospital-associated pathogens, and to identify how animals fit into this 
relationship (Figure 1). A broad literature search was conducted to identify information 
relevant to the scope of this work, see Figure 2. Articles published prior to June 2019 
were considered for review. 
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2.3 Hospital-Associated Gram-Positive Pathogens   
 
Healthcare-associated infections (HAI) are an increasingly prevalent threat in the Unites 
States healthcare system. The Centers for Disease Control and Prevention’s National 
Healthcare Surveillance Network (CDC-NHSN), a US surveillance system, estimates that 
about one in 31 hospitalized patients acquires an HAI (Centers for Disease Control and 
Prevention., 2017). This review focuses on Gram-positive bacterial pathogens, a 
significant cause of HAIs, which may survive longer on dry surfaces than Gram-negative 
bacteria (Barbut, 2015; Beard-Pegler et al., 1988). Methicillin-resistant Staphylococcus 
aureus (MRSA) was the first pathogen where spread through the hospital environment 
was documented, though targeted hospital efforts are contributing to its decline in the 
past decade (Centers For Disease Control and Prevention, 2019; Evans et al., 2017). It is 
relevant to One Health, as some MRSA strains and other multidrug-resistant 
staphylococci are associated with animals, livestock in particular (Larsen et al., 2015; 
Price et al., 2012).  
The second most common hospital associated Gram-positive pathogen is Clostridioides 
difficile (genus recently reclassified from Clostridium (Lawson et al., 2016)). Rates of 
resistance and transmission depends on strain, with higher rates seen in the PCR 
ribotype 027 and 078 epidemic strains, and documented resistance to quinolones, 
clindamycin, rifamycins, erythromycin, chloramphenicol, tetracycline and even 
imipenem (McDonald et al., 2018). It is included in this review because it is the most 
common hospital-acquired infection pathogen (~500,000 infections annually with up to 
30,000 deaths in the US) and antibiotic prescribing for other infections (such as MRSA) 
can be a risk factor for C. difficile infection; conversely treatment with the recommended 
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vancomycin protocol has been shown to lead to our third Gram-positive pathogen of 
concern (McDonald et al., 2018).  
The third Gram-positive pathogen we cover in this review, of increasing concern as a 
hospital-associated pathogen, is vancomycin-resistant Enterococcus (VRE). While not 
credited with the same degree of pathogenicity as MRSA or C. difficile, VRE causes 
infections in vulnerable patients, including outbreaks that are difficult to control due to 
its resistance to routine cleaning. All three important Gram-positive pathogens are able 
to survive in the environment for days to months and have low infectious doses—as low 
as 5 spores (C. difficile) or 4 CFUs (MRSA)— where inadequate environmental 




2.4 The Hospital Environment   
 
The Hospital Built-Environment 
Critical to a One Health approach is the role of the environment, including the unique 
characteristics of the built environment. The built environment is defined as the 
infrastructure created by people for spaces where they live and work, with consideration 
for how physical properties of these buildings influence health (Dannenberg & Capon, 
2106). The hospital environment can facilitate transmission of pathogens responsible for 
HAIs. The inanimate environment can be a MDRO reservoir (Mills, 2015; Rock et al., 
2018), with environmental contamination responsible for approximately 10–30% of 
patient MDRO acquisitions (Anderson et al., 2017).  
Table 1 summarizes select key studies on the role of the hospital environment in MDRO 
and other pathogen transmission. Contamination of high-touch surfaces with MDROs 
such as methicillin-resistant Staphylococcus aureus (Knelson et al., 2014; Lei et al., 
2017), vancomycin-resistant Enterococcus (Knelson et al., 2014; Ray et al., 2002), and 
Clostridioides difficile (Sitzlar et al., 2013; Weber et al., 2010) for prolonged time periods 
has been well documented, and thus can serve as a potential reservoir for onward 
infections to patients and healthcare workers. Multiple studies have shown that there is 
higher HAI risk for patients who are in rooms that were previously occupied by an HAI-
positive patient, even after routine cleaning and disinfection (Huang et al., 2006; 
Mitchell et al., 2015; Shaughnessy et al., 2011). 
Aspects of the hospital’s built-environment and design, including different surface 
materials, can influence microbial transmission. Plipat et. al. showed that MRSA may 
more easily and in higher burden contaminate porous surfaces, but when those 
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contaminated porous surfaces are touched by patients or healthcare workers they are 
less likely to transfer MRSA compared with non-porous surfaces (Plipat et al., 2013). 
Another example of hospital design is private versus open shared rooms. A review of 
over one million inpatient records from 335 US hospitals found a 10% increase in private 
rooms was associated with an 8.6% overall decrease in hospital-associated catheter 
infections (O’Neill et al., 2018; Stiller et al., 2016). Other hospital level risk factors for 
patient HAI acquisition include larger hospital size and higher patient density and 
clustering (Archibald et al., 1997; Davis et al., 2017a; Dickstein et al., 2016; Gohil et al., 
2015; Ray et al., 2016; Sousa et al., 2018). Hospitals that are highly connected to one 
another through a shared health-care system or through a referral system have more 
patient MRSA bacteremia incidence rates (partial correlation coefficient r = 0.33 (0.28 to 
0.38)) (Donker et al., 2012; Gibbons et al., 2016). Another key hospital design 
consideration is hospital-acquired pathogen strains may enter into the community 
through improperly treated hospital wastewater effluent, including MRSA and VRE 
(Hocquet et al., 2016), although discussion of this topic is beyond the scope of this paper. 
Hospital Fomites 
Inanimate objects within the hospital can frequently become contaminated with 
pathogens and serve as sources for contamination and potential colonization for 
individuals who come in contact with them. These important fomites can travel between 
hospital rooms and patients, serving as a mechanical vector in pathogen spread. Nearly 
any item in contact with skin can serve as a fomite in pathogen transmission, from 
wearables like white coats and ties to pens, medical devices, and mobile telephones. 
Hospital objects have been extensively sampled for pathogen carriage and colonization, 
with prevalence rates as high as 55% for stethoscopes, 52% for neckties, and 50% for 
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rings (Haun et al., 2016). Concise reviews of the major reservoirs have been published 
previously by the Centers for Disease Control and Prevention’s “Guidelines for 
Environmental Infection Control in Health-Care Facilities” (Centers for Disease Control 
and Prevention., 2003) and in the International Society for Infectious Disease’s “A Guide 
to Infection Control in the Hospital” (International Society for Infectious Disease, 2018). 
Other possible dissemination routes for pathogens, including. S. aureus and C. difficile, 
is airborne dispersion (Best et al., 2010; Gehanno et al., 2009; Roberts et al., 2008), 
promoting spread among the hospital environment and individuals.   
The Hospital Microbial Ecosystem 
However, human exposure to resistant pathogens occurs in the context of microbial 
ecosystems, and the hospital built environment can be a source for a number of other 
microorganisms that are less often pathogenic but can serve as potential reservoirs of 
resistant genes.  A hospital microbiome can harbor a diverse set of antimicrobial 
resistance genes that are extremely relevant to human health, and these ultimately could 
be reflected in HAI rates. For example, there is evidence for frequent horizontal transfer 
of the mobile genetic element Staphylococcal Cassette Chromosome mec (SCCmec) gene, 
which encodes for methicillin resistance, between S. aureus and coagulase-negative 
Staphylococcus (Otto, 2013). Coagulase-negative staphylococci are not traditionally 
regarded as pathogenic, but share the same ecological niche in the human anterior nares, 
leading to the opportunity for horizontal gene transfer (Otto, 2013). Understanding other 
potential sources of antimicrobial-resistant genes is fundamentally important in 
combating and understanding MDRO epidemiology. Bacterial diversity also varies 
among different hospital areas – it has been shown that the halls, living rooms, patient 
rooms, and rest rooms exhibit more diverse bacterial compositions than that of the 
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isolated ICU (Lax & Gilbert, 2015). Different ICU management practices, including more 
rigorous sanitation protocols, could exert selective pressure and foster survival of 
microorganisms that express genes for resistance to common disinfectants and 
antimicrobial agents (Christoff et al., 2019).  
Within the hospital built-environment, humans are a predominant source of colonizing 
microbes. Researchers found that bacteria in a patient room resembled the skin 
microbiota of the patient occupying the room and became more similar throughout the 
patient’s stay (Brooks et al., 2014). Additionally, they reported that patients acquire 
microorganisms that were present in the room before patient admission, indicating 
transfer both ways between patients and the hospital environment of all 
microorganisms—not just pathogens (Brooks et al., 2014). This means that patients and 
hospital workers likely alter the hospital’s microbial composition in the specific areas 
they occupy, resulting in unique micro-environments within the larger hospital. While 
this currently is an understudied research area, a better understanding of how 
microorganisms colonize, persist, and change in the hospital environment has the 
potential to elucidate major infection sources beyond attempts to focus on specific 




2.5 Human Factors  
 
Patient Characteristics  
Human factors are critical when assessing One Health in hospitals in the context of HAI 
transmission. According to some estimates, 5–10% of patients will develop an infection 
while in the hospital (Yokoe & Classen, 2008). Multiple studies have shown that around 
10% of patients who enter hospitals are asymptomatically colonized with at least one 
type of MDRO, emphasizing the substantial influx of MDRO from community settings 
into the hospital (Chen et al., 2019). A mathematical model of hospital pathogen spread 
showed that increasing the patient MDRO prevalence at admission to 12%, or doubling 
the average length of hospital stay, almost tripled the predicted overall prevalence of 
MDRO-colonized patients within the hospital (D’Agata et al., 2012). Established factors 
associated with increased risk of nosocomial infection include prolonged antimicrobial 
therapy, comorbidity with chronic health conditions, compromised immune function, 
and close proximity to other patients infected or colonized with an MDRO (Xue & Gyi, 
2012). Higher patient density, from both higher influx or longer length of patient stay, 
can increase direct contact rates between patients which could increase the probability of 
direct transmission of MDRO. In addition, because patients shed bacteria into their local 
environments, patient density can also increase contamination of the environment and 
environmental fomites, thereby increasing the indirect transmission of MDRO (Xue & 
Gyi, 2012). An increasing reservoir of MDRO through increases in patient admission or 
length of stay is important to address when assessing the efficacy of infection control 
interventions. If the reservoir of MDRO increases, then the benefits of preventive 
strategies may be minimized. Studies have shown higher prevalence of HAIs in hospitals 
within more densely-packed urban centers, hospitals in lower socioeconomic 
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neighborhoods, and hospitals in communities where the majority of residents are racial 
and ethnic minorities, independent of hospital risk factors (Bagger et al., 2004; David & 
Daum, 2010; Klevens et al., 2007; Morin & Hadler, 2001). 
Patients are often prescribed antibiotics as part of their hospital care, occasionally 
untargeted and unnecessarily, as published reports have estimated that 23%-46% of 
antibiotic prescriptions are inappropriate (Buehrle et al., 2019; Fleming-Dutra et al., 
2016; Gonzales et al., 2001; Lim et al., 2020; Ray et al., 2019; Sharland et al., 2019). This 
widespread antibiotic use places selective pressure on bacterial ecosystems, enhancing 
survival of bacteria with resistant genes. Such pressure has been shown to affect 
horizontal gene transfer rates between bacterial species (Davies & Davies, 2010). While 
most hospitals have antimicrobial stewardship programs that implement guidelines for 
judicious antimicrobial use, often antibiotic use is critical to patient care.  This often 
creates an environment that is conducive to the persistence of resistant pathogens. It has 
been well-documented that selective pressure from antimicrobials increases the MDRO 
bacterial load colonizing patients, and that the higher bacterial load leads to greater 
patient skin and hospital environmental contamination (Donskey, 2013). Conversely, the 
absence of selective pressure from antimicrobials results in lower MDRO bacterial loads 
and leads to a lower likelihood of skin and environmental contamination (Schinasi et al., 
2013). The genes from resistant bacteria can spread to the hospital environment and 
other individuals in the hospital, then spread to the greater community. Cycling of such 
strains from the community can be another route for re-entry into the hospital. 
Role of Healthcare Workers 
A primary transmission route of hospital-associated pathogens for patients is through 
contaminated healthcare workers (HCW). Thirty to forty percent of HAIs may be spread 
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by contaminated healthcare worker hands—hands that were contaminated either from 
direct contact with infected or colonized patients, or from their environment (Weber et 
al., 2010). Even without direct patient contact, healthcare workers can serve as vectors 
and spread pathogens between environmental surfaces throughout the hospital 
(Creamer et al., 2010). A meta-analysis and systematic review calculated that the pooled 
MRSA prevalence among HCW in non-outbreak settings was 4.4% (95% CI, 3.98%-
4.88%), with nursing staff at increased risk for MRSA carriage; nursing staff had an odds 
ratio for MRSA colonization of 2.58 (95% CI 1.83-3.66) when compared with other 
healthcare staff (Dulon et al., 2014). While contamination is typically found on HCW 
hands, other wearable fomites, such as stethoscopes, digital devices, white coats, and 
neckties, can commonly be contaminated with bacterial pathogens including MRSA 
(Bearman et al., 2014; Haun et al., 2016). Studies have concluded that pathogen 
transmission from colonized patients to HCW gowns and gloves is substantial, 
particularly for those whose job duties involve high contact activities (Roghmann et al., 
2015).  
In addition to the potential role HCWs play as vectors, increasing the risk of colonization 
and infection to patients, there is also the occupational safety concern for infection to the 
workers themselves. Hospital employees serve a critical function in society; a decreased 
labor force due to illness from infectious disease can have detrimental economic 
consequences (Lui et al., 2018). In a 10-year study across Dutch hospitals, there were 17 
reported MRSA outbreaks: 13 outbreaks involved HCWs, and in 8 cases HCW acquired 
MRSA infections despite following the current safety precautions, showing that HCWs 
are at risk as much or more so than the patients during these outbreak situations (Blok et 
al., 2003). Other occupational safety conditions, such as elevated stress, poor 
supervision and leadership, and weak communication networks, can increase 
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nosocomial pathogen spread (Stock et al., 2016). Increased patient density and 
overcrowding combined with understaffing may lead to failure of MRSA control 
programs through decreased HCW hand-hygiene compliance, increased patient and staff 
movement between hospital wards, and overburdening of screening and isolation 
facilities (Clements et al., 2008). Subsequently, high MRSA incidence leads to increased 
inpatient length of stay, which can exacerbate conditions of overcrowding and foster a 
feedback loop that perpetuates HAIs (Clements et al., 2008). Similar to patients, HCWs 
could play a more active role in community transmission due to the greater frequency of 
hospital exposure, although this hypothesis has not been tested.   
In addition to patients and HCWs, a hospital receives many daily visitors who contribute 
to the microbial composition of the hospital environment. It is estimated that the 
prevalence of pathogen colonization, including Community-Associated MRSA (CA-
MRSA), in healthy asymptomatic individuals ranges from 0.2 to 7.4% (Casey et al., 2013; 
Kim et al., 2018b; Turner et al., 2019). These studies showing higher prevalence rates in 
community visitors compared to common patient or HCW carriage rates may be partly 
due to success of infection prevention and control policies such as environmental 
cleaning and hand hygiene compliance in HCW and patients (DeLeo et al., 2010). Of 
note, individuals who visit the hospitals may be there for contractual service, such as for 
deliveries. Because these individuals are not considered employees of the hospital, they 
may not be as well trained on infection control measures nor may be subject to the 
infection control policies and practices that are job requirements of hospital-employed 




2.6 Animals in the Hospital 
 
The final aspect of One Health that has received less attention in the context of hospital-
associated pathogen control is the roles of animals. Table 2 summarizes selected studies 
that describe the relationship between humans and animals in the spread of infectious 
diseases. Animals are potential sources of pathogens, including ones commonly 
considered nosocomial, which can spread to humans. It has been documented in 
multiple studies that MRSA strains found in companion animals such as dogs and cats 
are identical to epidemic strains found in human hospitals (Leonard et al., 2006; Malik 
et al., 2006; O’Mahony et al., 2005). There are many ways that animals, and their 
corresponding and unique microbial ecosystems, can positively and negatively enhance 
transmission of infectious pathogens. Exposure to animals, from pets in the home to 
farm animal exposure, can increase an individual’s overall microbial diversity, which can 
then be protective against colonization of opportunistic pathogens (Bai et al., 2016; 
Hogan et al., 2019; Zipperer et al., 2016). This balance of being both a supply and 
deterrent of human pathogen colonization is the reason why animals are so essential to 
examine in any context, including the hospital environment. Our understanding 
regarding direction of transmission, colonization persistence, animal-human 
transmission rate, animal carriage and inter-species transmission risk factors, and the 
significance of companion animals as reservoirs for human pathogens are all incomplete.  
Pets in the Home  
There have been numerous examples of microbial sharing between people and their pets 
in the household, and pet ownership is a risk factor to acquire, maintain and spread 
potential pathogenic bacteria. For example, Ferriera et. al. found, in 49 MRSA-infected 
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outpatients households, 4 cases of MRSA colonization in companion animals (8.2%), 3 of 
which shared PFGE patterns from their owners, and no MRSA positive pets in the 
negative human control households (Ferreira et al., 2011). That study also found a 
human who was infected with MRSA resided with a dog colonized with methicillin-
resistant Staphylococcus pseudintermedius, a common veterinary pathogen in 
companion animals that occupies a similar niche as S. aureus and causes similar disease 
conditions in animals. It was hypothesized that SCCmec could have transferred between 
the related bacteria (Ferreira et al., 2011). Another study found similar findings; one of 
the 8 (12.5%) study households of MRSA-infected humans contained a MRSA-positive 
pet; conversely they also evaluated human colonization in homes with a MRSA-carrier 
pet and determined that over 25% (6/22; 27.3%) owners were MRSA-positive (Faires et 
al., 2009). This higher association of pathogen carriage for humans and pets in the same 
households, and the identification of indistinguishable MRSA isolates in both pets and 
humans in contact with them, strongly suggests interspecies transmission but it does not 
indicate the direction of transmission. However, given the preponderance of common 
human MRSA clones in household pets, it is possible that animals become contaminated 
through contact with colonized or infected humans and that they in turn serve as a 
source of re-infection or re-colonization (Harrison et al., 2014). Given that pets may clear 
carriage or contamination with removal from infected owners, veterinary guidance 
recommends contact isolation for household pets in the case of recurrent MRSA 
infection among humans in the household (Morris et al., 2017).  
Pets in the Hospital  
Animals can contribute to the hospital microbial ecosystems by directly entering the 
hospital. A patient may require a service animal, which according to the Americans with 
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Disability Act, have the legal right to enter the hospital. Therapy animals are employed in 
many healthcare settings and may visit multiple patients and visitors during their time in 
the hospital. Therapy animals are particularly important because they can visit multiple 
patients, multiple wards, and even multiple hospitals all within the same day (Dalton et 
al., 2018; Lefebvre et al., 2008a), indicating their potential as an effective mechanical 
vector in the spread of pathogens. Finally, some hospitals allow for periodic or routine 
visits from patients’ personal pet(s) during inpatient care; in a survey of 337 SHEA 
member hospitals, 121 (36%) healthcare facilities allowed personal pet visitations, of 
which 7 (5.8%) did not have formal guidelines in place (Murthy et al., 2015). In addition, 
resident animals in healthcare facilities have been known to be vectors of hospital-
pathogens, such as the case reports of a cat residing in a geriatric rehabilitation ward, or 
a nurse’s visiting pet dog that were implicated as the sources of MRSA outbreaks (Cefai 
et al., 1994; Scott et al., 1988). Since then, few studies have evaluated zoonotic disease 
carriage of therapy animals living in or entering the hospital. Lefebvre et. al. found that 
80 out of 102 (80%) asymptomatic therapy dogs who visited hospitals had a zoonotic 
pathogen positive fecal sample. The primary pathogen was C. difficile, which was 
isolated from 58 (58%) fecal specimens; 71% (41/58) of these were toxigenic and many 
were genotypically indistinguishable from the major strain implicated in ongoing 
outbreaks of highly virulent human C. difficile acute disease (Lefebvre et al., 2006a, 
2006c). The group also identified that acquisition rates of MRSA and C. difficile were 4.7 
and 2.4 times higher, respectively among therapy animals compared to household dogs, 
indicating their increased contact with hospitals could increase exposures to HAIs, 
similar to human risk factors (Lefebvre et al., 2009). Service animals, therapy animals, 
and personal pets will have different exposures, and thus have different microbial 
compositions. Just as patients can bring microbes into the hospital from the community, 
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animals can also serve as a vector between the hospital and community, and their unique 
microbial ecosystems could impact this vector function.  
Food Animals 
In addition to household pets, food animals, such as beef and dairy cows, poultry, and 
swine, each have unique microbial compositions and can influence pathogens circulating 
in the community and the hospital. Although the use of healthcare-prescribed 
antimicrobials in humans is an important risk factor in MDRO colonization in the 
population and environment, the use of antimicrobials in food animal production also 
contributes—at times substantially—to the reservoir of resistance (Silbergeld et al., 
2008). Medically important antimicrobial drugs may be used in food animal production, 
as well as companion animal practice, contributing to selection for and emergence of 
pathogens resistant to specific drugs, including those of critical importance to human 
medicine. Food animal uses of antimicrobial drugs can influence the hospital 
environment indirectly via MDRO-contaminated meat or other food products, indirectly 
via exposure of community members who live in proximity to agricultural production, 
and directly via animal contact. For example, in a study matching MRSA-colonized 
incoming patient cases to non-colonized control patients, cases had over 4 times higher 
odds of living near swine-rearing facilities (Schinasi et al., 2014). Another study found 
that MRSA carriage in HCWs in contact with livestock is 10-fold higher than in other 
HCWs (Wulf et al., 2008). Similarly, patients exposed to pigs or veal calves in Denmark 
were shown to have three times higher incidence of MRSA colonization (van Rijen et al., 
2008). Finally, in another study, 373 (9.7%) patients coming from a high-density 
farming region were MRSA-positive, which is similar to what is found in other non-rural 
settings, but 292 (78%) had livestock-associated MRSA strains rather than HA- or 
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general CA- strains (van de Sande-Bruinsma et al., 2015). For more detail, other reviews 
have been published which discuss the role of livestock and food agriculture operations 
in the spread of community pathogens (Goerge et al., 2017; McEwen & Collignon, 2018; 




2.7 Interventions to Reduce Exposure 
 
The challenge of complex microbial and pathogen inputs from community sources to the 
hospital environment—and the pathogen dynamics among individuals who are treated, 
visit, and work within this setting—requires an integrative perspective to design 
interventions to reduce the risk of human exposure, colonization, and infection. 
Therefore, focusing on individuals by themselves or a single type of MDRO may provide 
incomplete answers. Microbes, including pathogens, circulate between the hospital 
environment and the larger community, with individuals and animals serving as 
mechanical vectors. Most interventions are designed to target only one sector, but 
multimodal strategies may be more successful to break this cyclic feedback loop. 
Addressing the hospital environment and animal sectors can reduce human exposure of 
microbes and pathogens, and human-focused interventions can reduce colonization risk. 
We will discuss interventions within each One Health domains, as shown in Figure 3, 
and their effectiveness to address community-level factors and patient infectious 
outcomes. For this review, effective interventions are defined as those which reduce or 
nullify exposure or colonization risk yet are feasible to implement in a clinical setting, 
using the CDC NIOSH’s (National Institute of Occupational Safety and Health) 
Hierarchy of Controls as a strategy for ranking the effectiveness of interventions, as 
shown in Figure 4, where those grouped in the top of the graphic are potentially more 
effective and protective than those at the bottom. For MDRO control, elimination or 
substitution, the most effective forms of prevention against hazards would equate to 
elimination of the source of pathogen, such as creating policies that control animals into 
the hospital, thus limiting the risk of “sick” animals potentially carrying zoonotic MDRO 
into the hospital. Engineering and administrative controls, such as changing hospital 
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design or altering hospital safety culture, can be effective but do not nullify the exposure 
hazard. Personal protective equipment (PPE), such as gloves and gowns, are the most 
simplistic form of control measures, as they rely heavily on human motivation and are 
prone to human error, so should not be the sole means of infection control, as evident by 
multiple studies showing variance in PPE compliance (Ganczak & Szych, 2007; Harrod 
et al., 2019; McGovern et al., 2000; Michalsen et al., 1997). 
Hospital Interventions 
Interventions targeted at the environmental sector have been shown to have downstream 
benefits on the microbial carriage and colonization of humans (Dancer, 2009; 
Dettenkofer et al., 2004; Sitzlar et al., 2013). In the literature, interventions targeting the 
hospital environment are centered on “hands-on” manual cleaning/disinfection 
protocols and “no-touch” decolonization technologies and isolation through facility or 
administrative design or through other engineering controls. Cleaning with detergents 
has been shown to reduce MRSA levels that exist in the healthcare environment; 
however, detergents can be inferior at killing microbes compared to disinfectants, and 
cleaning products can become contaminated, furthering the spread of pathogens in the 
hospital (Dharan et al., 1999; Rutala & Weber, 2001). Disinfectants, while shown to 
decrease bacterial burden on a surface, can also release toxic fumes and can cause 
allergic and hypersensitivity reactions in HCW, which may limit the feasibility of 
increased use (Quinn et al., 2015; Rutala et al., 2008). Cleaning activities are behaviors 
and therefore may be more effective when monitored, either by direct observation, which 
is relatively easy and inexpensive but susceptible to human error, or with fluorescent 
markers, which offer an objective assessment of residual contamination after cleaning 
(Hota et al., 2009; Snyder et al., 2013). A number of studies suggest that targeted 
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cleaning focused on highly-touched common fomites is more effective than general 
cleaning, not only in efficacy of actual decontamination but also in effectiveness, since 
this intervention is feasible to implement frequently (Lei et al., 2017; Plipat et al., 2013). 
However, there are limitations to typical cleaning procedures. Microbial properties of 
organisms, including biofilm development, can make them more resistant to detergents, 
and even common disinfectants (Pidot et al., 2018; Vickery et al., 2012). A randomized 
controlled study that evaluated increasing daily cleaning frequency and targeted 
disinfection showed only modest decreases in patient VRE infections (relative risk 0.63, 
95% CI 0.41–0.97, p=0.034), and no changes in the incidence of S. aureus bacteremia 
(RR 0.82, 0.60–1.12, p=0.22) or C. difficile infection (RR 1.07, 0.88–1.30, p=0.47) 
(Mitchell et al., 2019). This indicates that cleaning itself is imperfect, possibly prone to 
human error. This is best captured in a natural experimental study by Vietri et. al., which 
found that a hospital move and adoption of radical new cleaning procedures did not 
result in a statistical decrease for MRSA colonization rates in patients and HCW (Vietri 
et al., 2004). 
“No-touch” technologies include decolonization strategies that may be less prone to 
human error. These include UV irradiation, which has been shown to be effective as a 
terminal disinfectant process after initial cleaning preformed to remove debris, but was 
seen to vary substantially based on location in a room relative to the UV device (Boyce et 
al., 2016; Rock et al., 2016). In addition to patient isolation rooms, aspects of the 
hospital built-environment design can contribute to infection control. Chiefly, certain 
surface materials have antimicrobial properties, although these have been found to be 
variable (Chyderiotis et al., 2018). Kim et. al found that the use of titanium dioxide-
based photocatalyst antimicrobial coating on common environmental touch surfaces 
significantly decreased MRSA acquisition rates in hospital patients (hazard ratio of 
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contracting hospital-acquired pneumonia during the intervention period compared to 
baseline period: 0.46; 95% confidence interval 0.23–0.94; p = 0.03) (Kim et al., 2018a). 
Other no-touch environmental interventions include aerosolized hydrogen peroxide 
vapor, HEPA-filtration systems, and negative-pressure rooms, which minimize 
aerosolized microbes and have been shown to be effective against MRSA and C. difficile 
(Boswell & Fox, 2006; Falagas et al., 2011; Farbman et al., 2013). If utilized, it is 
recommended these strategies are used as adjuncts to best cleaning and disinfection 
practices. Unanswered questions remain – when to use disinfectants versus detergents, 
when to focus on no-touch decontamination processes versus hands-on manual cleaning, 
and how best to monitor interventions and measure their effectiveness. 
Human Interventions 
Human-centered interventions reported in the literature have focused primarily on 
hygiene: patient decolonization, HCW hand hygiene, and wearable fomites 
decontamination. A meta-analysis evaluating patient washing with chlorhexidine 
washcloths and wipes in a hospital setting identified a total HAI rate reduction (odds 
ratio (OR): 0.74; 95% confidence interval (CI): 0.60-0.90; p = 0.002), although studies 
had moderate heterogeneity (I(2) = 36%) (Afonso et al., 2013). This effect was more 
evident in the Gram-positive subgroup (OR: 0.55; 95% CI: 0.31-0.99; p = 0.05) (Afonso 
et al., 2013). HCW hand-hygiene campaigns are a major component of multi-faceted 
infection control interventions, and a separate meta-analysis showed it had the strongest 
effectiveness for reducing nosocomial infection rates (median effect 49%, effect range 
12.7–100%) compared to other interventions (Murni et al., 2013). However, hand-
hygiene campaigns alone had a modest effect size. Other facets of a bundled infection 
prevention and control bundle include antibiotic stewardship, another key pillar of 
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human-centered infection control (Murni et al., 2013). Part of this may be due to the 
imprecise relationship between HCW’s risk perceptions and how these perceptions affect 
their use of risk-mitigating strategies. In fact, demographic, individual and 
organizational factors, including management structures, were found to influence risk 
perceptions and HCW’s adoption of infection control strategies (Murni et al., 2013). 
Studies that have evaluated reasons for this disparity and ways to improve behavior to 
prompt adequate hand-hygiene protocol addressed determinants of knowledge, 
awareness, action control, and facilitation of behavior. Fewer studies addressed social 
influence, attitude, self-efficacy, and intention, but the study authors found that 
addressing combinations of different determinants showed better results (Huis et al., 
2012). Increased surveillance and targeted interventions against those colonized have 
been shown to be effective in some circumstances (van Rijen & Kluytmans, 2009; van 
Trijp et al., 2007).  However such strategies have not been sufficient to control outbreaks 
in other situations (Kurup et al., 2010; Peterson et al., 2010; Pierce et al., 2017) and are 
generally not recommended due to the high resource burden (Weber et al., 2007). 
Contact precautions and isolation of patients known to be colonized with target 
pathogens has also been shown to be effective, although this is not a substitute for proper 
hygiene protocols (Mangini et al., 2007). 
A recent advance in human-centered interventions is the adoption of human factors 
engineering, which is a discipline that studies the capabilities and limitations of humans 
and the design of devices and systems for improved performance. In the context of 
hospital infection control, this deals with designing spaces and opportunities for 
individuals to avoid exposure and colonization to pathogens, a form of administrative 
control. This has the potential to identify major underlying causes and contributors to a 
problem. It goes beyond education and training, which are often the focus of infection 
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prevention interventions, to modify an individual’s context so that default decisions align 
with healthy and desired actions. It utilizes environmental design, such as handwashing 
or antiseptic alcohol stations at the exits of patient rooms and one-way human traffic 
flows, in a way that minimizes exposure to healthcare workers and other patients to 
effect downstream reductions in the contamination of other hospital surfaces and 
individuals (Stiller et al., 2016). This relies heavily on proper leadership for both 
implementation and oversight. Human factors engineering systems models with audit 
and feedback, when applied, can increase effective room cleaning and disinfection, 
decreasing bacterial bioburden in the patient room (Rock et al., 2019a, 2019b). An 
example of this is the addition goal setting and HCW engagement, resulting in a hospital 
safety climate, was associated with improved compliance (pooled odds ratio 1.35, 95% 
confidence interval 1.04 to 1.76; I(2)=81%) compared to the standard of training and 
education, observation and feedback, and reminders (Luangasanatip et al., 2015). 
Animal Interventions 
Just as animals have not been extensively examined in their role as vectors of pathogens 
and other microbes, there are also few studies on interventions in animals in either a 
hospital or community setting. Just as intervention programs focus on hand hygiene 
protocols in HCW because of their role as vectors of hospital-associated pathogen 
transmission between patients and the hospital environment, therapy and service 
animals may also fill a similar niche, but infection control programs that target animals 
in healthcare settings are lacking (Murthy et al., 2015). There are recommended 
guidelines for animals entering into the hospital environment (service animals, therapy 
animals, personal pet visitations) (Lefebvre et al., 2008a; Murthy et al., 2015), but the 
evidence of the recommended protocols’ effectiveness is based largely on extrapolation 
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from human data and many recommended interventions have not been validated in 
animals. Numerous documents on the control of MRSA in people have been published 
(Centers For Disease Control and Prevention, 2019; Dancer, 2014), and many of the 
principles may be applied to control in animals. However, caution should be exercised in 
extrapolating guidelines for MDRO control in people to animals because there may be 
significant differences in disease epidemiology (Morris et al., 2017; Weese et al., 2004). 
Because of their unique microorganism ecosystems and their role as an interactive 
fomite – a living moveable system independently interacting with individuals and its 
environment – controls focused on inanimate environmental surfaces may not be 
effective for animals that enter the hospital or such strategies may result in unintended 
effects.  
While antimicrobial stewardship in human medicine has been shown to decrease HAI 
prevalence in patients (Barlam et al., 2016), in a four-year study across Australia, the 
level of antimicrobial exposure in dogs and cats was less than half that for human 
exposure, and critically-important antimicrobials accounted for only 8% of all the 
antimicrobials prescribed over the study period (Yvonne et al., 2018), so improvement of 
judicious use of antimicrobials in companion animals may not yield many benefits in 
some settings. At present, no controlled studies have been conducted to provide data on 
key questions such as transmission between animals and humans in the hospital, and 
efficacy of decolonization procedures in animals. Further research is needed in 
interventions within this One Health domain. For future studies that adopt a One Health 
approach to evaluate transmission pathways to patients that involve consideration of 
human, animal, and environmental reservoirs, relevant checklists for study conduct and 




In this review, we have used a One Health framework to discuss the importance of 
addressing the hospital environment, the individuals who are treated, work, and visit the 
hospital, and the animals that directly and indirectly contribute microbial ecosystems, in 
the prevention and control of hospital-associated pathogens. Hospitals are located 
within human and animal communities, and the microbial ecosystems of the hospital 
can be influenced by community-level factors, from individuals who enter the hospital 
that serve as vectors in the spread of microbes, including pathogens, between the 
hospital and community. Animals who enter the hospital can also serve in this role and 
may have altered vector function based on their unique microbial composition, which 
will be different based on the role they serve (service animals vs. therapy animal vs. 
personal pet). Antimicrobial pressure in hospitals can be an incubator for MDRO; the 
cyclic loop between the hospital and community then will continue to foster resistant 
microbial ecosystems over time.  
We have examined current interventions targeted at the hospital environment and to the 
patients and HCW in the hospital, and the efficacy and drawbacks of each. It has been 
shown that the most effective intervention programs are multi-modal and designed to 
minimize individual pathogen exposure before such exposure progresses to colonization 
and infection. However, environmental decontamination and human hygiene practices 
decrease but do not eliminate the risk of colonization in other individuals and HAI rates 
seen in the hospital. A One Health approach may assist in the development of novel 
research and multi-modal intervention approaches by considering the relationship 
between the patient, the HCWs, and the hospital environment, and the role of the 
community. This includes known community-level risk factors for MRSA colonization in 
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patients, such as pet ownership or living in an animal agriculture community (Leonard et 
al., 2006; Malik et al., 2006; Rodrigues et al., 2018; van de Sande-Bruinsma et al., 2015).  
The largest knowledge gap this review exposed was the lack of data within the animal 
One Health domain. Little research has been done to explore pathogen transmission 
between animals and humans, within a home or hospital setting, and no studies have 
looked at the role of decontamination of the animal sector to see if this minimizes 
bacterial burden on the animal and has downstream effects on reduced transmission to 
individuals in contact. Compounding this is the need to understand microbial ecosystem 
dynamics in the context of hospital spread, particularly as such dynamics relate to 
microbial ecosystems unique to animals or humans, and how such ecosystems may even 
provide protection against the acquisition of pathogens through the sharing of 
potentially “beneficial” commensal microorganisms (Ege et al., 2011; Song et al., 2013; 
Trinh et al., 2018). 
Conclusions 
The complexities of hospital infection control deserve the joint focus of various 
disciplines. An integrated approach is needed to guide both research pathways and 
public policy mediations. Utilizing a One Health framework in this brief review allowed 
us to visualize key gaps in the current knowledge base surrounding hospital infection 
control and can help direct future research and implementation efforts by suggesting 
opportunities for advancement in non-traditional conduits.  
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2.9 Tables and Figures 
 
 
Table 1: Key Studies that Examine the Role of Environment in Patient 
Infectious Disease Outcomes 
Relation Organism Comments Reference 
Increased Acquisition 
ENV -> Patient MRSA Outbreak of MRSA in hospital that lasted two years 
was found in hospital dust with the same genotype. 
(Rampling et 
al., 2001) 
ENV -> Patient Not specific Patients assigned to shared bay rooms had a 21 
percent greater relative risk of a central line 
infection (p = 0.005), compared with patients 
assigned to private rooms. At the hospital level, a 
10% increase in private rooms was associated with 
an 8.6% decrease in central line infections 
(p<0.001), regardless of individual patients' room 
assignment. 
(O’Neill et al., 
2018) 
ENV -> Patient MRSA Three of 26 patients who acquired MRSA while in 
the intensive care unit acquired MRSA from the 
environment; strains from the patients and their 
immediate environment were indistinguishable 
(Hardy et al., 
2006) 
ENV-> HCW VRE Contact with contaminated surfaces in the rooms of 
colonized patients results in transfer of VRE to 
gloved hands, despite cleaning with disinfectants 
(Ray et al., 
2002) 
ENV -> HCW C. difficile Increasing levels of environmental contamination 
was positively associated with increasing amounts 
of C. difficile on the hands of healthcare workers, 
particularly for environmental sites that patients 
touch 
(Verity et al., 
2001) 
Patient -> ENV C. difficile Surfaces in rooms exposed to a C. difficile patient 
had significantly increased odds of being 
contaminated with C. difficile, compared to 
surfaces in unexposed patient rooms 




MRSA Two-thirds of staff enter a room containing an 
MRSA patient will acquire the patient’s strain on 
gloved hands or apron, even without touching 
patient directly (40%) 
(Boyce, 2007)  
Patient -> 
Patient 
MRSA, VRE Admission to a room previously occupied by an 
MRSA-positive patient or a VRE-positive patient 
significantly increased the odds of acquisition for 
MRSA and VRE. 




C. difficile Prior room occupant with CDI was a positive risk 
factor for new patient CDI acquisition, hazard ratio 
2.35 p = .01 
(Shaughnessy 







Pooled acquisition odds ratio of 2.14 (95% 
confidence interval (CI), 1.65e2.77) for several 
bacteria from prior occupants, Gram positive 1.89 
(95% CI: 1.62–2.21) 
(Mitchell et al., 
2015) 
Patient -> ENV 
-> HCW 
MRSA In the colonized patient’s room, HCW exposure 
occurred more predominantly through the indirect 
(patient to surfaces to HCW) mode compared to 
the direct (patient to HCW) mode. 
(Plipat et al., 
2013) 
Cleaning/Removal Reduces Human Acquisition 
ENV -> Patient MRSA Enhanced cleaning during an outbreak decreased 
the number of new affected patients, stopped 
outbreak, and saved an estimated £28,000. 
(Rampling et 
al., 2001) 
ENV -> Patient General Lower infection rates associated with routine 
disinfection of surfaces (mainly floors) 
(Dettenkofer et 
al., 2004)  
ENV -> Patient C. difficile Daily disinfectant high touch surfaces and 
dedicated cleaning staff reduced CDI positive 
cultures by 60% 
(Sitzlar et al., 
2013)  
ENV -> Patient C. difficile Hydrogen peroxide vapor decontamination 
reduced CDI rate by 37% 
(Manian et al., 
2013)  
ENV -> Patient VRE Hydrogen peroxide vapor reduced VRE by 80% (Passaretti et 
al., 2013)  
ENV -> Patient MRSA Reduction in acquired MRSA infections with 
enhanced targeted cleaning compared to routine 
cleaning, despite higher MRSA patient-days and 
bed occupancy rates during enhanced cleaning 
periods (P = 0.032: 95% CI 7.7%, 92.3%). 
Genotyping identified indistinguishable strains 
from both hand-touch sites and patients  
(Dancer et al., 
2009) 
ENV -> HCW VRE Decreasing VRE contamination of environmental 
surfaces decreases hand colonization of VRE and 
VRE acquisition rates 
(Hayden et al., 
2006) 
MRSA = methicillin-resistant Staphylococcus aureus, CDI = C. difficile infection, VRE = 






Table 2: Selected Studies on Potential Transmission of Pathogens between 
Humans and Animals in Various Settings 
Organism Comments Reference 
Ecological 
MRSA MRSA strains found in companion animals such as dogs and cats 
are identical to epidemic strains found in human hospitals 
(Leonard & 
Markey, 2008) 
MRSA Resistance patterns and genetic make-up of MRSA 
isolates from dogs and cats are generally indistinguishable from 
the most prevalent hospital-associated MRSA strains in the 
human population 
(O’Mahony et al., 
2005)  
MRSA Increase in companion animal MRSA, including MDRO, same 
clonal lines as CA&HA-MRSA 
(Couto et al., 
2016) 
MRSA Phylogenomic analyses showed that companion animal isolates 
were interspersed throughout the epidemic MRSA pandemic clade 
and clustered with human isolates from the United Kingdom 
suggesting a human source for isolates infecting companion 
animals 
(Harrison et al., 
2014) 
Pet Ownership 
MRSA Transmission of MRSA occurs between humans and companion 
animals and vice versa 
(Malik et al., 
2006) 
MRSA Identification of indistinguishable MRSA isolates in both pets and 
humans in contact with them 
(Baptiste et al., 
2005) 
MRSA MRSA was found in pets from MRSA-positive owners in 4/49 
(8.2%) vs. none of the pets of the 50 uninfected human controls. 
¾ of these pairs had concordant PFGE pattern 
 
(Ferreira et al., 
2011) 
MRSA MRSA-infected animal was initially identified, at least one MRSA-
colonized person was identified in over one-quarter (6/22; 27.3%) 
of the study households. By contrast, only one of the 8 (12.5%) 
study households of MRSA-infected humans contained a MRSA- 
colonized pet 
(Faires et al., 
2009) 
Enterococcus 76% of the isolates from companion dogs had belonged to 
hospital-adapted clonal complex, screening of 18 healthy humans 
living in contact with 13 of the dogs under study resulted in the 
identification of a single, intermittent carrier. This person carried 
one of the sequence types recovered from his dog 
(Damborg et al., 
2009) 
MRSA Identical strains from both pets and their owners were identified. 
Typical livestock-associated S. aureus lineages were observed in 
humans and/or companion animals and hospital and/or 




C. difficile PFGE patterns of some dog and human C. difficile isolates were 
over 90% similar 




MRSA 373 (9.7%) patients coming from a high-density farming area were 
positive for MRSA, 292 (78%) had livestock-associated MRSA 
strains and 81 (22%) non-LA-MRSA strains  
(van de Sande-
Bruinsma et al., 
2015) 
MRSA Patients exposed to pigs or veal calves were shown to have 3 times 
higher incidence of MRSA colonization  
(van Rijen et al., 
2008) 
MRSA MRSA carriage in HCWs in contact with livestock is 10-fold higher 
than in other HCWs 
(Wulf et al., 
2008) 
Hospital 
MRSA Dog was implicated as a reservoir for the re-infection of two 
nurses after their treatment to eliminate carriage of MRSA 
(Cefai et al., 
1994) 
MRSA Cat residing in a geriatric rehabilitation ward was implicated as 
the source of MRSA for nurses and patients 




Zoonotic agents were isolated from 80 out of 102 (80%) dogs who 
visit hospitals, primary pathogen was Clostridium [sic] difficile, 
which was isolated from 58 (58%) fecal specimens, Seventy-one 
percent (41/58) of these isolates were toxigenic 
(Lefebvre et al., 
2006c) 
 
MRSA Acquisition of MRSA by a pet therapy dog that had visited an 
elderly care ward in a healthcare facility 
 




Rates of acquisition of MRSA and C. difficile were 4.7 and 2.4 
times as high, respectively, among dogs that visited human 
health-care facilities, C. dif. 4% was toxigenic, MRSA hospital 
origin clone 
(Lefebvre et al., 
2009)  
C. difficile Canine fecal isolate from healthy dog who visits hospitals was 
indistinguishable from the major strain implicated in outbreaks of 
highly virulent CDAD, which were occurring at increased 
frequency in the facility around the time the dog’s fecal specimen 
was collected 
(Lefebvre et al., 
2006a) 
Veterinary Hospitals 
MRSA Cluster of five canine postoperative wound cases infected with 
MRSA were found to be associated with asymptomatic carriage of 
MRSA in one of the attending veterinary surgeons. The human 
and canine isolates were corresponded to the predominant 
epidemic strain prevalent in hospitals at this time 
(Leonard et al., 
2006) 
MRSA MRSA was isolated from 16% (14/88) of household contacts or 
veterinary personnel and in all 6 identified cases at least one 
human isolate identical to the initial animal isolate was found.  
(Weese et al., 
2006) 
MRSA Comparison of genetic markers shows that identical or very 
similar strains disseminate among animals and veterinary 
personnel. Companion animals harbor PVL-positive clones - 
Twenty-six pets and five veterinary personnel carried PVL-
positive S. aureus 
(Drougka et al., 
2016) 
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MR Staph Risk factors for nasal colonization by MRS in healthy humans: (i) 
being a veterinary professional (veterinarian and veterinary 
nurse) (p < 0.0001, odds ratio [OR] = 6.369, 95% confidence 
interval [CI, 2.683-15.122]), or have contacted with one MRSA- or 
MRSP-positive animal (p = 0.0361, OR = 2.742, 95% CI [1.067-
7.045] 
(Rodrigues et al., 
2018) 
MRSA One veterinary nurse, who carried Panton Valentine leucocidin-
positive ST338 MRSA, also owned a ST749 MRSP-positive dog 
(Worthing et al., 
2018) 
MRSA MRSA was isolated from 14 staff (17.9%), four dogs (9%), and 
three environmental sites (10%), which all had the same PFGE 
pattern. 
(Loeffler et al., 
2010) 
MRSA = methicillin-resistant Staphylococcus aureus, C. difficile = Clostridioides difficile, HCW = 
healthcare worker  
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Figure 1: Interaction of Humans, Animals, Hospital Environment, and the 
Community in Hospital-Associated Pathogen Transmission 
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Figure 3: Examples of Infection Prevention and Control Strategies within 






Figure 4: How Infectious Disease Intervention Strategies relate to the 
Hierarchy of Controls 
 
Legend: Adapted from the National Institute for Occupational Safety and Health (NIOSH, 
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The benefits of animal-assisted interventions (AAI), to utilize companion animals as an 
adjunctive treatment modality, is well-established and a burgeoning research field. 
However, few studies have evaluated the potential hazards of these programs, such as 
the potential for therapy animals to transfer hospital-associated pathogens between 
individuals and the hospital environment. Here we review the current literature on the 
possible risks of hospital-based AAI programs, including zoonotic pathogen 
transmission. We identified twenty-nine articles encompassing reviews of infection 
control guidelines and epidemiological studies on zoonotic pathogen prevalence in AAI. 
We observed substantial heterogeneity in infection control practices among hospital AAI 
programs. Few data confirmed pathogen transmission between therapy animals and 
patients. Given AAI’s known benefits, we recommend that future research utilize a One 
Health framework to evaluate microbial dynamics among therapy animals, patients, and 
hospital environments. This framework may best promote safe practices to ensure the 
sustainability of these valuable AAI programs.  
Keywords: Animal-assisted interventions; zoonotic infections; hospital-associated 
infections; hospital infection control 
Highlights:  
§ Despite the many benefits of animal-assisted interventions (AAI) for patients, 
there is a risk of therapy animals becoming vectors of hospital pathogens. 
§ There is an absence of literature on transmission of hospital pathogens between 
patients and therapy animals during an AAI session. 






The emotional benefits of human-companion animal relationships are well established 
in the scientific literature (Serpell, 1996). This concept has extended into the 
development of animal-assisted interventions (AAI), in which visiting animals 
participate as an adjunctive treatment in holistic patient care. AAI programs are 
increasingly popular in various healthcare settings and utilized for patients with widely 
diverse conditions, including mental health disorders and cancer. Research into the 
benefits of AAI continues to expand, with the many advantages of these programs 
supported by numerous epidemiological studies and meta-analyses that standardize and 
integrate these findings. These data support the hypothesis that AAI programs reduce 
patient stress, pain, and anxiety levels when incorporated into patients’ treatment plans 
(Bert et al., 2016; Kamioka et al., 2014; Lundqvist et al., 2017; Maujean et al., 2015; 
Serpell et al., 2017). 
However, infection control is a persistent problem in healthcare settings, both in routine 
care and in the use of complementary therapies. Similar to known fomites in hospitals, 
such as door handles and clinicians’ stethoscopes (Haun et al., 2016), therapy animals 
may unwittingly serve as mechanical vectors of hospital-associated pathogens, and 
contribute to the transmission of these pathogens between patients, or otherwise within 
the hospital environment. Patients can experience different levels of animal exposure 
from petting and licking, which can result in contamination of both the patient and the 
animal, thereby providing the opportunity for the spread of microorganisms (Lefebvre & 
Weese, 2009). Therapy animals also have the potential to introduce zoonotic pathogens 
directly into the hospital environment, for example, via the consumption of 
contaminated foods (Lefebvre et al., 2008b). Contamination by a pathogen could 
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potentially lead to pathogen replication and stable colonization; this is concerning not 
only for the possible risk of progression to infection, but also for the risk that the therapy 
animal may serve as a reservoir and spread these pathogens to the home and larger 
community (Enoch et al., 2005). Such perceptions of potential infection control 
challenges and resulting harm could limit the use of AAI programs and detract from 
their employment as a valid and valuable adjunctive therapy for patients. 
This review examines the current literature that focuses on potential hazards associated 
with hospital-based AAI therapy programs. We assessed both the breadth and quality of 
existing literature regarding infection control in AAI programs; these are discussed in 
the context of known and hypothetical pathways of microbial transmission. By 
identifying knowledge gaps, we provide focus for future research efforts and intervention 






This review utilized a more flexible search strategy in order to optimize capture of the 
peer-reviewed literature related to the risk of animal-assisted therapy. Multiple search 
approaches and terminology were employed to capture existing evidence relating to 
animal-assisted interventions for patients as a whole. Several unique terms can apply to 
AAI, such as animal-assisted therapy, animal-assisted activities, or pet therapy, therefore 
the search strategy was intentionally broad.  
The literature search on risks of animal use in hospitals was carried out using the 
following databases: PubMed, Scopus, Embase, Web of Science, CINAHL, and Cochrane 
Trials. The search was completed concurrently and independently by two of the authors 
(KRD, KBW), and the search strategy was framed using PICO (Population, 
Intervention/Exposure, Comparators, Outcomes) terms (Miller & Forrest, 2001). The 
Population was identified as healthcare-based AAI programs using any therapy animals, 
not just canines. The Intervention/Exposure and Comparators were kept flexible and 
were dependent on study design. The Outcomes were any potential hazards associated 
with AAI, particularly infectious disease, microbial, or biological risks. Study designs 
accepted for review remained flexible and included original epidemiological research, 
literature reviews, commentaries, and case-reports.  
Search Terms 
In collaboration with a librarian, we performed a systematic search using the terms listed 
below on the respective databases; search terms were adjusted according to individual 
database terminologies, and searches were restricted to title/abstract. We used the 
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following search strategy for the PubMed database: animal assist* OR pet assist* OR dog 
assist* OR pet therap* OR dog therap* OR animal therap* OR “animal facilitated” OR 
“pet facilitated” OR "therapeutic animal" OR "therapeutic animals" OR "therapeutic 
canine" OR "therapeutic canines" OR "therapeutic dog" OR "therapeutic dogs" OR 
[Animal Assisted Intervention MeSH Term]. Similar keywords were used to conduct 
searches within the other selected databases. 
Inclusion and Exclusion Criteria 
The articles identified from this broad search were then individually and independently 
screened by two of the authors (KRD, KBW), based on the title and abstract, for 
inclusion based on the following criteria: 
§ Did the article explain possible complications or hazards to either therapy 
animals or patients that can occur during a hospital AAI therapy session?  
§ Did the article describe an epidemiological study demonstrating the risk of 
animals within health care environments? 
§ Did the article provide novel commentary on current guidelines, or recommend 
new guidelines, for reducing associated risks of animals within healthcare 
environments? 
Articles that did not address any of the above criteria, or written in a language other than 
English, were excluded. Eligible studies underwent full-text review to further confirm 
eligibility (by KRD & KBW, arbiter MFD). After full-text review, references were 
examined to look for additional relevant articles that fit the inclusion criteria. We then 
extracted data from the selected studies on the research aims, study design, study 
population, exposure characteristics, type of intervention (if any), reported outcomes, 




Search Outcomes  
The initial database search returned a total of 5480 unique results (maximum number of 
returned articles from Embase), as shown in the flow diagram in Figure 1. After title 
and abstract screening of these articles, 110 were deemed potentially relevant based on 
the inclusion criteria. The remaining 5370 articles did not meet our prespecified criteria 
for inclusion, most commonly because the excluded articles evaluated the benefits of AAI 
programs on patient care. Upon full-text review of the 110 potentially relevant articles, 
86 articles were removed because they did not satisfy the inclusion criteria. An 
additional five articles were added after reviewing the reference lists of the remaining 
included papers. These five articles were not found in the initial database search because 
they were either 1) not located in the selected databases or 2) had improperly labeled 
keywords. A summary of the final 29 total articles reviewed can be found in Tables 1 
and 2. Thirteen articles were reviews or commentaries of current AAI guidelines that 
refer to therapy animals in healthcare settings, and sixteen articles were data-acquiring 
or epidemiological studies (6 cohort studies, 5 cross-sectional studies, 4 case reports, and 
1 ecological study). Most studies focused on therapy animals broadly or therapy dogs 
exclusively, but three studies included cats (Boyle et al., 2019; Coughlan et al., 2010; 
Sillery et al., 2004). 
Commentaries and Review Articles 
Of the 13 commentaries and reviews, there were a total of 7 commentaries and letters to 
the editors and 6 systematic or unstructured literature review articles. Four of the six 
reviews (Brodie et al., 2002; Cimolai, 2015; Guay, 2001; Sehulster & Chinn, 2003) and 
four of the seven commentaries (Disalvo et al., 2006; Khan & Farrag, 2000; Lefebvre et 
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al., 2008a; Murthy et al., 2015) focused on risks associated with infection control. The 
remaining articles primarily discussed AAI benefits, with only a brief mention of hazard 
reduction. Zoonotic infection and pathogen transmission were the primary hazards 
discussed, although some papers mentioned injury risk. One article, endorsed by the 
Society for Healthcare Epidemiology of America (SHEA), is the current source for the 
medical community on general guidance for animals in healthcare settings, both 
summarizing existing policies in hospitals and recommending practical directives to 
minimize risk (Murthy et al., 2015). In this article, the authors also acknowledge that this 
field remains insufficiently studied (Murthy et al., 2015). There was a consensus among 
the reviews and commentaries that with proper hospital infection control protocols in 
place, the risks associated with animal-assisted activities are minimized. All articles 
recommended using standardized regulations across healthcare facilities for infection 
control practices for patients and therapy animals. Three of the articles strongly 
recommended utilizing expert consultation in various animal and human health care 
fields, as well as environmental microbiology, to evaluate all possible routes of pathogen 
transmission (Chalmers & Dell, 2016; Disalvo et al., 2006; Waltner-Toews, 1993).  
Epidemiological Studies 
The three studies that surveyed hospital infection control policies demonstrated 
dissimilarities across hospitals. Among the combined 186 facilities surveyed, infection 
control policies regarding therapy animals varied, with 13% (Linder et al., 2017b; Murthy 
et al., 2015) to 90% (Waltner-Toews, 1993) of healthcare facilities having no existing 
standardized policies. Only 28% of facilities required documentation that the animal was 
healthy, and only 29% allowed solely registered therapy animals (Linder et al., 2017b). In 
addition to clinical practice policy discrepancies, animal handler knowledge of infectious 
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disease concerns and adherence to infection control policies varied across and within 
institutions. Lefebvre et al. found that 20% of 90 surveyed handlers did not practice any 
infection control and 40% of these handlers were unable to name one zoonotic disease or 
pathogen that may be transmitted by means of their dog, while Boyle et. al. found 
that 70% of their 40 handler respondents expressed no concerns regarding infectious 
disease transmission in AAI settings (Boyle et al., 2019; Lefebvre et al., 2006b). These 
institutional and individual discrepancies in AAI programs drive diversity in infection 
control practices both across and within healthcare facilities.  
Three studies reviewed electronic medical records to compare a change in the rate of 
diagnosed infections from AAI exposure. One study evaluated hospital-wide infection 
rates one year after the introduction of an AAI program in a pediatric hospital and, 
comparing these rates to the previous year, found no changes in overall infections or 
detected pathogens reported by the hospital’s infection control committee (Caprilli & 
Messeri, 2006). Another prospective cohort study followed 11 adult cardiac patients after 
receiving multiple AAI therapy sessions (average of 13 visits) and found no reports of 
infection in participants observed during the study period, but did not compare the AAI 
participants to a control group (Snipelisky et al., 2016). However, another electronic 
medical record review study identified eight newly-acquired infections two weeks post 
AAI therapy in nineteen pediatric oncology patients, but could not definitively attribute 
these infections to the therapy animal visit as there was no control group of hospitalized 
pediatric oncology patients not receiving AAI therapy (Chubak et al., 2017).  
The ten investigative epidemiological studies described cases of either animals or human 
patients becoming contaminated as a result of an AAI visit. The strongest weight of 
evidence was from prospective cohort studies in therapy animals (three studies, see 
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Table 1). Among these studies, the largest sample size was 200 therapy dogs, with most 
studies ranging from 10 to 20. In addition, the same group of investigators conducted 
most of these studies and utilized the same cohort of therapy dogs (Lefebvre et al., 
2006a, 2008b, 2009, 2006c; Lefebvre & Weese, 2009). These studies focused on 
zoonotic pathogen carriage in therapy animals, and detailed cross-sectional prevalence 
and longitudinal incidence. They observed asymptomatic carriage of both hospital-
associated and novel pathogens, such as methicillin-resistant Staphylococcus aureus 
(MRSA), Clostridium/Clostridioides difficile, Salmonella, Pasteurella, and intestinal 
helminths. This investigator group sampled therapy animals longitudinally over 12 
months, and detected incidence rate ratios for therapy dogs with hospital exposure 
compared to no hospital exposure of 4.7 for MRSA acquisition and 2.4 for C. difficile 
acquisition (Lefebvre et al., 2009). They also identified risk factors for acquiring or being 
colonized with these pathogens, such as a raw meat diet, being fed treats by patients, and 
licking patients. One of these studies uniquely sampled therapy animals’ human 
handlers for hospital-associated pathogen contamination before and after an AAI visit 
and demonstrated no contamination related to the AAI visit on the handlers’ hands 
(N=26) (Lefebvre & Weese, 2009). The five other epidemiological studies, not from that 
investigator group and study population, surveilled therapy animals and found a positive 
association between therapy visits and zoonotic pathogens. Two were case reports of 
zoonotic pathogens found in therapy animals (Enoch et al., 2005; Sillery et al., 2004). 
The three cohort studies found prevalence rates of zoonotic pathogen carriage in therapy 
animals of 11.8% (Boyle et al., 2019), 18.2% (Coughlan et al., 2010), and 24.3% (Gerardi 
et al., 2018).  
Unfortunately, all of these studies ignored assessment of the human patient, as well as 
assessment of other individuals involved in AAI, such as healthcare workers, visitors, 
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and, with the exception of the one study mentioned above, the therapy animal handlers. 
No studies evaluated the hospital environment as a source of pathogens, and the 
literature included scant data on the clinical health outcomes of the animals themselves. 
Furthermore, no studies systematically measured risk other than zoonotic 




While most of the literature currently available on animal-assisted interventions centers 
mainly on positive human psychosocial outcomes, there is an apparent lack of 
information and guiding data surrounding the potential infection control challenges to 
the inclusion of therapy animals in a healthcare setting. As evidenced by the relatively 
few and mostly small epidemiological studies discussed in this review (n=10), therapy 
animals can harbor hospital-associated pathogens, and while not validated in controlled 
research, these data are consistent with the hypothesis that animal contact with patient 
populations may increase the animal’s risk for contamination with pathogens. This is 
best evident in the study that showed therapy dogs that visit hospitals have almost five 
times higher odds of carrying MRSA as therapy dogs who visit other locations, such as 
schools (Lefebvre et al., 2009). Additional research is needed to investigate whether 
therapy animals can serve as pathogen vectors, from being contaminated by contact with 
one patient, and then transmitting these pathogens to another patient, leading to 
pathogen exchange. This is critical to test since many patients served by these therapy 
animals have a compromised health status and may be at higher risk of infection 
compared to the general population.  
While there are proposed guidelines published for AAI in hospitals, senior care facilities, 
and for individual animal therapy organizations, there are significant differences in 
infection control policies across these groups (Serpell et al., 2020). This can cause 
confusion among therapy animal handlers and individuals who participate in AAI 
programs and may be complicated by a lack of standardized, evidence-based standard-
of-care protocols that can be universally adopted. Current guidelines, including the 
SHEA guidelines, are based on biological plausibility and originate from hospital fomite 
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research and zoonotic transmission in other situations (pets in the home, etc.). Yet it is 
likely that therapy animals, with their unique exposures and ability to serve as an 
interactive living fomite, may have microbial communities that are different from 
standard pet animals. Therefore, exposure to animals in an AAI setting may 
fundamentally differ from exposure to household pets. This unique exposure profile 
could logically result in different risk factors and protective factors for pathogen 
contamination for both participants and the therapy animals. As such, infection control 
guidelines that rely on previous research on fomites and pet ownership may not 
realistically reflect adequate control measures for therapy animal exposures.  
Our review confirmed an even greater lack of quantitative research on hazards other 
than infectious disease agents in the context of AAI studies. While some articles 
commented on the risks of phobias, injuries, negative cultural perception of animals, and 
allergies, none examined these risk factors empirically. Explanations for few study 
findings in this area include that these highly-trained animals minimize the potential 
risk of injury and that patients, along with their supervising medical team, will self-select 
to participate in these programs, thus reducing therapy animal contact by those patients 
who have phobias or allergies. 
Our review also suggested a lack of effective educational campaigns and open 
communication networks between hospital infection control departments and therapy 
animal handlers regarding infection risk. This was suggested both by the variability in 
control practices among institutions and by the knowledge disparities among handlers 
observed in multiple studies (Boyle et al., 2019; Lefebvre et al., 2006b; Linder et al., 
2017b). Without these communication channels, therapy animal handlers may not have 
a clear understanding of the rationale for infection control protocols, as well as the 
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potential risks towards the patients, their therapy animals, and even the handlers 
themselves. Continued efforts from infection control departments and hospital program 
facilitators to provide knowledge-based motivation to adhere to hospital-enacted 
infection control protocols are essential, directed to both therapy animal handlers and 
healthcare workers involved in AAI sessions. Without such cohesive collaborations, 
hospital protocols created for AAI programs can be misinterpreted or poorly executed. In 
order to minimize the potential risk for all involved, attention should be paid to outreach 
and education programs that promote safe practices for both therapy animal handlers 
and hospital staff. In addition to efforts to harmonize infection control regulations across 
healthcare facilities, individuals involved in AAI should work within the hospital to 
integrate AAI programs into the overall institutional safety culture in order to maximize 
the benefits of these programs.  
A strong point of the established research is the evaluation of risk factors for pathogen 
carriage by therapy animals, namely animals fed a raw-food diet and those that have 
increased interaction with patients (through licking and being fed treats) are more likely 
to carry zoonotic pathogens. Studies that focus on risk factors can inform interventions 
to minimize pathogen carriage by therapy animals, and potentially decrease 
transmission to the patients with whom they subsequently interact. Expanding this work 
to studies that examine patient-level risk factors (such as concurrent disease conditions 
or specific animal-contact behaviors) or AAI-level risk factors (such as the number of 
patients interacting with the animal) will additionally inform the safety practices of these 
programs and have significant clinical impact. Clear hospital communication channels 
that impart infection control guidelines, backed by robust evidence-based science on 
potential risk factors, can empower healthcare workers and handlers to identify and 
minimize behaviors that pose risk to patients, therapy animals, and themselves.  
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The most significant knowledge gap is the lack of epidemiological data demonstrating or 
testing the transmission of zoonotic and hospital-associated pathogens related to AAI 
therapy sessions. The few published studies have small sample sizes (only two studies 
included more than 100 animals) and limited longitudinal data (only four retrospective 
or prospective cohort studies, two from the same cohort). This clearly limits statistical 
power to demonstrate even associations between pathogen carriage and AAI visits, much 
less actual illnesses associated with such carriage. Other than those three cohorts, most 
studies were cross-sectional or case reports, which limits causal inference because of 
their inherent inability to establish temporality, control for confounding, or account for 
interpersonal variability. The data from these cross-sectional studies and case reports, 
therefore, have minimal weight in our understanding of how AAI exposure may relate to 
pathogen carriage in therapy animals, patients, healthcare workers, and the hospital 
environment.     
At present, the studies that have assessed microbial sharing during a therapy session 
focused only on the microbial carriage of the therapy animal. Testing only the therapy 
animal demonstrates carriage of a zoonotic pathogen at a single time point, and does not 
capture a transmission event. Data and evidence for transmission between patients, 
animals, and the environment are limited without sampling of all these components. 
Identification of a transmission event requires longitudinal multi-source sampling 
(humans, animals, and the environment) with molecular typing to identify and 
distinguish specific microorganisms. Such data are required to trace the source, pathway, 
and directionality among therapy animals, the hospital environment, and all individuals 
involved, including patients, visitors, healthcare workers, and therapy animal handlers.  
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Longitudinal sampling will also allow insight into whether microbial exposure and 
transient contamination from AAI conditions can progress into stable bacterial 
replication and colonization, and then progress to a possible infection in both individuals 
and therapy animals. In the context of hospital-associated pathogens, it is established 
that exposure is necessary, but not always sufficient, to progress to infection (Weber & 
Rutala, 2013); longitudinal sampling can capture these stages of progression, and 
identify risk factors that promote such progression. This is particularly relevant to 
clinical outcomes in AAI patient participants, many of whom are children or have 
compromised health status, making pathogen exposure more likely to progress to an 
infection. Longitudinal sampling of the therapy animal will also test whether these 
animals can serve as a vector of disease within and between different hospitals, and in 
the greater community outside of the hospital, as well as evaluate health outcomes in the 
animals themselves. With only a few published studies conducted in a small number of 
single hospitals, and often including the same cohort, the present data are clearly of 





Future work in this area should aim to investigate the potential hazards that can occur 
during a therapy visit, both in terms of potential injury and infection control, and seek to 
quantify these possible associated hazards, while confirming these hazards do not 
interfere with the known benefits of AAI. It is recommended that future studies employ a 
One Health framework, a systems-thinking approach that addresses concerns at the 
nexus of human health, animal health, and the health of their shared environment, 
paying particular attention to the relationship between the entities rather than looking at 
them in isolation (Destoumieux-Garzon et al., 2018). This framework may facilitate 
future investigations and provide a more holistic view of the microbial dynamics between 
therapy animals, hospital patients, and the hospital environment.  
While further research into risk identification is necessary, clinicians and other 
healthcare workers who implement or are debating implementing an AAI program must 
also consider their hospital and patient needs, given the clear and established benefits of 
these adjunctive programs. A rational decision process involves a cost/benefit risk 
assessment that provides insight into the likely consequences of a proposed action. 
Balanced with this is the concept of the precautionary principle, which states that 
without a risk assessment involving hazard identification and analysis, one should 
minimize exposure to the potential risk. In the case of AAI programs, while there is an 
ongoing need for corroborating research, the recommended guidelines for animals in the 
healthcare setting can provide a starting point and scaffold for infection control policies 
that, when properly applied and followed, have potential to minimize the known and 
unknown risk factors, while still maintaining the known benefits as an adjunctive patient 
therapy, with the ultimate goal of making AAI more accessible and sustainable for 
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patients. Promotion of judiciously executed AAI programs will increase attention to its 
usage as a complementary therapy, and prompt awareness of the need for further insight 
into its safety and value as a critical tool for patient benefit.    
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3.7 Tables and Figures 
 












Study Design Goals Evaluated Measurements Covariates Findings 







Prevalence of zoonotic 
pathogens in therapy 
animals, and survey of 
handlers’ understanding 
of the risks of zoonoses 
and their adherence to 
infection control practices 
Screening test results 
from 22 dogs and 2 cats, 
with a survey of 40 
registered therapy 
animal handlers.  
Annual fecal parasitic 
float and bacterial 




surveys of handlers  
N/A 17 total positive results of the 118 
infectious disease screenings 
performed, 14 of which were 
potentially zoonotic 
organisms. 70% of handlers 
expressed no concerns regarding 
infectious disease transmission in 
AAI settings. 





Study looked for 
protozoan Giardia 
duodenalis and zoonotic 
gastrointestinal 
nematodes over the three-
month study period in 
dogs training for AAI. 
Fecal samples from 74 
dogs, and demographic 
questionnaire data 
Fecal parasitic exams Dog age, 
breed, sex, 
health status,  
Authors found 18/74 (24.3%) 
positive fecal samples - 8 with 
Giardia, 3 with co-infections of 
multiple gastrointestinal 
parasites. 










45 eldercare facilities, 45 
hospitals, and 27 
therapy animal 
organizations 
Survey assessed existing 
health and safety 
policies related to AAI 
programs 
N/A Health and safety policies varied 
widely and potentially 
compromised human and animal 
safety. Hospitals had stricter 
guidelines than elderly care 
facilities, which had stricter 
guidelines that AAI 
organizations. 







Pilot study on the risk of 
hospital-acquired 
infections following an 
AAI session in a pediatric 
oncology inpatient clinic 
Electronic medical 
records from 19 
pediatric patients, as 
well as patient, parent, 
and healthcare provider 
surveys. 
Newly acquired infection 
cases of the participants 
for 14 days following an 
AAI session 
NA Eight of the 19 patients developed 
a hospital-associated infection 
following an AAI session. 
However, this could not be 
attributed to AAI therapy 
sessions, as there was no control 
group to compare whether the 
infections resulted from exposure 







Pilot study to test the 
feasibility, receptiveness 
and safety of AAI in 
hospitalized patients 
11 patients followed for 
12 months, receiving 146 
therapy sessions.  
Medical record review 
for documented 
infections; also surveys 
N/A Authors found that while 
maintaining strict institutional 
infection control policy, no 
reports of infection or issues with 




of patient receptiveness 
to AAI therapy.  
ventricular assist devices, were 






Prevalence rates of MRSA 
in 12 resident animals at 
hospice 
11 cats and 1 dog, over 
course of 8 weeks  
1 nasal swab per week Health status 
of animal 
Author found 2 of the 11 cats were 
positive for MRSA (5 out of 8 
samples for one animal, and 2 out 





Letter to the 
Editor: Case 
Report 
To show the potential for 
therapy animals to 




26 therapy dogs with 26 
human handlers 
Paws and haircoat of 
each dog, and handler's 
hands, before and after 
therapy visit  
 No positive pre-visit samples, 1 
dog (4%) acquired C. difficile 
after a visit, and one human was 
positive for MRSA after petting a 
therapy dog, suggesting that dogs 
can became contaminated with 
pathogens during AAI visits, and 









To compare the risk of 
acquiring a pathogen 
between therapy dogs 
that visited hospitals 
versus therapy dogs that 
visited other venues 
(classrooms, etc.) 
96 therapy dogs that 
visited hospitals and 98 
dogs that visited other 
AAI events. 
Fecal and nasal samples 
from the dogs were 
collected every 2 months 
for a year 





Therapy dogs that visited 
hospitals were almost 5 times 
more likely to be contaminated 
with healthcare associated 
pathogens (IRR 4.7 MRSA, 2.9 C. 
difficile). Amongst those, therapy 
dogs that licked patients’ hands 







To determine if pathogen 
shedding is different in 
therapy dogs fed raw 
meat diet versus not 
200 therapy dogs Fecal samples collected 






Therapy dogs fed a raw meat diet 
were significantly more likely to 
shed pathogens, including 
antibiotic resistant strains. The 
authors recommended these dogs 






Evaluate dogs visiting 
hospitals for possible 
zoonotic disease 
pathogens 
102 visitation dogs 
(includes therapy 
animals and pets visiting 
owners) 
Fecal sample, hair-coat 
brushings and one 
rectal, aural, nasal, oral 
and pharyngeal swab 
were collected from each 







Zoonotic pathogens were found 
in 80 of the 102 dogs (80%), 
which indicates that these dogs 
can spread pathogens. The 
authors concluded that more 
information is needed on risk 
factors and transmission routes 








To determine the 
distribution of canine-
visitation programs in 
Ontario and to 
characterize the nature of 
the programs the dogs are 
affiliated with. 
Surveys from 223 
hospitals and 90 therapy 
dog handlers 
Surveys from hospitals 
regarding their usage of 
AAI programs. Surveys 
from therapy dog 
handlers regarding 






s (age, sex, 
breed).  
Acute care wards were 5.1 times 
more likely than other wards to 
prohibit therapy animals. 
Handlers reported highly variable 
screening protocols and infection 
control practices; 18 owners 
(20%) said they did not practice 
any infection control and 36 
owners (40%) were unable to 
name one zoonotic disease  
(Lefebvre et 
al., 2006a) 
Letter to the 
Editor: Case 
Report 
Report of a toxin-variant 
strain of C. difficile in an 
apparently healthy 
therapy dog.  
1 dog that was a part of 
the cross-sectional study 
described above 
Fecal sample N/A This canine isolate is 
indistinguishable from the major 
strain implicated in outbreaks of 
highly virulent CDAD around the 
world. The recurrent exposure of 
this dog to human healthcare 
settings suggests that the animal 
acquired this strain during visits 








Determine rates of 
hospital-acquired 
infections before and 
after the implementation 
of an AAI program, and 
patient-reported 
enjoyment 
138 pediatric patient 
participants and 
aggregated hospital-
wide infection rates 
Cases of newly acquired 
infections prior to 
introducing therapy 
dogs, and one year after 
dogs present in hospital 
NA Authors found constant rates of 
hospital infections after 1 year of 
dogs being present in the hospital 
weekly, compared to the previous 
year, and no documented 
contagious diseases were 
transmitted by dogs during their 
presence in the hospital. 
(Enoch et al., 
2005) 
Letter to the 
Editor: Case 
Report 
Describe a case of a 
therapy dog acquiring 
MRSA during a therapy 
visit to a hospital 
1 dog Nasal, head and paw 
swabs before and after 
therapy visit 
N/A The dog was negative for MRSA 
on entering the hospital, but was 
found positive when leaving, 
indicating patients may spread 
MRSA to therapy dogs.  
(Sillery et al., 
2004) 
Letter to the 
Editor: Case 
Report 
Describe a case of a 
patient with Pasteurella 
peritonitis that was 
suspected to be 
transmitted from the pet 
cat.  
1 human patient with a 
pet cat 
N/A N/A Therapy animals can potentially 
transmit Pasteurella multocida, a 
pathogen that can cause 
peritonitis in patients undergoing 
peritoneal dialysis. This is the 
first documented case of 
suspected transmission of the 
pathogen from animals, and 
introduces a novel control point 







First documented attempt 
to understand risk 
associated with AAI. 
Surveyed animal care 
facilities to determine the 
prevalence of AAI 
programs, concerns and 
experiences with AAI, and 
zoonotic disease 
precautions taken to 
prevent transmission 
150 systematically 
selected United States 
animal care agencies 
and 74 Canadian 
humane societies 
N/A N/A Half of the respondents 
expressed concern over zoonotic 
diseases, but few were based on 
actual experience. Less than half 
consulted with a human health 
professional about infection 
control and only 10% had written 
guidelines for prevention of 









Study Design Goals Evaluated Measurements Covariate
s 
Findings 




Review current literature 
of positive clinical 
outcomes and negative 
risk to patients from 
therapy animals 
11 papers looking at the 
risk of therapy animals, 
which include both 
epidemiological studies 
and protocol guidelines. 
N/A N/A Concluded AAI for hospitalized 
patients useful and safe for a 
wide range of diseases 
(Chalmers & 
Dell, 2016) 
Commentary Applying One Health 
principles to decrease risk 
in therapy dog programs 
and further research 
Did not include number 
of papers formally 
reviewed 
N/A N/A Author gives a framework for 
studying therapy programs in the 
animal-human-environment 
interface.  
(Hardin et al., 
2016) 
Commentary Describe implementation 
of a pet therapy program 
that includes guidelines 
for the prevention of 
transmitted infections. 
Did not include number 
of papers formally 
reviewed 
N/A N/A Guidelines were in place in a 
hospital for sixteen years with no 
documented cases of disease 
transmission, supporting that a 
pet therapy program can be put 




Letter to the 
Editor: Brief 
Review 
Short review of current 
studies/case reports of 
zoonotic infections from 
pets 
Did not include number 
of papers formally 
reviewed 
N/A N/A Author concludes that therapy 
programs do provide 
opportunities for patients to 
become exposed to zoonotic 
infections and requires strict 
infection control policies, not a 
relaxation of guidelines.  







Commentary Provide general guidance 
to the medical community 
regarding management of 
animals in healthcare, 
specifically in terms of 
hazard reduction.  
Did not include number 
of papers formally 
reviewed 
N/A N/A Created guidelines for animal-
assisted therapies, service 
animals, research animals, and 
personal pet visitation. Also 
recommends additional research 
be performed to better 
understand the risks and benefits 
of allowing animals in the 





Review  Review current published 
information regarding the 
efficacy of AAI in the 
inpatient population, and 
to review safety concerns 
associated with AAI.   
Reviewed 44 articles (26 
clinical studies, 15 
review articles, 1 case 
report and 2 letters to 
the editor). Five studies 
addressed infection 
concerns.  
N/A N/A The authors’ review of the 
literature showed that, in the 
inpatient setting, AAI is an 
effective therapy among patients 
of all ages and with various 
medical problems and is safe, 
with no transmitted infections 
reported. Found only 5 studies 
that addressed infection concerns 
in the inpatient setting. 
(Silveira et al., 
2011) 
Commentary Guidelines for a hospital-
based AAI program, 
which has been effective 
for a hospital in San 
Paolo, Italy 
Did not include number 
of papers formally 
reviewed 
N/A N/A AAI programs can be properly 
implemented in hospitals if strict 
attention is paid to animal 




Commentary Provides standard 
guidelines for animal-
assisted interventions in 
health care facilities, 
considering the available 
evidence. 
Did not include number 
of papers formally 
reviewed 
N/A N/A Created strict guidelines, 
centered on evidenced-based 
literature, for AAI programs to 
reduce risk of colonization and 
transmission of hospital-
associated infections for the 
animals and people.  
(Disalvo et al., 
2006) 
Commentary Compared guidelines for 
therapy animals in 
hospitals to guidelines for 
service dogs and family 
pet visitation 
Did not include number 
of papers formally 
reviewed 
N/A N/A Argued that therapy animals 
should have strict guidelines to 
reduce adverse events such as 




Review Centralized CDC 
guidelines for 
environmental infection-
control strategies and 
engineering controls to 
effectively prevent 
nosocomial infections in 
healthcare fields. 
Did not include number 
of papers formally 
reviewed 
N/A N/A Discussed general infection 
control policies, but also included 
therapy animal programs. 
Recommended minimizing 
contact with animal bodily fluids, 
and implementing hand hygiene 
after each contact. Recommended 
careful selection of therapy 
animals and bathing to reduce 
allergens.  
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(Brodie et al., 
2002) 
Review Review of current 
literature focusing on 
health risk to patients 
Did not include number 
of papers formally 
reviewed 
N/A N/A Zoonoses, allergies and bites - the 
three issues surrounding pet 
therapy causing greatest concern 
- have the potential to be 
controlled in a supervised health 
care setting, and can be 
minimized by taking simple 
measures. 
(Guay, 2001) Review Review of the most 
common zoonotic 
infections that might be 
expected in the long-term 
care setting from AAI, 
with recommendations 
for prevention and 
control.   
Did not include number 
of papers formally 
reviewed 
N/A N/A Recommends infection control 
policies and procedures, geared 
toward management and 
prevention of the different 
zoonotic illnesses discussed, 
should be developed and 
implemented in all nursing 




Commentary Critique of current animal 
therapy programs 
guidelines in the context 
of hazard reduction 
Did not include number 
of papers formally 
reviewed 
N/A N/A If put into place properly, animal 
therapy programs can have 
significant benefit to patients, 
with minimal risk of animal 
associated health hazards.  
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Background: Animal-assisted intervention programs, used widely for patient benefit, 
have increasingly been used for healthcare workers (HCW) to reduce occupational stress. 
However, there are barriers to these programs which limit their utilization, for both 
patients and HCW, specifically infectious disease concerns. The aim of the research 
project is to identify barriers and facilitators to program use for healthcare worker 
benefit, and determine knowledge, beliefs, and practices regarding infectious disease risk 
and control policies, in order to understand the contextual parameters of program 
implementation.  
Methods: We collected perceptions of key stakeholders involved with hospital AAI 
programs (HCW and AAI workers) through semi-structured in-depth interviews. We 
used framework analysis to guide thematic coding, completed independently by three 
researchers.  
Results: We interviewed 37 total participants. We divided our themes into two topic 
areas: program use for HCW and perceived infectious disease risk. Use for healthcare 
workers included perspectives on the benefits for HCW and program barriers and 
facilitators (specifically collaboration and leadership). Perceived risk included opinions 
on infectious concerns with AAI, thoughts on control measures to reduce this risk, and 
responsibility for safety during these programs.    
Conclusions: While significant benefits were reported for HCW, they were limited by 
administrative barriers and hazard concerns. Facilitators to surmount these barriers are 
best implemented with collaboration across the hospital and appropriate leadership to 
roles to direct safe program implementation. With these barriers addressed through 
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targeted facilitators in the form of evidence-backed guidelines, AAI programs can be 




The numerous benefits of the human-animal bond have extended into the use of animals 
in healthcare facilities as an adjunctive therapy for patient wellbeing. These animal-
assisted intervention (AAI) programs have been shown to reduce stress, pain, and 
anxiety in patients (Bert et al., 2016; Kamioka et al., 2014; Tsai et al., 2010). One novel 
use of these programs is for the benefit of healthcare workers (HCWs) in charge of 
patients, given the critical occupational burden that faces them from high-demand 
workloads, and secondary traumatic stress from acute negative work experiences. Such 
stressors can lead to physical, mental, or emotional symptoms such as burnout, 
depression, and anxiety (Hall et al., 2016; Pradas-Hernandez et al., 2018). Significantly, 
these symptoms can influence HCW job satisfaction and performance, which have 
downstream effects on poor patient care (Hall et al., 2016; Monsalve-Reyes et al., 2018). 
This indicates a crucial need for stress-reduction interventions for HCW, and many 
hospitals are adopting AAI to address this need. To date, no research has evaluated the 
effectiveness of AAI as a valid therapy to reduce stress in this vulnerable yet essential 
worker population. If evidence shows that AAI programs can improve occupational 
health and wellbeing, this will be a previously undescribed benefit of these programs and 
further promote the human-animal bond in healthcare settings.  
Despite the demonstrated benefits to patients, and potential benefits to HCW, there is 
still hesitancy in the adoption of AAI programs for both populations. At the forefront of 
these challenges is the concern for potential exposure to and spread of infectious disease 
agents to individuals who participate, a challenge that HCW acknowledge (Linder et al., 
2017). Previous research has demonstrated that therapy animals and patients who 
interact with them are at higher risk of exposure to hospital-associated pathogens 
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(Dalton et al., 2020; Lefebvre et al., 2009). This indicates the possibility for other 
individuals involved in AAI to become contaminated, including HCW who can transmit 
microbes to other patients in their care. While guidelines designed to reduce this 
infectious disease risk have been developed (Murthy et al., 2015), stakeholders at the 
forefront of these therapy sessions need to be aware of the potential risk and be 
motivated to deploy these control interventions. Thus, hospital infection control 
strategies for AAI therapy need to be effective yet practical to implement in the field, 
with engagement from HCW and other key stakeholders. There is currently no research 
on the infection control beliefs and practices for key personnel who work with hospital-
based AAI programs. Understanding key stakeholders’ concerns will allow for the 
development of interventions relevant to real-world hospital conditions and will be 
foundational to future research in this area. Proper implementation and adherence of 
control strategies will improve the safety and perception of safety for these crucial AAI 
programs, and increase their utilization for the benefit of both patients and HCW. 
Therefore, this research aims to collect perceptions of key stakeholders involved with 
hospital AAI programs on 1) the use of hospital-based AAI programs as an efficacious 
and practical occupational stress reduction intervention and 2) concerns and current 
practices of infection control during AAI programs. This qualitative study will use 
interviews to formulate more accurate and contextually relevant data, a process that has 
shown to be successful in studies on human-animal interaction, AAI programs, and 
hospital infection control (Degeling & Rock, 2020; Pedersen et al., 2012; Seibert et al., 
2014). This work will contribute foundational evidence regarding the risks and benefits 
of AAI programs to promote the health and wellbeing of workers and volunteers by 
preserving the human-animal bond. The ultimate outcome for this qualitative research 
project is to guide reduction of potential hazards associated with AAI programs by 
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improving their safety, so that these programs can be sustainable as a validated method 






The Johns Hopkins Bloomberg School of Public Health Institutional Review Board 
reviewed all instruments and study materials and approved this project. To document 
and describe the perspectives and opinions of hospital-based AAI programs on issues 
related to risks and benefits, we conducted a series of in-depth interviews with key 
stakeholders. Key stakeholders included healthcare workers (doctors, nurses, and other 
patient-care staff) and AAI workers (volunteer handlers and program directors) who 
work/volunteer in hospitals with existing animal-assisted intervention programs. All 
stakeholders were over 18 years old and fluent in English. We identified potential study 
participants from existing contacts and connections through concurrent research 
studies. Secondarily, we used snowball sampling to identify additional participants 
(Sadler et al., 2010). Participants were recruited via an email that introduced the 
research team and study goals.  
Interviews 
A semi-structured interview guide was developed by KRD using programmatic 
framework analysis, a deductive process focused on exploring predefined key concepts 
within the data (Gale et al., 2013). Prior to implementation, the interview guide was 
edited by co-authors (KR, RT, JA, MFD), and beta-tested with knowledgeable contacts. 
The interview questions addressed relevant themes connected to the participants’ 
experiences with hospital animal-assisted intervention, specifically regarding possible 
concerns and benefits to healthcare workers.  
Interviews took place with participants via an online web-conference software between 
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May to July 2020 (in-person interviewers were not possible due to COVID-19 contact 
restrictions in place at the time). Before the start of every interview, participants gave 
written consent via an electronic signature; occasionally oral consent was obtained from 
those unable to provide the electronic signature. All interviews were audio-recorded, 
with participants made aware of the recording before the start. The interviews were 
conducted by one of three research team members (KRD, WCA, or PC) and typically 
lasted between 40 to 60 minutes.  
Data Analysis 
Audio-recordings from the interviews were transcribed verbatim with the interviewees’ 
permission. All transcripts were then coded using a combination of previously 
established deductive codes and inductive codes that arose from the data, as per the 
programmatic framework analysis guidelines (Gale et al., 2013). Each transcript was 
coded by at least two research members (all coded by KRD, and WCA or PC coding half 
each). The researchers’ diverse professional backgrounds and perspectives facilitated 
openness to different interpretations during both the interview process and data 
analysis; the first author has a background in veterinary science and human-animal 
interaction, the second has a background in mental health and social work, and the third 
has a background in social disparities and environmental justice. To ensure rigor and 
inter-coder reliability, the researchers utilized “dialogical intersubjectivity” or open 
group discussion among both the three researchers and the wider co-author team for 
constant comparison of codes to ensure group consensus (Brinkmann & Kvale, 2015; 
Saldaña, 2015). 
Codes were then grouped into major themes and sub-themes (Malterud, 2001) to 
formulate new concepts on the topics. The final step was to explore how these themes 
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were related to each other in a synergistic fashion. Throughout the analysis, the authors 
reiteratively returned to the interview texts to check that the evolving themes and sub-
themes reflected the meanings conveyed by the participants. Representative quotes from 





Enrollment and Recruitment 
We completed interviews with 37 participants, which are described by occupation in 
Table 1. The interviews lasted from 25 minutes to 1 hour and 5 minutes, with an average 
time of 42 minutes. Participants were almost equally split between healthcare workers 
(51%) and individuals directly involved with AAI programs (49%). Three of the volunteer 
handlers were also healthcare workers, and all AAI program directors were hospital 
employees.  
Major Themes 
Based on our chosen framework analysis methodology, we planned our interviews to 
focus on the following two main topic areas: 1) the use of AAI programs for occupational 
HCW, and 2) perceived risks associated with hospital AAI programs. After data 
collection, we then organized our themes and sub-themes within each of these two topic 
areas as shown in Table 2. 
Topic Area 1 – Program Use for Healthcare Workers 
The first topic area that was selected as a focus a priori for the interviews was on the 
implementation of AAI programs for HCW usage, particularly best practices in 
establishing and sustaining sessions that are exclusively for HCW.  
All participants, both HCW and AAI workers, felt that these programs, originally 
designed as complementary interventions to improve patient wellbeing, could be 
adapted and used for occupational purposes. Some participants even commented that 
staff needed these programs more than patients. Within this topic area are opinions in 
three major themes; 1) benefits to HCW from AAI programs, 2) barriers to HCW AAI, 
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and 3) facilitators to overcome the barriers. 
Theme 1.1: Benefits to HCW 
All participants reported that AAI programs could benefit HCW, in ways that are similar 
and unique to patients’ benefits. Participants felt that benefits from AAI programs to 
HCW would be heterogeneous depending on personality and coping styles, as well as job 
function (better for more stressful jobs such as residents and night-shift workers). 
Reported benefits to HCW were aggregated into three main sub-themes. 
Sub-Theme 1.1.1. Stress Reliever and Morale Booster 
Similar to sessions for patients, participants felt that AAI programs for staff would be a 
positive distraction or a break from their regular routine. Terms such as “mindfulness” 
or “reset” were used to describe the positive distraction from these programs for HCWs. 
The benefits were reported even after brief interactions, with the therapy animal working 
“instantaneously.”  The most commonly reported effect from AAI programs used for staff 
was the concept of stress reduction. Both HCW and AAI workers reported that 
occupational stress in this cohort is a significant problem, and these therapy animals 
could reduce this stress burden.    
HCW: “I think that engaging with a dog in a meaningful way de-stresses people.”  
HCW: “I think there's also something when you're petting a dog, your body 
relaxes. You feel more at ease and less stressed.”  
AAI Worker: “I think it's easy to confuse reducing stress with things that are just 
very pleasant. There's nothing wrong with just having a few pleasant moments, … 
yet I think pet therapy goes beyond that and actually reduces the grit of the health 
care workers’ day in the moment for stress reduction.”  
Beyond reducing stress, participants felt that these programs bolstered morale and mood 
in HCW receiving this therapy, both for programs directed towards HCW and as 
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bystanders to patient-centered programs. This was reported on a personal level and a 
group level, in that having a therapy animal visit a unit or department raising the 
collective mood in the workplace. It was also mentioned that these positive benefits 
could reinforce the commitment of the hospital to holistic employee wellbeing.   
AAI Worker: “I just think to me it would just be natural that, yes, it would make 
healthcare employees happier.”  
AAI Worker: “Some of the managers have reported that when the dogs have come 
and visited that they feel like the staff is just in a better mood.”  
HCW: “I would think some of the reasons are not just maybe the immediate effect 
of having that dog, but some of it's also morale boosting. It's maybe an indication 
that the institution you're working for cares about things like that, and they're 
trying to help you have a better work experience.”  
Sub-Theme 1.1.2. Improved Job Function 
Participants reported that HCW benefited from AAI programs through improved job 
function. This was through its use as an adjunctive therapy modality in patient care, a 
unique “tool in the toolbox,” resulting in improved clinical outcomes and facilitated 
communication with patients. In addition, the positive benefits of stress reduction and 
morale bolstering in HCW also translated into better workplace performance by creating 
increased employee engagement and resilience.  
HCW: “I get an indirect benefit when my patients get a benefit. It's good for me to 
see them having that positive experience in the hospital and sometimes helps me 
build another level of rapport with them, which helps me do my job better.”  
AAI Worker: “We know that if our staff are happier and less stressed, that our 
patients are as well, that carries over to better patient care.”  
Sub-Theme 1.1.3. Gateway to Other Therapy 
The final benefit to HCW that was observed from participant responses was the concept 
that the therapy animals could serve a mechanism for open communication. Both AAI 
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workers and HCW reported feeling more open and freer to discuss mental health and 
other workplace stress-related factors with a therapy animal present.  
AAI Worker: “They can share their emotion with a dog that they're not going to 
do with another person or coworker while they're at work.” 
HCW: “There’s definitely something to that human-animal connection. People 
feel more comfortable disclosing information, I feel like, when the dog is there.”  
In addition, HCW were more likely to utilize other stress intervention modalities, such as 
professional counseling, if combined with AAI programs. The therapy animals served as 
both an incentive and a non-threatening bridge to what could be considered an 
“intimidating” or “unneeded” therapy. When combined, it was reported that these 
therapy programs would appeal to a greater audience, as well as address needs from a 
broader range of personalities, coping styles, and problems.   
AAI Worker: “We talk about the dog as sort of like a gateway to some other 
therapeutic interactions where people might be more open to talking to a 
specialist if they're, like, petting the dog while they do it.” 
HCW: “I have never gone to [a counseling session] because it's something that I 
tend to deal with more internally. But if they're like, come play with some big, 
fluffy golden retrievers for an hour, I'd be like great, I'm there. And I might be 
more willing to open up about stuff if I'm already in the room.”  
Theme 1.2: Barriers to Programs for HCW 
Despite the reported benefits, not all departments and hospitals were able to use AAI 
programs for their staff. Many of the stated barriers were the same administrative 
hurdles that were reported as barriers to program use for patients, such as an insufficient 
number of trained volunteer therapy animals and handlers. Other issues that were 
common to patient-use barriers included HCW’s fear of and allergies to the therapy 
animals. However, there were issues that were specific to the use of AAI in this 
population. Infectious disease concerns arose as a barrier to program utilization for 
HCW and patients; these concerns are addressed in more depth later (infra Topic Area 
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2). The other program barriers are broken down into three sub-themes.  
Sub-Theme 1.2.1. Conflicting Timing and Location with Normal Clinical Functions 
The most frequently reported barrier to program utilization for HCW was their 
conflicting priorities to their routine job duties. Many participants reported being unable 
to find time outside of their patient care responsibilities to focus on wellness initiatives, 
including pet therapy. Handlers also reported this as a barrier when they would attempt 
to include HCWs in their sessions. Timing issues dealt with both the difficulty of finding 
a suitable time for HCW-directed sessions, and how long those visits should last in order 
to be beneficial and worthwhile. The lack of convenience and accessibility of the location 
for AAI visits was also reported as a potential drawback. 
HCW: “I can't remember a time when a particularly difficult day has coincided 
with a dog being available for me to go visit. And if there was, I imagine that 
probably the timing would be difficult.”  
AAI Worker: “Our volunteer dogs can only be on site for an hour, and so, for that 
reason, they typically don’t work a lot with our staff.” 
HCW: “You can't spend 10 minutes getting somewhere for something that lasts 
10 minutes to spend 10 minutes getting back. It has to be very convenient for 
your workday.”  
HCW: “We don't have a lot of true spaces where staff can gather to utilize some 
type of modality of therapy for themselves. So, I think that's a real barrier.” 
HCW: “Is it something I look forward to? Yes. But I'm only ever able to go if I 
have a free moment to do so. So, it's not like I get to choose the pet therapy over 
my work.”  
AAI Worker: “I think [healthcare workers], they've got other job responsibilities 
and duties, and so that's always in the back of your mind.”  
Sub-Theme 1.2.2. Prioritizing Patient Needs Before Staff  
The final primary barrier to HCW AAI sessions was the concept that many HCW felt 
these sessions should be used for patients. HCW felt that using these programs for 
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themselves, especially knowing the constrained availability of therapy animal dogs and 
handlers, would remove this limited resource for patients. This concept was also 
supported by handlers and AAI program directors, who felt the need to prioritize 
patients because of individual choices or management pressures.  
HCW: “I guess the times I've heard of them have always been kind of patient-
directed and usually, for instance, programs like that, they, I don't know, I always 
get the impression that medical people, especially doctors, are not necessarily 
welcome … I feel like it's kind of for the kids and not for me, I guess.”  
AAI Worker: “I found that if I'm walking the dog around the unit, a lot of the staff 
feel like I'm taking the dog away from their patient.”  
AAI Worker: “We've always tried to do some level of [staff visits], although we 
would always prioritize, like, a patient need over that.”  
AAI Worker: “The other component is that [the therapy dog training 
organization] really wants these dogs to be working with the patients and 
families. They know that the staff need a little bit of support now and then, but 
for the majority of work they really want it to be focused on the patients … we 
really want to keep the patients and families at the forefront of why we're having 
these programs exist.”  
Sub-Theme 1.2.3. Infection Risk as a Barrier to HCW Program Use 
Our a priori chosen topic area on infection disease risk in AAI was found post hoc to be a 
sub-theme within the HCW program use topic area, namely that infectious risk was 
reported as a barrier to the establishment and sustainability of programs for HCW. As 
such, this sub-theme will be addressed in more depth later (infra Topic Area 2).   
Theme 1.3: Facilitators to Programs for HCW 
In addition to discussing barriers of AAI programs for HCW, opinions on ways to 
overcome these barriers were also examined. Again, many of the facilitators described to 
increase program use for HCW could also be used to increase their use for patients. 
Facilitators were grouped into three sub-themes.  
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Sub-Theme 1.3.1. General Implementation Thoughts 
Ideas were collected on general ways to run these HCW-directed AAI programs from 
participants. This included best practices from successful staff programs, and potential 
solutions to hurdles for those who face obstacles to these programs.  Many of these 
facilitators dealt with the best timing and location of sessions. Staff were divided on 
whether visits would be most effective as scheduled sessions or flexible, emergent 
sessions. Frequently, staff reported that these programs should be combined with 
existing scheduled occurrences, such as regular meetings or routine support events. This 
also goes along with perspectives on finding a convenient location to maximize HCW 
engagement, such as bringing the therapy dog directly to the department and finding a 
separate location from patients, such as an employee-only break room.    
HCW: “I think if there was just a centralized, I don't know, almost kind of like, … 
if a pet did rounds in a similar way as [the doctors]. Right. You knew between 
2:00 and 3:00 they'd be on the floor. I think that would be, that'd be the most 
feasible way to do it.” 
HCW: “I actually think just walking the dog even in the halls and having some 
unscheduled time for who happens to be there is a valuable thing.”  
AAI Worker: “I tell [staff leadership] that they should make sure that they have a 
separate room set aside for this. So the staff doesn't feel like they're being, they're 
taking this time away from the kids.”  
HCW: “If there was kind of, I guess, a more adult friendly space for the session to 
take place in, I think that would be a great way to do it.” 
Another frequent solution to implementation barriers was the idea of having facility 
dogs, which is a therapy dog that works in the hospital full time. Facility dogs were 
reported to be frequently used for healthcare worker stress reduction, including one 
hospital that had a facility dog exclusively for HCW. 
HCW: “Facility dogs are being used and because they are in the hospital for a full 
workweek as service animals, they're able to more often be utilized … because 
 111 
they are there all day, every day.”  
AAI Worker: “I think it's like one of the best opportunities the hospital can 
provide, because they can rotate staff so [the facility dog] will be in a room and 
staff come and go based on their schedule because she'll be there for like a 
prolonged period of time.” 
Sub-Theme 1.3.2. Importance of Appropriate Staffing 
A frequently reported facilitator was the value of having adequate staffing to support AAI 
programs. This was reported in terms of having adequate coverage so that HCW could 
participate in AAI sessions and not be burdened by clinical duties. The importance of 
having a staff member in a leadership position, at the institutional and unit level, to take 
care of appropriate scheduling and administrative tasks was also stressed as a critical 
factor for HCW AAI program success.  
HCW: “Nursing, therapist, everybody participated, and everybody supported 
each other. The nurses covered for each other. We scheduled around it. We made 
it happen because everybody wanted to participate [in the AAI session].” 
AAI Worker: “Having somebody to coordinate the program is essential.”  
AAI Worker: “The great thing about a certain dedicated person would be that that 
was their primary responsibility would be to provide some level of staff support. 
And in my mind, that person would have a lot more flexibility in terms of where 
they could go … I think we could reach a lot more staff that way.” 
Sub-Theme 1.3.3. Importance of Collaboration and Advocates 
The last sub-theme identified to aid hospital leadership and staff in implementing HCW-
focused AAI sessions was the concept of collaboration across hospital departments and 
management, including having advocates to promote the value of these programs for 
staff. These advocates are described as champions in hospital leadership, but also in the 
greater community who fund the therapy dogs and staff to run these hospital programs. 
Advocates were reported to be instrumental in securing hospital “buy-in” and increased 
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collaboration.   
HCW: “I think without a champion, it would not get done ... their setting up the 
protocol, not giving up when they hit barriers, making partnerships with places 
like legal-- I think it wouldn't get done without them, to be honest.”  
AAI Worker: “[Our physician champion] was the one that kind of went to bat 
work for us. He has a real passion for it, and he thought, as well, it would help the 
staff. And so he was the one that spoke up and got things going ... and got 
leadership team behind it ... and just making sure that all the appropriate parties 
are involved and making sure they feel like they have some input into the 
program and what it would look like.” 
HCW: “I think it would need to be like a donor who understands the benefit of it 
… I just think there have to be at least some support initially from the hospital 
and then move it out into the community. Yeah. And I think there are people who 
would definitely support it. You know, that we wouldn't have to convince that 
that how beneficial it is.” 
AAI Worker: “One of the things I did to help speed things along was I put 
together a [AAI] therapy advisory team - I’ve got somebody from infection 
control, from risk, from general counsel, from family partners, from medicine, 
and from allergy sitting on that team … I think that advisory team is really helpful 
because we have a lot of people with a lot of different experience. That's been 
really helpful in getting things done.” 
 
Topic Area 2 – Perceived Infectious Disease Risk 
The second topic area that was selected as a focus a priori for the interviews was the 
concept of the risk of infectious disease exposure and transmission during AAI 
programs. This referred to risks to the patients, HCWs, handlers, and therapy dogs. 
Interviews also concentrated on opinions of infection control policies in place in the 
hospital. 
Participants stated various levels of perceived risk involved in these problems, as well as 
differences in perspectives on control measures to reduce risk. This level of risk was for 
AAI programs overall, including sessions for patients and HCW. It was found in the data 
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that the two topic areas overlapped, in that infectious disease risks were stated to be a 
barrier to program implementation, both for patients and HCW (supra Theme 1.2). 
Within this topic area are opinions in three major themes; 1) perceived concerns in AAI 
programs, 2) control measures, and 3) safety responsibility.  
Theme 2.1: Concerns 
Participants discussed general opinions on hazards associated with AAI programs, and 
described specific incidences that supported these concerns. Concerns for these 
programs centered mainly on four sub-themes.  
Sub-Theme 2.1.1. Infectious and Non-Infectious Concerns 
For infectious disease risks, the most common concern was the therapy animal serving 
as an intermediate vector in the spread of pathogenic microbes between patients, HCW, 
or even the handlers. While the study focused primarily on opinions regarding infectious 
disease risk, participants frequently commented on other hazards, such as phobias and 
allergies to therapy animals, and dog misbehavior (biting, jumping, etc.). Another non-
infectious hazard was the therapy animal handler inadvertently causing distress to the 
patient (through probing questions or privacy issues), but these latter issues were 
reported as minimal concerns.  
HCW: “I think that, you know, there is concern that there may be sort of zoonotic 
transmission of germs from dogs to patients, particularly in patients who don't 
have an immune system to sort of adequately fight off those germs.” 
HCW: “I'm concerned about multiple people are touching the same animal. 
Whatever the person before me passed on, is it staying on the dog? Is it just like 
another surface that I can just pick it up off of?”  
AAI Worker: “I understand the concerns of transferring illness from one person 
to another with the dog is a factor.”  
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Participants mentioned that these concerns, particularly infectious disease concerns, 
were compounded by the lack of available research and data in this area.  
AAI Worker: “I'm curious if there are studies that are suggesting the dogs are 
bringing in any awful thing.” 
HCW: “How much extra risk does a dog confer versus me running around that 
whole hospital?”  
Sub-Theme 2.1.2. Negative Perceptions of the Programs 
Participants reported a barrier to AAI program use was the negative perceptions 
surrounding having animals in the hospital. While none of the participants reported 
having these negative perceptions, it was reported they often dealt with individuals 
(patients/visitors and co-workers) who did.  These second-hand perceptions included 
the idea that the animals were unclean, a “dirty dog”, or would misbehave. Participants 
reported that part of the root cause of this misinformation was a lack of understanding in 
the training needed to be a therapy animal and the difference between a service animal 
(used for disability), a therapy animal (used for treatment), emotional support or other 
companion animal (with no training requirement), and personal pets (again with no 
training requirement), and the distinction in allowance regulations into the hospital for 
each group.   
HCW: “People are surprised that you can have a dog in a hospital and so just 
always wanting it to be a really good forward-facing appearance so that you have 
a positive perception of just the professionalism and all that is associated with it.”  
HCW: “I think there is a lot of misnomers when it comes to animals and their 
cleanliness.”  
AAI Worker: “I just worry that less-than-adequately-trained dogs may harm the 
overall environment for hospital dogs.”  
Sub-Theme 2.1.3. Source or Cause of Infectious Disease Risk 
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Participants commented on what they felt was the likely source or reason for these 
infectious disease risks. Answers included the patients and other individuals, the therapy 
animal, or the hospital environment, with participants mentioning a combination of all 
three sources.  
HCW: “I would guess it would be all the other people who are there, who are 
present. It's not just going to be the kid; it's going to be the kid and their parents 
who are there and all the other kids and their parents are there.”  
AAI Worker: “Sometimes the dog gets tired and then sits on the floor of the 
hospital. You wonder, is the floor clean? I hope it is. That's the only time that I 
worry.”  
Sub-Theme 2.1.4. Not Concerned About the Programs 
While various concerns mentioned above were expressed, a majority of the participants 
were overall not concerned about these programs and felt the risk for infectious disease 
was low. Most participants related this to confidence in the control measures in place 
and adherence to those controls. Many participants also stated that people are unlikely 
to get infectious diseases from a dog. These opinions were shared equally between 
healthcare workers and AAI workers, and across the individual roles within each group.  
HCW: “I’ve always been a little bit more of a pragmatist on things like that. You 
eliminate all risks. And so, I think it's probably a pretty minimal risk.”  
HCW: “There really have been zero reports of dogs transmitting anything in the 
hospital environment. I think we're all very cognizant of the rules about contact 
isolation, but fortunately, the dogs don't get a lot of the human diseases and 
humans don't get a lot of the dog diseases.” 
AAI Worker: “No, I've no concern about [the dog] transmitting to a patient. I 
mean, I've never heard of it. And dogs don't spread diseases. … I don't see that a 
dog is any more of a vector than any doctor who walked in the room. I mean, but 
we don't think of doctors bringing in disease, but we all bring in bacteria, germs 
or whatever. I don't see the dog as more of a vector just because he likes to roll in 
the mud.” 
Theme 2.2: Controls 
Data were collected on knowledge and attitudes about control strategies in place to 
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minimize infectious disease risk in hospital AAI programs. These attitudes were 
aggregated into four sub-themes. 
Sub-Theme 2.2.1. General Thoughts on Control Strategies and Their Goals 
Participants shared their thoughts on current policies, and the suspected rationale for 
these policies, when asked about the goals of hospital infection control strategies. It was 
mentioned by both HCW and AAI workers that communication and dissemination of 
these control strategies and any policy updates are critical to program success and can 
vary across hospitals and departments. A majority of participants responded that the end 
goal for these control strategies was ultimately to protect the patient population, but 
others mentioned protecting the safety of visitors, employees, volunteer handlers, and 
the therapy animals themselves. Overall, all participants felt control measures and rules 
were necessary to reduce infectious disease risk and other hazards.  
HCW: “Making sure that there’s wide dissemination and knowledge about the 
protocols and policies that are out there so that confusion doesn’t happen.” 
HCW: “We tend to take infection control very seriously, and so for the dog to get 
through the proper channels, there would have been important policies in place 
to protect the children.” 
AAI Worker: “I think the [volunteer handlers] who do it are totally into it. 
They're proud of their dogs and they just want to do the right thing. You just want 
these kids to be happy and you want them to get better … the rules are there for a 
reason to protect us as well as the patients.”  
Sub-Theme 2.2.2. Targets of Control Strategies 
Participants were asked which component of the AAI session should be the focus of 
control strategies: the therapy animals, the patients and other individuals, or the hospital 
environment. Most participants felt that all three components needed to be addressed in 
order to comprehensively reduce risk. For those who did select one component, the 
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hospital environment was the component that participants felt should be targeted. 
Participants, especially AAI workers, felt, in general, that there were more controls 
directed towards the therapy animals than towards individuals or the hospital 
environment.  
HCW: “I mean, I really think all three. I think you need to control which patients 
participate, hand hygiene, and I think the handlers are controlling the cleanliness 
of the dog, and the hospital environment should be clean.” 
HCW: “I think there's less risk to the animal itself. And I think if you are kind of 
focusing on the hospital environment, you're able to cover adequately the patient 
and staff.” 
AAI Worker: “I think it's a three-pronged approach. You have to have it all. It's 
like a stool, if you have two legs, it's going to tip over. You really need all three. 
You do need the hospital controls. You do need to screen your dogs and have the 
right dogs. And I lump handlers in with the dogs, teams I guess I should say. And 
the patients have to be the appropriate patients for the dog, and they have to do 
the hand hygiene.”  
Sub-Theme 2.2.3. Effectiveness of Control Strategies 
Participants were asked how successful the current control strategies were towards 
reducing infection risk of individuals and therapy animals in AAI programs, and 
measures not currently being done that could be added. Almost all participants felt 
control strategies in place were effective as long as they were followed and cited not 
having any reported negative incidences as evidence of their effectiveness. Participants 
shared measures that they were currently doing to increase safety during the visits, 
above the required protocols, including spacing out the time and location of visits to 
minimize patient-patient contact, and additional cleaning of the hospital environment, 
the dog, and dog items (leash, collar, vest, etc.). Also discussed were other possible add-
on control measures, such as increased hand-hygiene signs in the hospital’s main lobby 
and protocols for post-visit dog and handler infection control.   
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HCW: “I think that overall the process that we have has really proven to be very 
effective and very safe since we've had little to no incidents with any of the 
programs … I feel like our policy is pretty comprehensive because it definitely 
touches on dog behavior, human behavior, infections coming into the hospital, 
like infections from patient to patient interacting with the dog.”  
AAI Worker: “I don't know that they've had any incidences. They must be 
effective.  I can't really imagine doing more, to be honest with you.” 
AAI Worker: “But I haven't really seen a lot of focus that is directed that much on 
either after-care, like after the visit or like addressing the needs, the kind of 
particular needs of the animal or the handler.” 
HCW: “Sometimes several times a day we'll wipe [the therapy animal] down 
[with antiseptic wipes]. But we just decided to do that ourselves. Our Infection 
Prevention team didn't tell us to do that. But I saw that a lot of places were doing 
that, so we just decided to do that practice as well.” 
Sub-Theme 2.2.4. Adherence to Control Strategies 
Participants reported that in general adherence to current infection control strategies 
was very high. Volunteer handlers especially mentioned that they did not want to do or 
not do any actions that would take away the allowance of them being in the hospital. The 
measure that was stated to have the most variability of adherence was the hand hygiene 
of patients, visitors, and staff. Other policies, such as no contact precaution patients and 
pre-visit dog bathing, were said to be adhered to very strictly. It was reported that these 
control strategies could occasionally be a barrier to participating in AAI sessions by both 
therapy animal teams and HCW. Handlers mentioned that bathing the dog before every 
therapy session was not always feasible or healthy for the dog.  
AAI Worker: “We're pretty vigilant. It's really drilled into us. And it's a privilege 
to go there. So you don't want to do anything to remove that privilege for yourself 
or for the others.” 
HCW: “The one that's probably broken most often is the [hand hygiene] and 
some handlers are more and that.... I think, like in a clinical setting on the unit, 
it's probably adhered to better than when the dog gets down into more of the 
public spaces and there aren't the antiseptic dispensers everywhere … that 
doesn't seem to be followed as closely.” 
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AAI Worker: “Folks are supposed to foam up before they pet the dog. I would say 
that one's not 100-percent adhered to … but, we're very good about not breaking 
those rules. We don't want to lose the capacity to have our dogs there. It's not 
worth it.” 
Theme 2.3: Responsibility 
A theme that arose from the data was the concept of who is in charge of safety during 
these visits, and what training goes into preparing these individuals for that 
responsibility. Perceptions in this theme were broken into three sub-themes.  
Sub-Theme 2.3.1. Individual in Charge of Program Safety 
Opinions were split between participants on who was responsible. Some stated that the 
volunteer handler was the person primarily in charge of protecting safety, particularly 
those programs where the volunteer would see patients without the escort of a hospital 
employee. Other participants said it was a combined responsibility, where the hospital 
employee was in charge of the patient and the handler was in charge of the dog. It was 
also mentioned that hospital leadership (both AAI program directors and hospital 
administration), as well as the organizations certifying the therapy dog teams, had an 
important role in the safety of these visits, since they were in charge of designing control 
measures and ensuring adherence.  
AAI Worker: “It's my job. That's my volunteer position to handle my animals 
properly, to abide by the rules and to have a safe and happy experience with the 
children.” 
HCW: “I would say in my experience the therapist needs to lead the session, but 
really I feel like the handler and the therapist have equal responsibility in the 
safety. My goal-- mine is to keep my patient safe, and I think the handler should 
keep the dog safe, so if they're both safe we're good.” 
Sub-Theme 2.3.2. Training of Handlers and Other Responsible Parties 
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Since handlers were frequently reported to be in charge of these visits, opinions on the 
level of training they received to reduce infectious disease risks were reviewed, and how 
effective their training was in making sure they are comfortable to lead these AAI visits. 
In general, participants felt the training was adequate, with both the volunteers stating 
they felt prepared and HCW commenting on the knowledge of volunteer handlers.  
HCW: “I can understand for being super cautious with that too. So I think just a 
volunteer, making sure that that person has an understanding and the training to 
be interacting with a lot of different families and different circumstances and 
experiences day to day.” 
HCW: “It was interesting to see the dogs were very well trained. They were gentle. 
And the provider who came with them was also well-trained, was really good with 
working with the kids.”  
AAI Worker: “Handlers should try to educate themselves about that so they can 
be advocates for themselves and for their [animal] partners to have a safer 
experience.”  
AAI Worker: “I would say that really good training of your volunteers is 
important, in addition to having the best dogs. You get back what you put in ... 
that's why I put so much training into our volunteers, because they're going to be 
the point person.” 
Sub-Theme 2.3.3. Risk to Handlers and Therapy Animals 
Responsibility and training were related to the potential risks that the therapy animal 
team undertook during these visits. In addition to infection risk to both the handler and 
the dog, other possible concerns specific to the hander included how seeing patients in 
physical or mental distress could be alarming. For the therapy animal, concerns were of 
stress or burnout during the visits, and the risk of physical harm.  
HCW: “I think about the handlers a lot because our program is volunteer 
handlers, that they're walking into, in my case, a pediatric intensive care unit, 
which might be something if it's their first visit, that is something they've never 
encountered. And so I want to make sure that what the handler experiences isn't 
beyond their ability to cope with it, and that they're well prepared.” 
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AAI Worker: “I've had two or three incidents where somebody was a little too 
rough with [the therapy dog], not intentionally, but they just don't quite have 
control over their motor skills. So, making sure you maintain safety for the 
handler and dog as well, I think is really important.”  
AAI Worker: “You don't want to scare people away from participating, but you 
want them to make an informed decision about, you know, risks that they might 





This study evaluated perspectives on risk and benefits in hospital AAI programs from key 
stakeholders, including healthcare workers and AAI workers. The qualitative 
methodology study design, which has been previously shown to be effective at identifying 
benefits for AAI in patient populations (Shen, Abrahamson 2016), allowed us the obtain 
knowledge, beliefs, and practices from individuals who are intimately involved in these 
programs. We found major themes within each of the two topic areas; program use for 
staff including benefits, barriers, and facilitators, and infectious disease risk, including 
concerns, control measures, and responsibility. These themes link together and can 
provide insight into appropriate program implementation.  
Perceived Risk influences Program Utilization, for Staff and Patients 
The benefits of AAI programs for staff—stress reduction, morale booster, improved job 
function, and gateway to other therapy—were stressed throughout the interviews by both 
HCW and AAI workers. Stress reduction and morale bolstering have been previously 
shown in adult patient populations (Ein et al., 2018; Waite et al., 2018), however even 
though HCW face different occupational stressors than patients, they expressed similar 
benefits. Stress reductions interventions directed towards healthcare workers have been 
associated with improved job function, such as mental health counseling, 
yoga/mediation, and group bonding discussions (Brand et al., 2017; Hall et al., 2016; 
Pradas-Hernandez et al., 2018), yet this was the first study to show the potential utility of 
AAI for this purpose. An interesting finding that arose was how AAI sessions could be 
combined with other proven therapy programs to have a potential multiplicative 
beneficial effect, as well as be more inclusive of people with different personalities and 
coping styles. For program implementation, it may be advantageous if therapy dog 
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handlers receive training in basic human stress reduction techniques, which could be 
applied to patients and HCW.  
However, the benefits of AAI programs are limited by the reported barriers described by 
participants; that timing and location of programs can conflict with clinical duties, and 
conflict with agreement that the top priority for AAI programs was to target patients. 
These opinions were shared equally by both HCW and AAI workers. However, 
participants also conveyed various facilitators that could be used to resolve these 
program obstacles. There were diverse opinions on how best to implement these AAI 
programs, in terms of timing and location, reflecting the need for individualized 
programs based on unique hospital and department staff needs and schedules. Having 
appropriate staffing to cover clinical roles was perceived to reduce the burden on HCW, 
so they would feel they have adequate time to join in AAI programs. The importance of 
leadership roles was particularly highlighted, both within the department to help with 
staff scheduling, and at the administration and management level, to advocate for the 
use of these programs as an important tool for HCW wellbeing, independent of their 
patient benefit. AAI was reported to be a finite resource, in terms of staff support, 
number and availability of therapy dog teams, and program funding, limiting its use for 
patients and even more so for HCW, who would rather it be used for patients. However, 
with successful advocacy and administrative buy-in, these programs could obtain the 
support they need to grow, to create a “win-win” situation for patient and HCW 
wellbeing. With these facilitators in place, this can overcome many of the barriers and 
lead to an increase in program utilization for HCW benefit. Leadership and program 
advocates could push that HCW involvement be part of the mission statement of hospital 
AAI programs, and harmonize the benefits for patients and HCW. 
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The other topic area was risks related to hospital AAI programs, both for patients and 
staff, and both HCW and AAI workers primarily reported infectious disease concerns. 
Nonetheless, while concerns, and the source of those concerns, were explored, a 
surprising number of participants reported that they had few concerns for these 
programs. The lack of concern was mainly attributed to the efficacy of (with strong 
adherence to) control measures. This is reflected in published guidelines from major 
healthcare organizations that promote AAI therapy as a low-risk activity (Murthy et al., 
2015). Yet, there is a drawback to this lack of concern— this could be a barrier to 
properly designed and applied control measures that would reaffirm people who do have 
concerns and hesitancy for AAI, particularly those in positions of power 
(leadership/management). The best situation is if individuals on the ground (HCW and 
AAI workers) are aware of the risk, understand the magnitude of the risk (how serious it 
is in reference to other procedures), and know the appropriate methods to reduce that 
risk. Previous qualitative studies have shown that HCW perceptions and attitudes affect 
the implementation of precautions to prevent transmission of hospital pathogens and 
have identified communication and knowledge as a vital component of those attitudes 
(Nichols & Badger, 2008; Saint et al., 2008; Seibert et al., 2014; Yiwen et al., 2010). It is 
necessary that staff be aware of and understand existing policies, including their 
rationale, which relates back to the role of leadership in proper training and 
communication. Interestingly, in this study, most participants commented on the low 
risk of therapy dogs in the context of the dogs bringing an infectious agent into the 
hospital, but only a few talked about the role of the dog as a potential vector, and even 
fewer discussed the role of the handler. Research has shown that therapy animals can 
carry hospital-associated pathogens (Dalton et al., 2020), therefore acknowledging this 
potential risk and focusing on ways to minimize this risk is critical for the continued 
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safety of these programs.  
Program benefits may be strengthened by understanding potential risk, the design and 
implementation of appropriate control measures, and ensured adherence and 
monitoring from the designated responsible parties. Infectious disease concerns are one 
of the major barriers to program utilization for both patients and HCW. This barrier is 
addressed through control strategies, leadership, and collaboration, which will ensure 
the continued use and potential expansion of these beneficial programs. Like many other 
human-animal bond programs, a comprehensive and holistic outlook is needed into 
order to ensure program sustainability.   
Limitations 
While this research has many strengths and innovations, there are a few limitations. The 
first is that the majority of our participants worked or volunteered at pediatric hospitals, 
rather than adult hospitals. While AAI programs are more frequently used in pediatric 
populations (Linder et al., 2017), capturing opinions on adult populations may lead to 
potentially different perspectives and more widespread findings that could be applied to 
other settings, such as nursing homes and long-term care facilities. Second, it was 
recognized there were significant differences in protocols across hospitals, and the 
majority of our participants were from three hospitals. Including more hospitals with 
heterogeneous program implementation guidelines, staff knowledge and buy-in, and 
infection control policies may lead to different findings.   
Future Directions 
The findings from this research can be used to design a wide-reaching quantitative 
survey, which can capture differences across patient populations and hospital protocols. 
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Qualitative data has been used successfully to design and implement quantitative 
surveys, due to its intricate ability to provide in-depth context to a topic matter, which 
will allow future research to design survey questions that are appropriate, unambiguous 
and meaningful (Degeling & Rock, 2020). Particularly since the field of human-animal 
interactions is so complex and multi-faceted, this qualitative groundwork will lead to 
more suitable objective means and measurements.  
The results of this study, and future work in this field, can significantly impact the 
preservation of hospital-based AAI programs. While it has long been known how 
beneficial these programs are for patients, their use in HCW populations is a novel 
application. Given how critical the problem of occupational stress and burnout is to this 
population, novel strategies are needed. These foundational results suggest their positive 
usage for HCW, which could potentially be extended to other high-stress occupations, 
such as first responders. Evidence-based guidelines that address both administrative and 
hazard concerns will make possible the safe and effective implementation of hospital AAI 
programs, and reassure hospital administrations and other leadership roles of the value 




4.6 Tables  
 
Table 1: Participant Recruitment Job Classifications  
 
Study Population Total 
Healthcare Workers 19 (51%) 
Physicians 4 
Nurses 6 
Child Life Specialists 3 
Rehabilitation Therapists (PT/OT) 2 
Clinical Social Workers and Psychologists 4 
AAI Workers 18 (49%) 
Volunteer Handlers 13 
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Animal-assisted intervention (AAI) programs have been used extensively in healthcare 
facilities due to their numerous reported benefits to patients (Bert et al., 2016; Kamioka 
et al., 2014; Waite et al., 2018). These programs have also increasingly been used for 
healthcare workers, as a targeted intervention to reduce occupational stress and burnout 
symptoms (Abrahamson et al., 2016). However, barriers, specifically infection control 
concerns, prevent AAI programs from being used in many hospitals and populations.  
This qualitative pilot study aimed to assess key stakeholders’ opinions on benefits and 
concerns related to hospital AAI programs, particularly occupational health benefits for 
hospital staff and infectious disease concerns. We report on key stakeholders’ 
perspectives and experiences and, through these reports, develop a conceptual 
framework to recommend measures in order to better implement and support these 
programs. 
As part of a larger study on hospital AAI program-related risks and exposures, we 
interviewed 37 healthcare workers and therapy animal handlers from multiple hospitals. 
We thematically coded interview transcriptions based on deductive programmatic 
framework analysis. The study underwent research ethics review and approval. See 
[Chapter 4] for further details on methodology and study participants.  
Participants reported that these programs did benefit hospital staff by reducing stress 
and bolstering morale. This indirectly led to an improvement in job performance 
through increased employee engagement, as well as directly providing an “additional 
tool in their toolbox” for improved patient care. Finally, these programs were reported to 
be a gateway and incentive to other therapy programs, such as mental health counseling. 
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Administrative barriers were reported, mainly prioritizing these programs for patients 
and balancing routine clinical functions. Participants conveyed that these administrative 
barriers could be overcome with appropriate staffing and leadership, as well as 
collaboration across the hospital and management “buy-in,” to underscore their 
importance for staff usage.    
Infection concerns were reported as a frequent barrier to program implementation, both 
for patient and healthcare worker use. Participants described their concern of the dog 
serving as an intermediary vector in the spread of pathogens between patients, staff, and 
the hospital environment. However, many of the participants, both pet therapy handlers 
and healthcare workers, felt this risk was minimal through the adherence of effective 
control measures, which should target the animal, the patients, and the hospital, 
designed with practical input from multiple stakeholders. The primary facilitator to 
appropriate enactment of control measures was the designation of individuals 
responsible for safety, including staff leadership and volunteer handlers, and relevant 
training of all individuals involved with these programs, about potential risks and ways 
to mitigate risk.   
Through these reports, we developed a conceptual framework (Figure 1), adapted from 
the Consolidated Framework for Implementation Research (CFIR) (CFIR Research 
Team, 2017) and the Environmental Protection Agency’s (EPA) Risk Management 
Framework (US EPA, 2014), that links our major themes in the context of program 
implementation. Hospital objectives and needs feed into program implementation, part 
of which is addressing program barriers through facilitators. Perceived barriers, both 
administrative and infection risk as described, can be addressed through a risk 
management framework: 1) identify the hazard (e.g., infection concerns), 2) assess and 
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characterize said hazard, and 3) manage that hazard through the enactment and 
monitoring of mitigation strategies (control measures). This results in an adaptive, 
tailored protocol based on individual program needs. Critical to the design and execution 
of program implementation is multi-stakeholder engagement and hospital leadership 
roles, to ensure diverse, comprehensive input and protocol adherence. Implementing 
adaptive AAI programs, through targeted facilitators, results in program benefits for 
both patients and staff, since many program barriers and facilitators are for both. This 
ultimately creates a reinforcing feedback loop of improved program implementation by 
substantiating hospital needs. 
Our qualitative study provided insight into the appropriate AAI program 
implementation, both directed towards patients and HCW, based on the unique 
experiences and perspectives from individuals who are actively involved in these 
programs and have crucial roles in their administration. Through participant reports and 
the development of our conceptual framework, we identified three major areas for 
program improvement. First is the need for a tailored risk assessment to understand 
barriers unique to individual programs, hospitals, departments, and patient populations, 
to develop tailored adaptive protocols. Secondly, hospital leadership roles are essential to 
ensure training and appropriate communication of these policies critical to program 
success. Lastly, collaboration across the hospital is needed to design protocols for AAI 
programs with input from multiple stakeholder groups. This will ensure that program 
guidelines are comprehensive and practical.    
Understanding diverse perspectives and issues from those on the ground can be used to 
develop targeted interventions and guidelines. The resulting conceptual framework 
model can serve as a scaffold guideline for those hospitals wishing to start or extend AAI 
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programs, noteworthy for hospital administrators, particularly those involved in 
infectious disease control and epidemiology, and occupational health and safety. The 
detailed level of contextual qualitative data obtained from our participants can be 
utilized to develop a practical quantitative survey in order to collect data from a wider 
scope of hospitals and participant groups and to increase the generalizability of the 
research findings and recommendations. The results of this, and future work, will have 
significant implications in the utilization and preservation of these valuable AAI 
programs.    
 136  
5.2 Figure 
 
Figure 1: Conceptual Framework for Hospital Animal-Assisted Intervention Program Implementation 
 
Adapted from CFIR and 
EPA Risk Framework 
(yellow box). Blue box = 
program barriers and 
facilitators, grey box = 
program implementation, 
red boxes = external 
influences. Circled arrow 
with R = positive 
reinforcing feedback loop, 
where appropriate 
program implementation leads to an increase in program benefits, which validates and increases hospital needs for these programs.  
* Most commonly documented patient benefits from systematic reviews of previous literature (Bert et al., 2016; Kamioka et al., 2014; Waite et al., 
2018) 
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Therapy animals in hospital-based animal-assisted intervention programs are an 
invaluable part of holistic patient care. However, these dogs may be exposed to hospital-
associated pathogens through these activities. This pilot study sought to examine a 
therapy-dog decolonization strategy for infection control by exploring the effects on the 
therapy’s dog entire microbial composition. We found that the chlorhexidine 
decolonization intervention altered microbial alpha diversity and shifted microbial 
structures in these therapy dogs, particularly more phylogenetically rare taxa. 
Specifically, the intervention reduced the abundance of Staphylococcus 
pseudintermedius but did not reduce levels of S. aureus, a common human hospital 
microbe. These preliminary findings hint at the importance of taking into consideration 
holistic microbial communities when undertaking infection control strategies and stress 
the need for further research to understand the unintended consequences of their usage 





The benefits of the human-animal bond have extended into the use of animal-assisted 
interventions, which are increasingly used in healthcare facilities for their widely 
recognized benefits (Kamioka et al., 2014; Waite et al., 2018). However, risks to both the 
patients and therapy animals from exposure to hospital-associated pathogens are not 
fully characterized. Previous work has shown that therapy animals that volunteer in 
hospitals are five times more likely to carry methicillin-resistant Staphylococcus aureus 
compared to therapy animals that volunteer in other non-healthcare settings (Lefebvre et 
al., 2009). Infection control strategies designed to reduce the spread of pathogens 
between patients and therapy animals have been considered to improve program safety 
and increase their beneficial utilization.  
A common infection control practice is the use of disinfectants on frequently touched 
environmental surfaces, or fomites. This can include the fur and gear of therapy animals. 
Topical disinfectants have been shown in previous research to reduce the bacterial 
burden of culture-based Staphylococcus aureus on therapy animals, as well as reduce 
the transmission to patients (Dalton et al., 2018). However, disinfectants have been 
shown to alter the microbial composition of both humans and dogs. In humans, topical 
disinfectant effects were dependent on personalized and body site-specific colonization 
signatures but lowered overall microbial diversity level (SanMiguel et al., 2018). In dogs, 
chlorhexidine disinfectants are frequently used to treat atopic dermatitis, which is 
characterized by a higher abundance of staphylococcal species and lower overall diversity 
(Chermprapai et al., 2019; Tress et al., 2017). Treatment with a topical disinfectant and 
targeted antimicrobials restored the dermal microbiome in atopic patients (Bradley et 
al., 2016). It is unclear what impact topical disinfectants might have on the skin and 
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nasal microbial communities of healthy therapy animals. Therapy animals, with their 
frequent hospital exposure, may have unique microbial compositions compared to 
normal pet dogs. These distinct communities could then be differentially affected by the 
disinfectant.  
Therefore, the goal of this research is to describe the skin and nasal microbial 
composition of therapy dogs and how this composition is influenced by the use of a 
chlorhexidine decolonization intervention. The results of this work will inform the design 
of more extensive studies, with implications for infection control strategies.  Such work is 
critical to minimize unintended consequences to the health of these volunteer therapy 





This pilot study was conducted in a mid-Atlantic hospital between July 2016 and May 
2017. The study protocol was approved by all applicable institutional review boards, 
institutional animal care and use committees, and scientific review committees prior to 
data collection. Canine participants were registered therapy animals volunteering at an 
academic hospital’s animal-assisted intervention program. These therapy visits were 
group sessions, lasting one hour, where multiple pediatric patients interacted with the 
animals.  
Data Collection 
Enrolled therapy dogs underwent two observational control visits, where they adhered to 
existing hospital guidelines, requiring the dog to be bathed using an over-the-counter 
shampoo of the owner’s choice within 24 hours prior to entering the hospital. Matched 
samples were collected from all individuals before and after the therapy session. All 
sample collection was done by trained research staff.  
A detailed description of sample collection is described elsewhere, see [Chapter 7]. 
Briefly, we obtained nasal, oral, inguinal, and perineal samples from the therapy dog 
before and after every therapy session. Samples were collected using sterile flocked 
swabs (Puritan, Guilford, ME, USA), which were stored at -80ºC until processing. 
Handlers were asked survey questions about their therapy dog’s medical history and 
volunteer work at every visit. We captured the total number of patients that interacted 
with the dog at every visit.  
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Intervention 
After two control visits, the therapy dog team underwent two intervention visits using a 
two-part decolonization intervention on the therapy dog. First, the therapy dog handler 
used a 4% chlorhexidine-based veterinary prescription shampoo (DUOXO Ceva, 
Libourne, France) prior to the study visit. Second, during the therapy visit, the dog was 
wiped down with 3% chlorhexidine wet cloths (DUOXO Ceva, Libourne, France) down 
the dorsal head and back, “the petting zone”. Handlers were given information about 
both products before usage. The same data collection protocol was implemented for 
these intervention visits, as described above.  
Laboratory Processing for Microbial Communities 
A detailed description of laboratory and sequencing protocols are described, see 
[Chapter 7]. DNA was extracted from the thawed sterile flocked swabs, and the V1-3 
region of the 16S rRNA gene was PCR-amplified and sequenced using established 
protocols for microbial composition analysis using the Illumina MiSeq (Illumina, San 
Diego, CA) at the University of Pennsylvania Next Generation Sequencing Core (Fadrosh 
et al., 2014). 
QIIMEv2.7 was used to match sequencing reads to samples (Bolyen et al., 2019), and the 
DADA2 pipeline was used for quality filtering and clustering samples into features 
(amplicon sequence variants, ASVs) (Callahan et al., 2016). ASVs were matched to 
taxonomy and phylogeny using established pipelines, see [Chapter 7]. Unidentified 
sequences not matched to taxonomy on our classifier were manually entered into the 
NCBI BLAST database for taxonomic classification. Quality control was ensured through 
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identifying likely taxa contaminants through negative controls collected during field 
sampling, DNA extraction, and sequencing (Davis et al., 2018). 
Statistical Analysis 
Statistical analyses were performed in RStudio v1.1.423 (R Development Core Team, 
2010). To maintain the maximum number of samples for comparison, the sequencing 
data was not rarefied for statistical analysis. Taxa tables, and matching phylogeny and 
taxonomy, were analyzed using the phyloseq pipeline to calculate alpha (within sample) 
and beta (between samples) diversity metrics (McMurdie & Holmes, 2013). The negative 
binomial-based model DESeq2 program was used to identify differential abundance of 
key taxa between groups (Love et al., 2014). Kruskal-Wallis nonparametric one-way 
analysis of variance test was used to examine differential alpha diversity between all 
groups, and Wilcoxon rank-sum test was used for pair-wise comparisons between 
groups, both adjusted for multiple comparisons using the Benjamini-Hochberg false 




Study Population and Samples 
A total of 4 dogs were included in the study over 13 visits, with 5 intervention study 
visits, shown in Table 1. Ages were equally distributed, and more dogs were female. 
Therapy dog handlers reported recent veterinary antibiotic usage in the last month in 
38% of the visits, and a recent veterinary hospital visit in the last month in 23% of the 
visits. Therapy dog handlers reported being involved in AAI programs more than once a 
week after 38% of the visits. Of the 13 visits, 54% had more than 3 patients interacting 
with the dog during the therapy visit. A total of 100 swabs were collected for microbial 
analysis - 26 each nasal, oral and perineal swabs, and 22 inguinal samples. All samples 
were matched for pre- and post-visits.  
Taxa Abundance 
The relative abundance of taxa was different both across sample locations and individual 
dogs, as shown in Figure 1.A-D. Both the nasal and oral samples tended to be 
dominated by key taxa, such as Staphylococcus (mean relative abundance 0.111), 
Porphyromonas (mean 0.099), Corynebacterium (mean 0.095), and Moraxella (mean 
0.073) genera, while inguinal samples had a higher number of more unique taxa. 
The intervention impacted levels of the top genera in different ways, also shown in 
Figure 1.E. The intervention reduced the mean relative abundance of Staphylococcus, 
Corynebacterium, and Capnocytophaga taxa (DESeq p<0.0001). Conversely, 
Conchiformibius and Fusobacterium were increased in intervention visits (DESeq 
p<0.0001). No significant difference was found in taxa between pre- and post-visit 
samples overall, and within each site.   
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Staphylococcal Species Abundance 
Figure 2 represents the relative abundance of the top three Staphylococcus species - S. 
aureus, pseudintermedius, and schleiferi, and demonstrated no significant changes 
between pre and post samples (absolute abundance depicted in Supplement Figure 
1). However, there was a significant difference in the relative abundance of S. 
pseudintermedius between control and intervention samples among pre samples 
(relative abundance 0.043 in control and 0.0008 intervention, Wilcoxon rank-sum test 
p=0.002) and post samples (relative abundance 0.042 in control and 0.004 
intervention, Wilcoxon rank-sum test p=0.008).  
S. schleiferi abundance was also shown to be decreased due to the intervention (mean 
relative abundance 0.026 in control and 0 in intervention, Wilcoxon p=0.036), with 
equal association seen in both pre and post samples. S. aureus levels were not 
significantly different between control and intervention visits, within pre or post 
samples.  
Alpha Diversity 
Alpha diversity by site was evaluated with Shannon and Faith’s phylogenetic metrics, 
shown in Figure 3.A&B. When comparing across anatomical sites, nasal, oral and 
perineal samples were more similar to each other in alpha diversity levels, which were all 
statistically different than the overall alpha diversity in inguinal samples (Kruskal-Wallis 
test p<0.001 for all pairwise comparisons with inguinal samples, for Shannon and 
Faith’s). There was no statistical difference in Wilcoxon rank-sum test when comparing 
the overall alpha diversity levels from pre- to post-visit, in all samples and within each 
site, and across individual dogs. 
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In individual-level changes, shown in Figure 3.C&D, there was an overall increase in 
alpha diversity after control visits (mean Shannon change 0.18, mean Faith change 6.54) 
and an overall decrease in intervention visits (mean Shannon change -0.26, mean Faith 
change -1.93). Perineal and nasal samples showed the most substantial difference 
(significant difference in Faith metric using Wilcoxon rank-sum test p<0.05). This same 
effect was seen in both pre and post samples. All other comparisons of diversity levels at 
each sample site, both overall and within pre and post samples, were not significant. 
Supplement Table 1 shows how additional dog demographics, such as age, sex, and 
medical history, impacted alpha diversity levels. Significant associations were observed 
based on recent antibiotic usage and veterinary hospital visit, as well as reported AAI 
frequency (the number of times the dog participated in AAI programs) and the number 
of patients in the visit.  
Beta Diversity 
Principal coordinate analysis plots are displayed in Figure 4, overall and within each 
site, using both weighted UniFrac and unweighted UniFrac distance. Clustering was 
observed by sample site (PERMANOVA FDR-corrected p<0.001 for both weighted and 
unweighted UniFrac distance) and by subject overall and within each individual site 
(PERMANOVA p<0.001 for both weighted and unweighted UniFrac distance). There 
were no differences in microbial composition when comparing before versus after the 
visit, overall and within each site.  
There was a difference in microbial composition between samples in control visits and 
intervention visits (PERMANOVA p=0.03 unweighted and p=0.009 weighted). The 
impact of the intervention on microbial composition was different based on the sample 
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site. For unweighted UniFrac, only perineal samples showed microbial composition 
differences between control and intervention visits (PERMANOVA p=0.03). Using the 
weighted UniFrac metric, only nasal samples had a significant PERMANOVA p-value 
below 0.05. There was no difference in intervention effect when stratifying by pre or post 
visit.  
Supplement Table 1 shows the distance between two samples by dog demographic 
factors, such as age, sex, and medical history. There was a significant difference in the 
microbial composition of dogs based on their age, sex, and recent antibiotic usage, using 
both unweighted and weighted UniFrac distance. Recent veterinary hospital exposure 
and the number of patients in the therapy visit were shown to impact the unweighted but 
not weighted UniFrac distance, while reported AAI frequency did not have an 




The research aimed to explore the microbiota of healthy, non-atopic dogs that 
participate in an animal-assisted intervention program and to examine the influence of 
topical chlorhexidine use on therapy dogs in the context of a pilot infection control 
intervention. We found that body sites were uniquely affected by the chlorhexidine 
intervention, and more phylogenetically rare taxa and dogs-specific taxa such as S. 
pseudintermedius were shown to be reduced post-intervention.  
Therapy Dogs Compared to Normal Pet Dogs 
Similar to normal companion dogs, therapy dogs showed unique patterns across body 
sites. Samples were more similar to the same site on another individual dog than to 
another site on the same individual, confirming that the ecological body site niche is a 
more significant determinant of microbiota composition (Chermprapai et al., 2019; 
Cuscó et al., 2017; Grice et al., 2009; Misic et al., 2015). As with humans, the skin 
microbiota in our canine participants varied between different body sites, presumably 
because of differences in the local cutaneous microclimate. Previous studies have shown 
that the canine bacterial community is diverse and variable across different body sites 
within the same dog, and across the same site in different dogs (Hoffmann et al., 2014). 
Alpha diversity metrics, assessed by Shannon’s and Faith’s Phylogenetic diversity, were 
shown to be unique across body sites, with nasal samples dominated by few key taxa and 
inguinal samples having a higher number of more unique taxa. Similar to previous 
studies, therapy dogs had higher diversity levels in haired regions (inguinal skin) than 
mucosal areas and mucocutaneous junctions (Hoffmann et al., 2014). Staphylococcus 
was increased in these therapy dogs, particularly in nasal samples, compared to prior 
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reports that Moraxellla tends to be the dominant taxa (Bradley et al., 2016; Tress et al., 
2017). Nonetheless, Staphylococcus spp. in these therapy dogs was less than what is 
reported in dogs with underlying pathologies, such as atopic dermatitis, pyoderma, or 
chronic rhinosinusitis (Bradley et al., 2016; Tress et al., 2017; Weese, 2013). Although no 
comparison dogs were sampled for this pilot study, the differences between this study 
and the literature may suggest that frequent hospital exposures experienced by these 
dogs could affect their microbial composition. This same finding has been reported from 
research on healthcare workers when comparing their microbial composition to the 
general population (Rosenthal et al., 2013). 
Effect of the Decolonization Intervention on Microbiota 
Diversity metrics, both alpha (within-sample) and beta (between-sample), was shown to 
be influenced by the chlorhexidine in similar ways. Dogs tended to have increased alpha 
diversity in control visits from pre to post samples, and decreased diversity from pre to 
post samples in intervention visits. There were minimal changes in alpha levels within 
samples comparing pre to post samples, as well as minimal changes in beta differences 
in microbial composition between pre samples compared to between post samples. 
However, there was a significant difference between control versus intervention samples. 
Intervention samples tended to have lower alpha diversity and have significantly 
different microbial compositions compared to control samples. This association was 
more robust when using phylogenetically weighted metrics (Faith’s alpha diversity and 
weighted UniFrac beta diversity) and within nasal and perineal sites. 
Taking the results from both alpha and beta diversity together, the differences 
appreciated due to the chlorhexidine intervention are driven primarily by more 
phylogenetically rare taxa rather than common taxa. Previous studies on pet dogs (Davis, 
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2016; Oh et al., 2015; Song et al., 2013) have shown that dogs have more diverse unique 
microbial communities compared to their human counterparts. It can be proposed that 
these phylogenetically rare taxa originate from the dog, which are reduced by the dog 
decolonization. Nasal and perineal sites, which both tend to have lower diversity levels 
overall, are more influenced by this disturbance. This is an interesting finding, that a 
topical treatment could be associated with altered microbiome on sites not directly 
exposed to the chlorhexidine (shampoo just on the skin, and wipes just on the dorsal 
back/head).  
To determine which microorganisms were associated with this change in diversity, we 
evaluated the abundance of identified taxa, which were differentially impacted by the 
chlorhexidine intervention. Staphylococcus, Corynebacterium, and Capnocytophaga 
species were shown to be reduced during the intervention, while Fusobacterium and 
Conchiformibus tended to be increased during the intervention. Staphylococcus and 
Corynebacterium spp. have been shown to be higher in abundance in dogs with medical 
conditions, such as atopic dermatitis (Hoffmann et al., 2014; Pierezan et al., 2016). In 
one study, Capnocytophaga was found in be increased in nasal neoplastic samples 
compared to healthy nasal samples (Tress et al., 2017). Studies on the effect of 
chlorhexidine in human skin have also identified an association with decreases in overall 
diversity levels and decreases in specific Staphylococcus and Corynebacterium taxa 
(SanMiguel et al., 2018). 
Due to its clinical significance, Staphylococcus was further evaluated at the species level. 
The chlorhexidine intervention impacted the abundance of S. pseudintermedius and to a 
lesser degree S. schleiferi, more so than S. aureus, the three dominant staphylococcal 
species observed. Both S. pseudintermedius and S. schleiferi were shown to be decreased 
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during the intervention, significantly so for S. pseudintermedius, while S. aureus slightly 
increased abundance in intervention visits (in both relative and absolute levels). Again, 
even though the intervention was used just on the skin, nasal samples showed the 
greatest difference. This is not surprising because Staphylococcus species frequently 
colonize the nose in dogs (Iverson et al., 2015; Weese & van Duijkeren, 2010). S. 
pseudintermedius and S. schleiferi tend to be dog-specific microbiota and tend to only 
incidentally contaminant humans (Weese & van Duijkeren, 2010). 
It is uncertain from our single timepoint samples if the intervention selectively removed 
or reduced certain taxa, such as dog-specific S. pseudintermedius, S. schleiferi, and 
phylogenetically diverse microbiota. Another possibility is that the decolonization 
removed or reduced all microbiota equally, but prior to sampling, the therapy dog was 
recolonized with microbiota that are more commonly associated with humans or the 
hospital environment. This would result in what appeared to be no change in the 
abundance of common taxa, such as S. aureus. The source of this re-colonization could 
be from hospital exposure, from interaction with other individuals while going to the 
therapy visit (prior to our pre-visit sampling), or even from the therapy handler.  
Limitations and Future Directions 
A limitation of this pilot study is that our samples only reflect carriage of 
microorganisms at one timepoint. We cannot make inferences from our data on whether  
these microbial exposures and observed changes are transient contamination or stable 
colonization. Future research in this field will examine the temporal progression and 
stability of microbial community alterations due to the decolonization; abundance of key 
taxa of clinical concern and dog-specific microbiota, as well as overall diversity levels. 
Further study would also benefit from understanding the secondary health consequences 
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of the decolonization intervention within this therapy dog population, such as the role of 
S. pseudintermedius as a protective commensal versus opportunistic pathogen, and 
possible competition with S. aureus. The zoonotic potential of both is important to 
consider as these therapy dogs frequently interact with patients with compromised 
immune function.  
Conclusions 
This study benefits from being the first to examine the microbiota of therapy dogs and 
the effect of a decolonization intervention on therapy animals in hospital animal-assisted 
intervention programs. Understanding cutaneous microbial ecology is essential to create 
future targeted therapies that might require not only a reduction in exposure to 
pathogenic bacteria, but also a promotion of the symbiotic commensal microbiota. This 
pilot study presents the feasibility and importance of assessing holistic microbial 
communities in this essential canine worker population. The study demonstrates the 
potential for infection control practices, designed to limit exposure to pathogens, to alter 
microbial communities more broadly, with unknown consequences. This has important 
implications for handlers and practitioners in charge of these therapy dogs’ care and 
hospital administration, on the importance of considering the holistic microbial 
environment when designing interventions to keep these hospital animal-assisted 
intervention programs safe for patients and the therapy dogs.    
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6.6 Tables and Figures  
 
Table 1: Study Population 
  Total 
Unique Dogs 4 
Age < 6 years old 2 (50%) 
Male 1 (25%) 
Study Visits 13 
Intervention Visits 5 (38.5%) 
Antibiotics Last Month 5 (38.5%) 
Veterinary Hospital Visit Last Month 3 (23%) 
AAI Frequency >1 week 5 (38.5%) 
Patients in Visits Total > 3 7 (54%) 
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Figure 1: Relative Abundance of Top Genera, by Site and Visit Type (genera with mean abundance >25%) 
 
A-D: Bars represent individual sample-level relative abundance of genera that have a mean abundance above 25%, stratified by site. Black 
horizontal bar divides samples taken from control visits and intervention visits. E: Mean relative abundance of top genera by visit type, aggregated 
pre/post samples and different sites. *** DESeq results p<0.0001 for differential abundance by visit type, red = higher in control, blue = higher in 
intervention  
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Figure 2: Relative Abundance of Key Staphylococcal Species, by Visit Type 
and Time 
 
Bars are aggregated mean relative abundance of top three Staphylococcus species, colored by 
sample site, with error bars for standard error.   
*** Wilcoxon Rank-Sum Test continuity-corrected p<0.01 Control vs Intervention. 
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Figure 3: Shannon and Faith’s Alpha Diversity Levels by Sample Site (overall and changes during visit) 
 
A & B aggregated alpha diversity levels (Shannon A, and Faith B), by sample site, C & D individual level change (post-pre visit) alpha diversity 
levels by sample site 
*** Wilcoxon-Test p<0.05", "Control vs Intervention 
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Figure 4: Principal Coordinate Plots for Unweighted and Weighted UniFrac Beta Diversity Levels by Dog and Site, 
and by Visit Type 
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6.8 Supplementary Materials 
 
Supplement Figure 1: Absolute Abundance of Staphylococcal Species by Site 
 
 
Bars are aggregated mean absolute abundance of top three Staphylococcus species 
dodged by sample site, stratified by pre and post visit and visit type. 
*** p<0.0001 DESeq differential absolute abundance by visit type (overall abundance 
and within nasal samples)
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Supplement Table 1: Changes in Alpha and Beta Diversity Levels based on Dog Factors 
 Alpha Diversity  Beta Diversity 









p-value   











Age                   
<6 years old 3.55 (1.36) 0.9556 30.1 (20.3) 0.1218  0.638 (0.119) 0.0001 0.756 (0.193) 0.0001 
>6 years old 3.54 (1.2)   33.3 (16.8)    0.662 (0.118)   0.737 (0.224)   
         
between group 
distance+ 0.662 (0.105)   0.777 (0.224)   
Gender                   
Male 3.15 (1.13) 0.0097 26.0 (12.4) 0.0064  0.623 (0.141) 0.0001 0.709 (0.224) 0.0001 
Female 3.74 (1.29)   34.4 (20.1)    0.657 (0.109)   0.768 (0.201)   
          
between group 
distance 0.665 (0.108)   0.769 (0.177)   
Antibiotics  
last month                   
Yes 3.03 (1.23) 0.0001 24.3 (12.0) 0.0016  0.617 (0.137) 0.0001 0.745 (0.227) 0.0001 
No 3.87 (1.19)   32.2 (20.2)    0.661 (0.104)   0.756 (0.192)   
          
between group 
distance 0.667 (0.137)   0.773 (0.184)   
Hospital  
last month                   
Yes 2.88 (1.0) 0.0012 21.1 (7.54) 0.0032  0.578 (0.118) 0.0002 0.738 (0.213) 0.0148 
No 3.74 (1.28)   34.3 (19.4)    0.570 (0.106)   0.768 (0.193)   
          
between group 
distance 0.647 (0.117)   0.758 (0.192)   
AAI frequency                   
>1week 3.12 (1.27 0.0084 24.5 (13.3) 0.0002  0.628 (0.120) 0.0053 0.775 (0.223) 0.0018 
<1week 3.79 (1.21)   36.5 (19.7)    0.664 (0.106)   0.748 (0.178)   
          
between group 
distance 0.66 (0.115)   0.773 (0.198)   
Child Total                   
> 3 3.92 (1.2) 0.0001 35.9 (19.1) 0.0014  0.664 (0.103) 0.0002 0.752 (0.193) 0.0018 
£ 3 3.07 (1.2)   20.2 (16.1)    0.631 (0.125)   0.768 (0.202)   
          
between group 
distance 0.664 (0.112)   0.768 (0.192   
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*KW = Kruskal-Wallis test for median alpha differences between groups 
+ Beta distance presented as within group distance (eg. mean distance on PCoA 
microbial composition plot between two young dogs) or between groups (eg. mean 
distance on PCoA plot between a young and old dog). PERMANOVA model for beta 
distance differences between groups with FDR-corrected p-value.  
Example: Dogs without antibiotics in last month had higher Shannon alpha diversity, 
and were significantly different in microbial composition for both weighted and 
unweighted UniFrac distance, compared to those who received antibiotics recently
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Hospital animal-assisted intervention programs are a validated and valuable part of 
holistic patient wellness. However, concerns of microbial transmission limit program 
utilization in healthcare settings. This pilot study evaluated the potential for microbial 
sharing between pediatric patients and therapy dogs, both pathogens and general 
microbiota, and determined if patient-dog contact level and a dog decolonization 
protocol modified this sharing. Patients, therapy animals, and the hospital environment 
were sampled before and after every group therapy session. It was found that 
microorganisms were transmitted between patients and therapy animals, as evidenced 
by changes in the relative abundance and overall diversity levels of the microbiome and 
changes in rates of cultured Staphylococcus aureus. Higher contact was associated with 
increased sharing between patients and therapy animals, and between patients. A topical 
chlorhexidine-based dog decolonization intervention was associated with lower 
microbial sharing between therapy dogs and patients, particularly from the removal of 
rare-dog microbiota, but did not significantly affect sharing between patients. This 
suggests that the therapy animal is not the only source of microorganisms during these 
group hospital AAI sessions, and other pathways of exposure to patients should be 
further explored to determine their relative importance. Infection control protocols 





Throughout history, companion animals have demonstrated societal benefits, including 
improved owner mental health and fitness. This concept has led to their use in 
healthcare settings; hospital-based Animal-Assisted Intervention (AAI) therapy is the 
use of animals, typically dogs, as an alternative treatment to improve physical, mental 
and social functions in holistic in- or out-patient care. AAI has been widely implemented 
as a therapy modality in a range of physio-social conditions in various settings in 
healthcare facilities, and is increasingly popular, especially for pediatric patients. 
Research into the effectiveness and overall benefits of AAI is increasing, with the most 
common benefits including a reduction in patients’ requirement for pain medication, 
enhanced socialization, and reduced stress and anxiety (Bert et al., 2016; Charry-
Sanchez et al., 2018b, 2018a; Kamioka et al., 2014; Waite et al., 2018).  
Conversely, one must consider the potential risk of incorporating animals into this type 
of setting, which includes individuals with decreased immune function. Not only are 
allergies and phobias potential problems, but there is a potential for zoonotic disease 
transmission, the spread of diseases from animals to humans. Further, hospitals can be 
incubators for infectious disease agents, such as methicillin-resistant Staphylococcus 
aureus (MRSA), that more typically spread human-to-human or via the environment. 
While close contact and antimicrobial selective pressure inherent to healthcare settings 
enhance pathogen circulation, therapy animals may unwittingly serve as mechanical 
vectors of transmission. Current research on the hazards associated with AAI has shown 
that therapy dogs can carry common hospital-associated pathogens (Boyle et al., 2019; 
Dalton et al., 2020; Lefebvre et al., 2009). But, the evidence is lacking on the spread of 
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these pathogens to humans, potential subsequent infections in both people and therapy 
animals, and the role of the hospital environment.  
However, we know that microbes, including pathogens, function in the context of their 
holistic microbial community, and other microbiota besides pathogens may be 
transmitted during these AAI sessions. Specifically, dogs have unique microbial 
compositions (Hoffmann et al., 2014; Oh et al., 2015; Swanson et al., 2011), which, 
compared to humans, could result in a distinct ability to acquire, carry, and spread 
hospital-associated pathogens, as well as uniquely influence the microbial composition 
of individuals they come into contact, in a way that is fundamentally different than 
contact with other people or objects in the environment. This is best illustrated when we 
look into the research surrounding the microbial shifts resulting from pet ownership, 
which is associated with more diverse microbial compositions that are more frequently 
shared between pet owners (Misic et al., 2015; Song et al., 2013). Early life pet ownership 
is associated with decreased incidents of various immune dysfunctions, and exposure to 
diverse microbes from farming environments, including animals, is protective against 
the development of asthma in children (Azad et al., 2013; Fall et al., 2015; Stein et al., 
2016; Tun et al., 2017). However, these studies refer to chronic exposure from living with 
pets. It is uncertain if these same microbial shifts will occur with transient, often less 
than one hour, exposure of patients to a therapy animal.  
This pilot study aimed to explore the potential for microbial sharing between pediatric 
patients, therapy animals, and the hospital environment during animal-assisted 
intervention programs. We hypothesized that therapy dogs could serve as intermediary 
mechanical vectors in the transmission of microbes between the hospital environment 
and patients, increasing patients’ risk of microbial exposure due to interaction with the 
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therapy animal, as shown in Figure 1. We examined if the level of contact between 
patients and therapy dogs modifies this microbial sharing. We deployed a novel 
adaptation of an existing FDA-approved topical treatment as a targeted intervention on 
the therapy animal intended to reduce the risk for therapy animals to enhance microbial 
transmission among patients and mitigate potential risks from exposure to infectious 
agents to patients participating in AAI. We secondarily hypothesized that this 
intervention, aimed to decrease bacterial colonization in the therapy animal, will have 
downstream effects on microbial composition in patients. Finally, we wanted to ensure 
that the intervention did not impact the potential benefits from these sessions. This 
research will aid clinicians and healthcare managers in the proper implementation of 
AAI therapy, to ensure the safety and sustainability of these valuable programs in the 




I. Study Population 
This pilot study was conducted at a pediatric oncology outpatient unit in a mid-Atlantic 
hospital between July 2016 and May 2017. At the time of this study, the department had 
an established group therapy dog program. The study protocol was approved by all 
applicable institutional review boards, institutional animal care and use committees, and 
scientific review committees prior to data collection. All participants, ages 2 to 20, were 
cleared by their primary clinician before being eligible to both participate in the therapy 
session and enroll in the pilot study. Parents of child-patients provided written informed 
consent. The therapy dog program schedules one therapy team (one dog with one human 
handler) per week for one hour, during which approved patients could visit the dog. 
Frequently, multiple patients interacted with the dog at the same time. Parents and non-
patient siblings also interacted with the therapy dogs and handlers but were not included 
in the study.  
II. Data Collection 
For enrolled therapy dog teams, the first two study visits used the existing therapy dog 
program protocols, which required the therapy animal to be bathed 24 hours before 
entering the hospital. The overall goal of sample collection was to collect samples prior to 
dog-patient interaction and then again following interaction from the hospital 
environment, the therapy dog, and all patient participants as part of the session (see 
Supplement Figure 1). Trained research staff performed all sample collection. 
 II.a. Environment 
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Prior to the therapy dog entering the gymnasium, we collected samples of floor dust from 
a standardized area with a vacuum filter and a sterile electrostatic cloth 
(Swiffer™, Proctor & Gamble, Cincinnati, OH, USA), as described in other studies (Davis 
et al., 2012). Once the study visit was completed and all the participants and therapy 
team had left, we resampled the same sites using the same protocol.  
 II.b. Therapy Dogs 
When the therapy team entered the gymnasium, the dog was sampled with swabs; Copan 
E-swabs (Copan Diagnostics, Murrieta, CA, USA) for targeted culture and sterile flocked 
swabs (Puritan, Guilford, ME, USA) for microbial communities. Sites sampled included 
the nasal and oral mucosa, and inguinal and perineal skin. A sterile electrostatic cloth 
was run along the dorsal surface of the dog’s back, in the “petting zone.” During this 
collection, we asked handlers questions about the dog’s recent medical history, such as 
antimicrobial and other medication usages, and recent diagnoses or surgeries. After 
initial sampling was complete, the dog interacted with patients for the full hour, then 
was resampled at the same sites using the same protocol.  
 II.c. Patients 
Prior to interacting with the therapy dog, we collected nasal samples (Copan E-swabs for 
culture and sterile flocked swabs for microbial community analysis) from participants 
who enrolled in the study. At that time, we took blood pressure and heart rate 
measurements, and asked participants questions about their mental wellbeing. During 
the visit, we observed interactions of the study participants with the dog, making notes 
on types and frequencies of certain behaviors (petting, hugging, etc.) and the total length 
of time the patient interacted with the dog. After the patient was done visiting the dog, 
 172 
we collected the same swabs, vital measurements, and mental wellbeing questions from 
participants.  
Blank sterile flocked swabs were collected at every visit as a microbiome negative 
control. The Copan E-swabs were stored at 4ºC until processing within one week of 
collection, and the sterile flocked swabs and vacuum dust were stored at -80ºC.  
III. Intervention 
In the study design, the therapy dog team was to complete two observational control 
visits abiding established hospital protocol, then cross-over to two intervention visits 
with modifications to the hospital therapy dog protocol. Prior to the first intervention 
visit, the handler was given a 4% chlorhexidine-based veterinary prescription shampoo 
(DUOXO Ceva, Libourne, France) to use 24 hours before the study visit. During the 
therapy visit, the dog was wiped down along the dorsal petting zone with a 3% 
chlorhexidine wet cloths (DUOXO Ceva, Libourne, France) every 5 to 10 minutes. 
Handlers were given information about both products before usage. We implemented 
the same data collection protocol for these intervention visits as described above. 
IV. Laboratory Processing - Microbial Communities 
IV.a. Sequencing 
The sterile flocked swabs and vacuum filter dust were thawed prior to DNA extraction. 
Refer to the [Supplement] for the detailed sequencing protocol, and as previously 
described (Misic et al., 2015). For each set of extractions, one blank swab exposed to 
laboratory air was processed as a negative laboratory control. Prior to sequencing, the 
total DNA concentration was obtained from PicoGreen instrument, and the 16S rRNA 
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gene copies per unit DNA was evaluated using quantitative PCR. The V1-3 region of the 
16S rRNAgene was amplified using barcoded primers (27F, 534R) for the Illumina 
platform as previously described (Fadrosh et al., 2014). Sequencing was performed on 
the MiSeq instrument (Illumina, San Diego, CA) using 300 base paired-end chemistry at 
the University of Pennsylvania Next Generation Sequencing Core. Microbial Mock 
Communities B (Even-Low v5.1, BEI Resources, NIAID NIH HMP) were amplified and 
sequenced as positive controls.  
IV.b. 16S rRNA Gene Analysis and Quality Control 
QIIMEv2.7 was used for paired-end read assembly and quality filtering for the sequences 
from all samples (Bolyen et al., 2019). DADA2 plug-in for QIIME2.7 was used to remove 
chimeric sequences and sequences greater than 300bp in length, and cluster sequences 
into amplicon sequence variants (ASVs) (Callahan et al., 2016). ASVs were matched to 
phylogeny using mafft program for multiple masked sequence alignment (Katoh et al., 
2002) and FastTree to generate a phylogenetic tree from the masked alignment (Price et 
al., 2010). Taxonomy assignment used a Naive-Bayes classifier (Wang et al., 2007) that 
was trained on our dataset (trimmed to 300bp and matched to our primers), applying 
Greengenes13.8 99% OTU match (McDonald et al., 2012). Results from our taxonomic 
classification was confirmed by comparing the identification of the known Mock 
Community samples. For quality control purposes, suspected contaminants were 
identified and removed from the resulting feature table using the ‘decontam’ R package, 
based on the prevalence of taxa in the negative controls and the frequency of taxa as a 
function of the total DNA concentration and the 16S rRNA copies from qPCR (Davis et 
al., 2018). Contaminants were identified independently at each processing step (field 
sampling, DNA extraction, and sequencing) and were sequentially removed.  
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V. Laboratory Processing - Targeted Culture 
Copan E-swab and electrostatic cloth samples were processed at the Johns Hopkins 
Clinical Microbiology laboratory or a laboratory lead by the study PI specializing in 
Staphylococcus aureus.  Refer to [Supplement] for detailed culture laboratory protocols.  
VI. Statistical Analysis 
Statistical analysis was performed in RStudio v1.1.423 (R Development Core Team, 
2010). 
V.a. Microbiome 
To maintain the maximum number of samples for comparison, the sequencing data was 
not rarefied for statistical analysis. Taxa tables, and matching phylogeny and taxonomy, 
were analyzed using the phyloseq pipeline to calculate alpha and beta diversity metrics 
(McMurdie & Holmes, 2013). Differential abundance of specific taxa between groups 
were analyzed using DESeq2 (Love et al., 2014). Kruskal-Wallis nonparametric one-way 
analysis of variance test examined differential alpha diversity between all groups, and 
Wilcoxon rank-sum test was used for pair-wise comparisons between groups, both 
adjusted for multiple comparisons using the Benjamini-Hochberg false discovery rate 
(FDR) correction. To determine which factors were most important in determining 
microbial composition, statistical tests were performed using the non-parametric 
permutational multivariate analysis of variance (PERMANOVA) with weighted and 
unweighted UniFrac distance metrics.  
V.b. Targeted Culture 
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Crude prevalence rates of S. aureus and MRSA based on qualitative culture were 
calculated for the patients, therapy animals, and hospital environment. Changes in 
prevalence of S. aureus was calculated before versus after therapy dog interaction, 
stratified by control and intervention visits and by contact level, and compared using 
non-parametric descriptive chi-squared test. Changes in quantitative S. aureus bacterial 
burden was assessed with statistical test of difference (Welch’s t-test for mean difference 





I. Study Population 
A total of four dogs were included in the study over 13 visits, with 5 (38%) intervention 
study visits. Forty-nine pediatric oncology patients elected to enroll in the study, as 
shown in Table 1, with a mean age of 11.7 years old (SD 4.7). Four participants returned 
in following weeks to be re-enrolled in the study for a total of 45 unique patients, but 
each visit was treated as an individual entry. There was a mean of 3.8 participants at 
each therapy visit (SD 1.4, range 2-6). 39 participants (79.6%) reported owning a pet at 
home, with 30 (61.2%) owning a dog.  
Individual contact behaviors and total patient-dog interaction time is presented in 
Supplement Table 1. The frequency of key behaviors and total time spent with the 
therapy dog was aggregated to create an ordinal contact score. The median score was a 
threshold to create a binary contact level of “High” or “Low” contact. 51% of patients 
were classified as “High” contact, and this was evenly distributed across visit types.   
II. Samples 
A total of 445 swabs were collected for microbial analysis, as shown in Table 1. This 
includes 203 for microbiome analysis and 242 for targeted culture analysis. An 
additional 33 samples were processed for microbiome quality control. Eight patients 
elected to not provide any swab samples, due to either fear or scheduling conflicts. Two 
patients did not provide pre-visit culture swabs, and three patients did not provide any 
post-visit swabs. Two inguinal samples were not captured from dogs, due to protocol 
changes during the study.  
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III. Microbial Sharing Results in Distinct Patient Microbial Communities based on 
Contact Level and Visit Type  
To analyze microbial communities in patients and therapy dogs, the V1-3 region of the 
16S rRNA gene was amplified and sequenced from swabs. Information on the sequencing 
library and quality control measures can be found in Supplement Table 2.  
III.a. Beta Diversity Distribution 
Supplement Figure 2 shows the overall distribution of samples in principal 
coordinate analysis plots for both unweighted and weighted UniFrac beta diversity 
metrics, by hosts (patient, dog or hospital environment), site, and pre- and post-visit 
status. Loose clustering was observed by host and sample site, but not by pre and post 
sample. Clustering was also not observed by individual subject or visit membership. 
Overall the axes accounted for a maximum of 7.8% variation in unweighted UniFrac and 
33.5% variation in weighted UniFrac.  
III.b. Beta Diversity Distance 
As a result of microbial sharing, patients were more similar to other patients after the 
visits in their microbial composition distance (beta diversity) (PERMANOVA pre vs. post 
FDR-p<0.001) and were more similar to therapy dogs (PERMANOVA pre vs. post FDR-
p<0.001) (example calculation Supplement Figure 3, results Supplement Figure 4 
and Supplement Table 3).  
When accounting for the difference in microbial composition after the visits compared to 
before, patients with high contact were more similar to other patients (Figure 2.A) and 
to the therapy dog (Figure 2.C) after the visits, compared to low contact patients, using 
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unweighted UniFrac metric (PERMANOVA FDR-p=0.0001-0.0003). The same pattern 
was observed in both control and intervention visits. When looking at the weighted 
UniFrac metric, high contact patients were more similar to other patients in control 
visits (p=0.0005), but not in intervention visit (Figure 2.B). The reverse trend was seen 
where both high and low contact patients were equally more similar in microbial 
composition to the therapy dog in intervention visits (p=0.0001, 0.0005), but not in 
control visits (Figure 2.D).   
III.c. Alpha Diversity  
Alpha rarefaction curves are presented in presented in Supplement Figure 5. There 
was a statistical difference in alpha diversity levels between sites and hosts, as measured 
by the Shannon (Figure 3.A) and Faith’s Phylogenetic (Figure 3.B) metrics (Kruskal 
Wallis p<0.001). When evaluating pairwise comparisons across the different 
combination of sites, nasal samples from the kids and dogs are similar in diversity levels 
to dog oral and perineal samples, all of which are statistically different than dog inguinal 
and dust samples (Wilcoxon test p<0.0001), which are similar to each other. There was 
no effect difference when stratifying these by pre or post and by visit type. 
When looking at individual level changes in alpha diversity that occur during a therapy 
visit, in high-contact patients there was an overall increase in within-sample diversity 
levels during control visits, and an overall decrease during intervention visits, while 
either no difference or the opposite difference occurred in low-contact patients, as shown 
in Figure 3.C-F. There was a significant difference between alpha change in control 
versus intervention visits in high contact patients using Faith’s metric (Kruskal Wallis 
p=0.05), but not a significant difference using the Shannon metric.  
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III.d. Relative Abundance 
There was a difference in the abundance of microorganisms across both host and sample 
location, as shown in Figure 4.A, which shows the percent relative abundance of the 
top 25 most abundant genera. There were some species that were statistically 
differentially abundant when comparing across sites, including Staphylococcus species 
in the nasal samples of both patients and dogs. Patient and dog nasal samples had 
similar microbial compositions, with Staphylococcus species being dominant, but dog 
nasal samples had a greater abundance of Moraxella compared to patients’ greater 
abundance of Streptococcus. Relative abundance mean values by host and site are 
presented in Supplement Table 4.  
Patients had altered microbial abundance based on contact level and visit type, as seen in 
Figure 4.B&C. Within control visits, patients with low contact had a higher abundance 
of Streptococcus species after the visits compared to before, but there was no difference 
in abundance for any genera in high-contact patients between pre- or post-visit samples. 
Within intervention visits, patients had greater abundance of Streptococcus species 
before the visit and greater abundance of Staphylococcus species after the visit. This 
effect was observed for both high and low contact patients. When further evaluating 
which species was driving the change, S. epidermidis (and not S. aureus) was the 
dominant Staphylococcal species (Supplement Figure 6).  
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IV. Culture Detection Confirms Microbial Sharing of Clinically Important 
Staphylococcus aureus is Altered by Contact and Visit Type 
Because Staphylococcus species in humans can be commensal (S. epidermidis) or 
potential pathogens (S. aureus), species identification of Staphylococcus was determined 
via microbial culture using a highly sensitive protocol.  
 IV.a. Exposure 
Staphylococcus aureus was detected from child patients and dogs as shown in Table 2. 
The primary outcome evaluated was S. aureus and MRSA exposure, or if a patient had a 
negative/non-detectable level of S. aureus or MRSA prior to the therapy dog session, but 
detectable S. aureus or MRSA after the session. Table 2 shows that the hospital 
environment was the most commonly contaminated, or positive detection, of both S. 
aureus and MRSA, and the dogs were less commonly contaminated in intervention 
visits. Patients who had higher contact with the dog were more commonly exposed to S. 
aureus and MRSA, but that higher association was reduced in intervention visits, 
particularly for MRSA. 
Among those patients with S. aureus exposure, we preformed spa-typing to classify 
positive isolates, within 7 visits. Supplement Figure 7 shows nine unique spa types 
were identified in our positive samples from patients and therapy dogs, with potential 
crossover of detected isolates between patients and between patients and therapy dogs.        
 IV.b. Quantification  
Since our binary culture detection was highly sensitive, we further evaluated S. aureus 
burden with quantitative PCR (qPCR). Figure 5 shows the log transformed difference 
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(post-pre visit) of S. aureus fem gene copies (/1ul sample) within patients. In control 
visits, high contact patients had a significant gain in mean gene copies compared to low 
contact patients (mean 2.45 high, -1.66 low, Welch’s t-test p=0.08). There was a 
significant loss of mean gene copies in intervention visits compared to control visits, in 
high contact patients (mean 2.45 control, -1.71 intervention, Welch’s t-test p=0.04).  
We also tested quantification of S. aureus on the therapy dog “petting zone” back 
samples, to confirm effectiveness of the decolonization intervention (Supplement 
Figure 8). Overall, there was a significant decrease in culture-based CFU count in 
intervention visits compared to control visits (change CFU count 47 control, -33 
intervention, Welch’s t-test mean difference p=0.05).  
V. The Intervention Did Not Diminish Positive Patient Benefits  
 We lastly wanted to confirm that our novel application protocol for therapy dog 
decolonization did not alter the positive physical and mental health benefits reported 
from AAI programs. Supplement Table 5 shows a decrease in both blood pressure and 
heart rate in patients after the visit, as well as a decrease in reported negative mental 
wellbeing status associated with being in the hospital. Both of the benefits were not 




This innovative yet pragmatic pilot study explored microbial transmission, both key 
pathogens of clinical concern and general bacterial communities, among pediatric 
patients and therapy animals during hospital-based AAI programs. This study was the 
first to sample patients, therapy animals, and the hospital environment before and after 
every group therapy session, and the first to explore microbial community dynamics in 
this setting. As a result of microbial sharing that occurred during the AAI sessions, we 
found microbial compositions of patients were altered, both overall diversity levels and 
relative abundance of specific taxa, via molecular sequencing. This sharing was also seen 
with culture-based analysis for Staphylococcus aureus, a common hospital-associated 
pathogen.  
We explored the effect of contact level between patients and therapy dogs on microbial 
sharing and found that higher contact was associated with increased sharing between 
patients and therapy animals, and among patients. Finally, we determined that a 
decolonization intervention targeted to the therapy dog modifies the association between 
contact level and microbial sharing between therapy animals and patients, and between 
patients. This indicates that pathways of microbial exposure to patients, including the 
therapy animal, should be further explored during group hospital AAI sessions to 
identify their relative importance and determine their relevance to infection control 
strategies. 
Distinct Microbial Profiles of Patients and Therapy Dogs 
Patients, therapy dogs, and the hospital environment had distinct microbial 
communities, as evident by their difference in the relative abundance of key species, 
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difference in alpha diversity levels, and unique clustering of microbial composition in 
beta diversity. Whereas human and dog nasal sites tend to be dominated by a few taxa at 
relatively high abundance (namely Staphylococcus, Streptococcus, and Moraxella), dog 
oral, perineal and especially inguinal sites, as well as hospital environment dust, 
harbored a more even mixture of a variety of taxa, resulting in higher alpha diversity 
levels, and distinct beta diversity clusters on PCoA plots.  
Microbial community shifts were shown to occur in patients and therapy dogs during an 
AAI therapy session. This is demonstrated by the increase in within sample alpha 
diversity levels in patients and dogs using Shannon and Faith’s Phylogenetic metrics, 
more similar microbial compositions after the visits using the weighted and unweighted 
UniFrac distance metrics, and change in the relative abundance of species taxa, 
specifically Staphylococcus. Culture-based analysis was additionally used to identify 
which patients were exposed to viable Staphylococcus during AAI visits. It is important 
to note that the culture protocol has been demonstrated to have a limit of detection 
between 10 and 100 CFUs (Davis et al., 2012), and to be more sensitive than typical 
protocols used in clinical microbiology laboratories (Davis et al., 2016); it is possible for 
exposure as defined in this study to be transient contamination that would neither result 
in colonization nor infection. 
Closer Contact Between the Patient and Therapy Dog Increased Microbial Sharing  
Patient-dog contact level was shown to modify microbial sharing between patients and 
therapy dogs and between patients. While contact level was assessed primarily as an 
indicator of interactions between a patient and a therapy animal, this contact score also 
is representative of interactions of the patient to other aspects of the therapy visits, 
shown in Figure 1. A patient with a high contact score will have higher contact with the 
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therapy dog and with other patients and individuals, including the therapy dog handler, 
and with the hospital environment. Thus, high contact increases all pathways shown in 
Figure 1, and was positively associated with increased microbial sharing. Patients with 
high contact were more likely to be exposed to both Staphylococcus aureus and MRSA 
during a visit based on culture-based detection. In quantitative burden, patients with 
high contact also had significantly higher levels of S. aureus gene changes during the 
visit compared to low contact patients. Overall, higher observed contact level resulted in 
increased exposure to S. aureus during a therapy visit.  
Beta diversity distance, represented by both unweighted and weighted UniFrac metric, is 
the most convincing demonstration of microbial sharing, as it evaluated shifts in the 
microbial community structure that occurred during the visits. The unweighted UniFrac 
metric does not take into consideration the phylogenetic distance between different taxa. 
Using this metric, patients with high contact were more similar to other patients after 
the visit compared to low-contact patients, presumably due to microbial sharing among 
patients, and were also more similar to therapy dogs after the visit compared to low-
contact patients, indicating high contact level resulted in more overall microbial sharing 
between patients and dogs. For the weighted UniFrac metric, which factors in 
phylogenetic distinction between microbial compositions, there was not a significant 
change in microbial composition differences between patients and dogs, indicating that 
there was not significant sharing of phylogenetically rare taxa between patients and dogs, 
but there was significant sharing of rare taxa among high-contact patients.   
Contact level was shown to be associated with within-sample alpha diversity levels, in 
that high contact patients had increased levels of both Shannon’s and Faith’s 
Phylogenetic alpha diversity after the visit compared to before the visit. Conversely, low-
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contact patients showed no change in Shannon’s metric and a decrease in Faith’s 
phylogenetic metric after the visit. Overall, increased interaction with various aspects of 
the therapy programs in high-contact patients was associated with increased within 
sample bacterial diversity. Faith’s phylogenetic diversity, as opposed to Shannon’s 
diversity, considers more phylogenetically rare taxa, so it is more unique microbiota that 
are driving the increased alpha diversity in patient samples.  
Taken together, these findings suggest that rare taxa are shared among patients, 
resulting in increased within-sample diversity, but are not as commonly shared between 
patients and dog. Our PCoA distributions and relative abundance results, in addition to 
previous studies on pet dogs (Davis, 2016; Oh et al., 2015; Ross et al., 2018; Song et al., 
2013), have shown that dogs have diverse unique microbial communities compared to 
humans, which could possibly be driving the differences seen in weighted beta metrics in 
patient-to-dog composition difference compared to patient-to-patient composition 
difference. This denotes that dogs can serve as intermediary vectors in the spread of 
human-origin common microbiota between patients, but may not be sharing their own 
unique microbiota to patients. Yet there was still significant sharing of rare taxa among 
patients and an increase in within sample diversity levels driven by rare taxa in patients. 
This indicates that the therapy animal is only one potential pathway of microbial 
transmission during these group AAI therapy sessions and may not be as significant as 
an influence in the transmission of microorganisms as other pathways in Figure 1.  
Canine Decolonization Intervention Modified Microbial Sharing  
As part of this study design, we tested a novel application of a common veterinary 
disinfectant to therapy dogs and how that canine decolonization intervention influenced 
microbial sharing among patients. The intervention involved changing the dog’s regular 
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pre-visit bathing routine to a chlorhexidine-based shampoo and wiping the dog with 
chlorhexidine wipes at regular 5-10-minute intervals during the therapy session. The 
goal of the intervention was not only to reduce the bacterial burden on the dog, but to 
lessen the dog’s ability to serve as an intermediary vector in the spread of 
microorganisms between patients, or between other sources to patients. In terms of the 
pathways in Figure 1, the intervention blocked the contributions of the dog.  
Our intervention was shown to be effective in its primary objective - to reduce the 
bacterial burden on the dog. This was observed in both decreased levels of binary S. 
aureus levels before and after the therapy visit in dogs in intervention visits compared to 
control visits, as well as decreased quantitative bacterial burden of Staphylococcus 
aureus, assessed by CFU level.  
We determined that the dog decolonization intervention modifies the relationship that 
we observed with high-contact patients and increased microbial sharing. The 
decolonization intervention was shown to affect more phylogenetically rare taxa, as 
different effects were seen using phylogenetically weighted versus phylogenetically 
unweighted diversity estimates. Since the intervention worked on the dogs’ microbiota, it 
allowed us to isolate the therapy animal’s microbial contribution to patient microbial 
sharing. Within intervention visits with the therapy dog microbiota removed, microbial 
sharing of common taxa was still observed among patients and between patients and 
therapy dogs. But, unlike in control visits, rare taxa were not shared among patients.  
The intervention blocked the pathway of microbial sharing between patients of rare 
phylogenetically diverse taxa, also reflected in a decrease in within patient sample 
phylogenetically rare alpha diversity, but not the sharing of common taxa. If the therapy 
dog was the only or primary source of microbial sharing to patients during AAI sessions, 
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we would expect to see reduced sharing of both common and rare taxa between patients 
and dogs in intervention visits when the therapy dog pathway is blocked, and if the 
therapy dog served as a major intermediary point, we would expect to see reduced 
sharing among patients. Since we only see this pattern with phylogenetically rare taxa, 
not common taxa, this reinforces the concept that while the therapy dog can serve as an 
intermediary point, the dog is one of only many possible pathways, and these other 
pathways may be greater contributors to microbial changes seen in patients. 
The most important outcome affected by the intervention, which best demonstrates 
microbial sharing between patients and therapy dogs, is the microbial community shifts 
as evaluated by the unweighted and weighted UniFrac beta distance metrics. Significant 
sharing was observed between high-contact patients within intervention visits, as 
significant as in control visits, using the unweighted UniFrac metric. However, using the 
weighted UniFrac metric, as opposed to in control visits, there was no difference in 
microbial composition between patients in intervention visits at either contact level. This 
indicates that sharing of common microbiota still occurs between patients, even with the 
intervention blocking the dog pathway, but patients are now sharing fewer 
phylogenetically rare taxa between them in intervention visits.  
The intervention also altered the beta distance between patients and therapy dogs. Using 
the unweighted UniFrac metric, control and intervention visits both had similar 
patterns. High-contact patients were more similar in microbial composition to the 
therapy dog after intervention visits, indicating that the intervention did not alter 
microbial sharing of common taxa between patients and therapy dogs. However, using 
the phylogenetically weighted UniFrac metric, patients of both high and low contact were 
more similar in microbial composition to therapy dogs after the visit, opposite to control 
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visits were both contact levels were less similar. Unlike in previous examples where 
microbial composition similarities appeared to be due to the spread of microbiota among 
individual patients, it is possible that this microbial community shift is due to the effect 
of the decolonization on the dog’s microbiota. The decolonization selectively removes 
unique dog taxa from the dog itself, resulting in the microbial compositions of the 
therapy dogs being more similar to the microbial compositions of patients. 
Similar to beta diversity compositional differences, altered alpha diversity levels 
demonstrated the effect of reduced patient exposure to rare taxa as a result of the 
intervention, indicating that our canine-centered decolonization had indirect effects on 
the microbial diversity levels within patient samples. In intervention visits, there was a 
slight decrease in Shannon metrics within high contact patients after the visit – the 
opposite trend in control visits – yet there were minimal changes to low contact patients. 
This effect was more substantial when looking at Faith’s phylogenetic metric. When the 
therapy dog’s microbial contribution was removed by the intervention, patients with 
high contact had lowered diversity levels after the visit compared to before the visit, 
particularly a reduction in rare taxa. High-contact patients in intervention visits also had 
significantly decreased alpha diversity levels than their high-contact counterparts in 
control visits.  
The intervention also was associated with changes in the abundance of specific taxa. 
High-contact patients who interacted with decolonized therapy dogs had higher relative 
abundance of staphylococcal species post visit compared to high contact patients post 
control visits. Instead of S. aureus, this change was primarily driven by S. epidermidis, a 
predominant human nasal commensal. Since this metric compares relative, not absolute, 
abundance within each sample group, it is not surprising that human commensals are of 
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greater relative abundance in intervention visits than control visits, since patients are 
exposed to fewer taxa from the therapy dog.  
We also found changes in cultured levels of Staphylococcus aureus based on the 
intervention. For binary S. aureus exposure, the intervention did not directly reduce the 
incidence of S. aureus and MRSA detection in patients before or after the visit. However, 
it nullified the risk of exposure in patients with high contact, so that there was no 
difference in the likelihood of exposure in high-contact and low-contact patients within 
intervention visits. Essentially, all patients had an equal chance of becoming exposed to 
S. aureus, regardless of contact level. It did not completely eliminate the risk— there 
were still detectable concentrations in patients post intervention visits—but it reduced 
sharing from one pathway (the therapy dog) shown in Figure 1. The same effect could 
also be observed in the quantitative qPCR results, where high contact patients had 
significantly higher mean S. aureus fem gene change compared to low contact patients in 
control visits, but no difference based on contact level in intervention, where the therapy 
dog pathway is blocked. The dissimilar impact on high-contact rather than low-contact 
patients is not surprising, since the intervention targeted the therapy dog.  
Overall, while the intervention indirectly affected patient microbial composition, 
diversity levels, and sharing, it primarily worked on the therapy’s dog microbial 
composition. Because we still observed equal microbial sharing among patients in both 
control and intervention visits, this is another potential indicator that the dog is only one 
possible pathway of microbial transmission during these group therapy sessions. While 
the therapy dog can be vector in the spread of microbes, as shown in our culture-based S. 
aureus results, other pathways, shown in Figure 1, may have a weightier influence on 
the microbial alterations observed in patients as a result of the therapy visit. This 
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concept has important implications when considering the design and implementation of 
control policies for these AAI programs; targeting the dog alone may be insufficient to 
prevent spread of microorganisms, specifically pathogens.  
Canine Decolonization Did Not Negatively Impact Patient AAI Experience 
It is important to note that the intervention did not diminish the positive benefits we 
observed from patients who participated in these visits, both a decrease in heart rate and 
blood pressure, and a decrease in self-reported negative feelings. This is critically 
important in the design of any intervention to improve safety - that the intervention does 
not detract from the ultimate goal of the therapy session to improve holistic patient 
health.  
Strengths, Limitations, and Future Directions 
While designed as a pilot study to assess feasibility, this is the first study to the authors’ 
knowledge to expressly target microbial transmission that occurs during hospital AAI 
programs by sampling multiple components before and after each visit. Previous studies 
to date have focused exclusively on carriage in the therapy animal or have assessed 
aggregated rates of infection diagnosis in departments with or without AAI programs 
(Dalton et al., 2020). By sampling multiple components—the patients, the therapy 
animals, and the hospital environment—we can begin to elucidate exposure pathways 
from these individual data points. In addition to our sampling strategy, this study is the 
first to assess the contact level between patients and therapy dogs as a risk factor. 
Human-animal contact level has been previously described to be a risk factor in the 
exposure and acquisition of pathogens in the case of pet ownership (Morris et al., 2012; 
Rodrigues et al., 2018), but it was unknown if the same positive association would be 
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seen with the brief contacts between patients and therapy animals. This study also 
benefits from the novel deployment of an established canine decolonization procedure, 
adapted from veterinary clinical protocols for canine dermatology patients, to decolonize 
therapy animals as an infection control strategy. It was found that the intervention did 
decrease the role of the therapy dog both to spread its own unique microbiota to 
patients, but also to reduce its role as an intermediary vector in the spread of 
microorganisms between patients or other individuals and the hospital environment. 
This intervention appeared to be effective to limit exposures to S. aureus, and further, it 
did not detract from patient enjoyment and the overall positive goal of these therapy 
sessions.  
While novel, this study does have practical drawbacks that the researchers were unable 
to address in the study design. Its primary purpose was to determine the feasibility to 
conduct a larger infection control trial, including the implementation of the 
decolonization intervention. As such, a limitation is the smaller sample size, particularly 
when considering the number of unique dogs. Sampling other sites, both on the patients 
and in the hospital environment, as well as other individuals, such as healthcare workers 
and the handlers, may have led to alternative hypotheses. As shown by the spa-typing 
results, multiple pathways demonstrated in Figure 1 prove challenging to examine, and 
blanket statements inferring directionality of transmission from therapy dogs to patients 
or vise-versa should be taken with caution. Finally, the purpose of this experiment was to 
assess microbial exposure at one time point. It is uncertain from our data if the changes 
observed during the visit will be temporally stable and, if so, for how long. We also 
cannot make any claims as to the health outcomes related to these microbial community 
shifts, particularly related to the exposure of potentially pathogenic microorganisms and 
to rare taxa from the therapy dog.    
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Future work in this topic will expand the study design to include AAI sessions that 
involve only one child per dog, thus providing more insight into potential microbial 
pathways, and increase the generalizability of findings to other situations. To also 
increase generalizability, future plans are to sample within different hospital 
departments with varying compositions of patient, and various hospitals. Lastly, we seek 
to explore the temporal stability of these microbial shifts observed in patients and 
determine if it leads to clinically significant outcomes. This is especially important when 
considering the exposure to rare dog taxa, given that early-life exposure to pets is 
associated with decreased incidence of allergic and atopic diseases in children (Havstad 
et al., 2011; Mandhane et al., 2009), and having a diverse microbiome is protective 
against numerous health outcomes and can be protective against colonization from 
pathogens (Grice & Segre, 2011; Naik et al., 2012). If we can show that exposure to 
therapy animals, even briefly during AAI programs, can benefit microbial diversity and 
microbial community resilience over a longer-term, this will be a previously undescribed 
benefit to AAI and may increase its utilization in patient care. Many hospitals and 
individual practitioners are hesitant to adopt these known beneficial programs, given the 
uncertainty surrounding their risk with regards to infection control. The goal of this and 
future work is to address those concerns, and to design and implement practical 





The results of this work could have significant clinical implications in terms of infection 
control. These findings indicate that, while there is microbial sharing between the 
patients and dogs and the potential for the dog to serve as an intermediary vector of 
microbial spread, other potential transmission pathways (patient-to-patient, and 
hospital-to-patient) were also important for microbial sharing during group visits. 
Infection control efforts during these visits should reflect all the possible pathways of 
microbial transmission.   
Conversely, the therapy dog could be a source of more unique microbes to patients. As 
hospital exposure and certain therapies have been shown to decrease microbial diversity 
in patients, therapy dog exposure can possibly provide a novel way to counterbalance 
this imbalance and share potential beneficial microorganisms that could be protective 
against hospital pathogen exposure. This pilot study shows that microbial community 
alterations in patients and therapy dogs during these therapy programs warrants 
additional research, which will make these programs safer and more sustainable.  
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Table 1: Study Population and Samples 
 
  All Visits Control Visits 
Intervention 
Visits 
Study Population       
Patients   N (% total) N (% total) 
N total sampled 49 *45 26 (53%) *23 23 (47%) *22 
Male (%) 31 (63%) 15 (58%) 16 (69%) 
Age (y), mean (range) 11.68 (1.9-20.4) 11.07 (1.9-18.4) 12.41 (3.5-20.4) 
High Contact (%) 25 (51%) 12 (46%) 13 (56%) 
Visits   N (% total)   N (% total)   
Total 13 8 (62%) 5 (38%) 
Patients per visit, mean 
(range) 3.77 (2-6) 3.25 (2-5) 4.6 (3-6) 
Therapy Dogs       
N Unique Dogs 4     
Male (%) 1 (25%)     
Age (y), mean (range) 6.43 (1.5-12)     
Samples       
Culture   N (% total)   N (% total)   
From Patients 90 46 (51%) 44 (48%) 
From Dogs 126 76 (60%) 50 (40%) 
From Environment 26 16 (62%) 10 (38%) 
Microbiome   N (% total)   N (% total)   
From Patients 79 43 (54%) 36 (45%) 
From Dogs 100 60 (60%) 40 (40%) 
From Environment 24 16 (62%) 10 (38%) 
Field Blanks 12 7 (58%) 5 (42%) 
Laboratory Controls 21     
*45 patients with microbial samples collected, 23 in control and 22 in intervention 
  
 196 
Figure 2: Beta Distance for Microbial Composition Difference, by Contact 
Level and Visit Type (post – pre visit) 
 
  
PERMANOVA model p value results for difference in microbial composition beta distance 
between patients pre compared microbial composition beta distance between patients post visit 
(kid-kid) or difference in microbial composition beta distance between patients and therapy dogs 
pre compared microbial composition beta distance between patients and therapy dogs post visit 
(kid-dog), within each stratification (visit type and contact level). 
Refer to Supplement Figure 3&4 for example caluclations and pre/post distances 
BOLD FDR-corrected p <0.005 
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Figure 3: Alpha Diversity by Sample Host and Site, and Within Patient 
Samples  
 
Thin lines = within subject changes, bold lines = aggregated group means 
** Kruskal-Wallis test p=0.05 for median difference in change in alpha diversity level (post-pre) 
in control vs intervention (in high contact patients) 
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Figure 4: Relative Abundance of Top 20 Genera   
 
*** Benjamini-Hochberg adjusted p-values <0.001 for differential abundant genera using a negative binomial model (DESeq) between sample 
sites   
Within Patients: Blue *** = higher in post samples, Red *** = higher in pre samples 
Mean total DNA concentration in patients in control = 6.28, in intervention = 4.42 (ng/ul) 
Mean qPCR 16S gene copies in patients in control = 22254, in intervention = 8691 (/ul DNA) 
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Table 2: Staphylococcus aureus Exposure based on Culture Data 
 Staphylococcus aureus detection MRSA detection 










Detection             
Patients             
Pre N= 45 24 (53%) 12 (52%) 12 (55%) 20 (44%) 10 (43%) 10 (45%) 
Post N= 45 25 (56%) 13 (56%)  12 (55%) 18 (40%) 10 (43%) 8 (36%) 
Therapy Dogs (any 
site)             
Pre N= 13 10 (77%) 7 (88%) 3 (60%) 6 (46%) 4 (50%) 2 (40%) 
Post N= 13 9 (69%) 7 (88%) + 2 (40%) + 8 (62%) 7 (88%) ++ 1 (20%) ++ 
Environment             
Pre N= 13 13 (100%) 8 (100%) 5 (100%) 12 (92%) 7 (88%) 5 (100%) 
Post N= 13 13 (100%) 8 (100%) 5 (100%) 11 (85%) 7 (88%) 4 (80%)  
Exposure (pre negative - post detect) ~ 
All Patients 8 (18%) 5 (22%) 3 (14%) 5 (11%) 4 (17%) 1 (5%) 
High Contact N= 23 6 (26%) 4 (36%) 2 (17%) 5 (22%) ** 4 (36%) ** 1 (8%) 
Low Contact N= 22 2 (9%) 1 (8%) 1 (10%) 0 ** 0 ** 0 
Culture-based detection of Staphylococcus aureus (PCR nuc gene positive) and methicillin-resistant Staphylococcus aureus (PCR nuc and mec 
gene positive), stratified by visit type.  Presented as total number positive and percent of total (in all visits and within visit type and contact level).  
N = total number of samples (patients and environment) or sampling points (therapy dogs, since aggregated site total) 
~ Exposure = an individual’s pre-visit sample is PCR negative (non-detectable staphylococcal levels on PCR) and post-visit sample is PCR positive.  
++ p<0.05  + p<0.1 chi-squared difference cases control vs intervention  
** p<0.05  * p<0.1 chi-squared difference cases high vs low contact
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Figure 5: Patient qPCR Staphylococcus aureus gene Gain and Loss by 
Contact Level and Visit Type (post-pre, log transformed) 
 
diamonds = means 
** Welch's T-test difference means control-intervention p<0.05 
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7.9 Supplementary Materials 
 
Supplement: Detailed DNA Extraction Protocol 
The Puritan swab samples were thawed, and 0.5 µL of Ready-Lyse Lysozyme (Epicentre 
Biotechnologies, Madison, WI) was added to each tube and incubated for 1 h with 
shaking at 600 rpm and 37°C. The swab was re- moved, placed into a spin basket, and 
centrifuged for 1 min at 9,400 × g to extract any remaining liquid. The sample was then 
added to a glass bead tube (0.5 mm; MO BIO, Carlsbad, CA) and vortexed for 10 min at 
maximum setting. The samples were then incubated in a heat block for 30 min at 65°C 
and 600 rpm, followed by ice for 5 min and a brief spin. A 150 µL of Protein Precipitation 
Buffer (Epicentre Biotechnologies, Madison, WI) was added, and the samples were 
vortexed briefly, then centrifuged at 22,000 × g for 10 min. The supernatant was 
removed and the protein pellet was discarded. The supernatant was mixed with 500 µL 
isopropanol and inverted to mix. The mixture was added to a spin column from the 
Genomic DNA Isolation Kit (Life Technologies, Grand Island, NY), and the remaining 
steps were followed according to manufacturer’s protocol. The samples were eluted with 
50 µL Elution Buffer (Life Technologies, Grand Island, NY).  
Supplement: Detailed Laboratory Culture Protocol 
Refer to previous studies for detailed laboratory protocols (Davis JCM 2016). Briefly, 
samples were qualitatively cultured (presence/absence) for S. aureus using a highly 
sensitive protocol, and confirmed with polymerase chain reaction (PCR) for the nuc gene 
(presumptive S. aureus) and universal mec gene (for methicillin-resistance, presumptive 
MRSA) (Shahbazian 2017). Therapy dog dorsal petting zone samples were quantitatively 
cultured (via counts of bacterial colony forming units, CFUs) on Baird-Parker media 
(Hardy Diagnostics, Santa Maria, CA, USA), while patient samples were qualitatively 
evaluated using real-time qualitative PCR for the staphylococcal femB gene (Klotz 2003). 
A subset of positive isolates from both patients and dogs were subjected to sequencing of 
the spa gene, and spa-typing was performed for classification (Karynski 2008). 
Supplement References: 
Davis, M. F., Hu, B., Carroll, K. C., Bilker, W. B., Tolomeo, P., Cluzet, V. C., … Nachamkin, I. (2016). Comparison of 
culture-based methods for identification of colonization with methicillin-resistant and methicillin-susceptible 
staphylococcus aureus in the context of cocolonization. Journal of Clinical Microbiology, 54(7), 1907–1911.  
Shahbazian J, Hahn P, Ludwig S, et al. Multidrug and Mupirocin Resistance in Environmental Methicillin-Resistant 
Staphylococcus aureus (MRSA) Isolates from Homes of People Diagnosed with Community-Onset MRSA Infection. 
Appl Environ Microbiol. 2017;83(22):1-14.  
Klotz, M., Opper, S., Heeg, K., & Zimmermann, S. (2003). Detection of Staphylococcus aureus enterotoxins A to D by real-
time fluorescence PCR assay. Journal of clinical microbiology, 41(10), 4683-4687. 1.   
Karynski M, Sabat AJ, Empel J, Hryniewicz W. Molecular surveillance of methicillin-resistant Staphylococcus aureus by 
multiple-locus variable number tandem repeat fingerprinting (formerly multiple-locus variable number tandem 
repeat analysis) and spa typing in a hierarchic approach. Diagn Microbiol Infect Dis. 2008;62(3):255-262 
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Supplement Figure 1: Study Design and Sampling Points 
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Supplement Table 1: AAI Behavioral Observations and Patient-Therapy Dog 
Contact Scores 
 
Observed Interaction Behaviors Patients Observed           
N * 46 
Total time spent with dog, in minutes mean 
(range) 14 (2-42) 
Interact with Dog N (%) 44 (95.7) 
Sat on Floor N (%) 28 (61.9) 
Touch Head N (%) 43 (93.5) 
Touch Back N (%) 27 (58.7) 
Touch Belly N (%) 13 (28.2) 
Touch Paws N (%) 11 (23.9) 
Feed Dog N (%) 24 (52.2) 
Walk Dog N (%) 10 (21.7) 
Kiss Dog N (%) 2 (4.3) 
Hug Dog N (%) 5 (10.9) 
Contact Score Level Calculation 
Interact Score+ mean (range) 7.89 (0-17) 





Contact Score Level 
High (³median) N (%) 




* observations not recorded for 3 patients   
+ score based on total tally of individual behaviors, weighted based on closeness of 
contact: 1 point for interact with dog, walk dog, and sat on floor, 2 points touches, 3 
points for feed, hug, or kiss dog.  
^ score multiplied by total time with dog  
 207 
Supplement Table 2A: Microbial Community targeted 16S rRNA gene 
Sequencing Library Results 
Read Counts 
Sample Min Mean Median Max 
Total 1 10736 13342 21890 
Child N 164 11639 14100 19430 
Dog All 
        N 
        MO 
        I 





















Environment 1 12051 13048 16109 
Field Blank 520 4676 4307 10064 
Controls 
 Extraction 
  Sequence 

















Total DNA Concentration (ng/ul) 
Total 0.04 8.517 3 41.39 
Child N 0.05 5.434 2.25 31.67 
Dog All 
        N 
        MO 
        I 





















Environment 0.07 19.77 19.98 38.82 
Field Blank 0.2 0.7717 0.745 1.61 
Controls 
 Extraction 
  Sequence 

















qPCR 16S gene copies (/ul DNA) 
Total 43 1.42e6 4570 6.26e7 
Child N 111 16073 2470 2.58e5 
Dog All 
        N 
        MO 
        I 





















Environment 185e5 7.94e6 5.91e6 2.45e7 
Field Blank 88 481 405 1040 
Controls 
 Extraction 
  Sequence 

























Common Genera Prevalence 




























Final Taxa 13680 total ASVs 
(3.55%) 
  
Using ‘decontam’ package  
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Supplement Figure 2: Beta Diversity Principle Coordinates Analysis Plots 
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Supplement Figure 3: Graphical Example for Calculations of Beta Distance 
in Figure 2 
 
















Supplement Figure 4: Visit Type and Contact Level in Microbial 
Composition Differences Between Patients and Between Patients and 
Therapy Dogs 
A. Unweighted UniFrac Distance  
 
B. Weighted UniFrac Distance  
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Supplement Table 3: Microbial Composition Differences between Patients and Between Patients and Therapy Dogs 
Before the Visit Compared to After Visit, Based on Visit Type and Contact Score  
Results for Beta Distance via PERMANOVA model  
Group Metric 
Kid-Kid Distance Kid-Dog Distance 
F-statistic p F-statistic p 
Unadjusted Effect Pre versus Post 
All Samples Unweighted UniFrac 47.068 0.0001 38.168 0.0001 
  Weighted UniFrac 19.33 0.0001 36.378 0.0001 
Control Visits Unweighted UniFrac 15.926 0.0002 2.294 0.128 
  Weighted UniFrac 17.78 0.0001 4.274 0.025 
Intervention Visits Unweighted UniFrac 8.737 0.003 35.188 0.0001 
  Weighted UniFrac 1.049 0.313 44.689 0.0001 
High Contact Unweighted UniFrac 89.538 0.0001 82.758 0.0001 
  Weighted UniFrac 16.017 0.0001 28.701 0.0001 
Low Contact Unweighted UniFrac 2.418 0.118 0.067 0.829 
  Weighted UniFrac 0.474 0.514 9.766 0.001 
Multivariate Adjusted Effect 
Pre versus Post visit Unweighted UniFrac 47.642 0.0001 38.626 0.0001 
  Weighted UniFrac 20.962 0.0001 36.422 0.0001 
Contact Level Unweighted UniFrac 10.317 0.0002 2.245 0.135 
  Weighted UniFrac 6.691 0.0003 0.829 0.328 
Visit Type Unweighted UniFrac 1.325 0.263 4.728 0.011 




PERMANOVA FDR-corrected p<0.001, p 0.01-0.001  
Unadjusted Effect = difference in microbial composition distance between patients in pre-visit samples compared to microbial composition 
distance between patients in post-visit samples (kid-kid distance), or significant difference in microbial composition distance between patients and 
therapy dogs in pre-visit samples compared to microbial composition distance between patients and therapy dogs in post-visit samples (kid-dog 
distance) within each exposure group.  
Example interpretation – In control visits, there is a significant difference in the microbial composition between patients before the visits 
compared to after the visit (p=0.0002 unweighted, 0.0001 weighted) 
Adjusted Effect = independent effect of each exposure of the microbial composition distance between patients (kid-kid distance) or microbial 
composition distance between patients and therapy dogs (kid-dog distance).  
Example interpretation – There is a significant difference in the microbial composition between patients with high contact compared to microbial 
composition between patients with low contact, independent of collection time (pre versus post) or visit type (control versus intervention) 
(p=0.0002 unweighted, 0.0003 weighted)  
 214 
Supplement Figure 5: Alpha Diversity Curves by Host and Sample Site 






















Supplement Table 4: Relative Abundance by Host and Site by Phyla and Genus (Taxa > 3%) 
Taxon (Phyla & 





Actinobacteria 0.0483 0.0330 0.0432 0.2035 0.0197 0.0522 
Corynebacterium 0.1130 0.0330 0.0922 0.2035 0.0431 0.1968 
Micrococcus      0.0313 
Actinomyces       
Bacteroidetes 0.0137 0.0213 0.0893 0.0704 0.0236 0.0248 
Porphyromonas  0.0602 0.1604 0.1065 0.0673  
Capnocytophaga   0.0883    
Bacteroides    0.0734   
Prevotella    0.0312  0.0365 
Firmicutes 0.0667 0.1147 0.0212 0.0360 0.0341 0.0633 
Staphylococcus 0.2714 0.2886 0.0333 0.0649 0.0453 0.0465 
Streptococcus 0.1834 0.0411  0.0952 0.0432 0.1011 
Faecalibacterium      0.0688 
Blautia    0.0433   
Alloiococcus 0.0382      
Lactobacillus      0.0369 
Dorea    0.0317   
Fusobacteria  0.0120 0.0415 0.0370 0.0103  
Fusobacterium   0.0415 0.0370   
Proteobacteria 0.0368 0.0832 0.0559 0.0420 0.0191 0.0204 
Moraxella 0.0572 0.1927 0.0396 0.0386   
Conchiformibius  0.0462 0.1879    
Lautropia   0.0741    
Campylobacter    0.0648   
Escherichia    0.0435   
Pantoea      0.0427 
Neisseria   0.0408    
Sphingomonas     0.0349  
Pseudomonas     0.0345  
Spirochaetes   0.0274    
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Supplement Figure 7: spa-Typing of Staphylococcus aureus Isolates from 
Patients and Therapy Dogs  
 
Results shown only for visits where at least one patient had Staphylococcus aureus 

















































Supplement Figure 8: Gain and Loss in Staphylococcus aureus Bacterial 
Burden in Therapy Dogs via Culture-Based CFU (Colony-Forming Unit) 
Count Difference (post-pre visit) 
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Supplement Table 5: Patient Physical and Mental Wellbeing Benefits during 
Control and Intervention Visits 
  
 All Visits Control Visits Intervention Visits 
Physical Parameters 
Systolic Blood Pressure 
Mean Difference post-pre 
-5.8 (11.2) -4.8 (10.4) -7.3 (12.5) 
Diastolic Blood Pressure 
Mean Difference post-pre 
-2.99 (10.6) -1.2 (12.9) -5.5 (5.7) 
Heart Rate 
Mean Difference post-pre 
-2.78 (7.9) -3.46 (9.8) -1.82(4.5) 
Mental Wellbeing Parameters 
Reports of Pain* 
Mean Difference post-pre 
-0.06 (0.44) -0.13 (0.45) 0 (0.43) 
Reports of Worry* 
Mean Difference post-pre 
-0.22 (0.69) -0.33 (82) -0.09 (0.53) 
Reports of Sadness* 
Mean Difference post-pre 
-0.08 (0.41) -0.17 (0.48) 0 (0.31) 
* Graded on Likert Scale 1-5, with 5 being more negative feeling (painful/worried/sad), hence a 
negative value mean difference reflects feeling more positive after the visit. 
No significant t-test in differences of means between control and intervention visits
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Chapter 8: Conclusions 
8.1 Summary of Findings 
 
Animal-assisted intervention (AAI) programs are a validated and valuable part of holistic 
patient care in hospitals, and their use has extended to healthcare worker benefits. 
However, concerns regarding these programs limit their beneficial utilization, namely 
the possibility of infectious disease spread between patients and other individuals, the 
therapy animal, and the hospital environment. As such, these concerns would be best 
addressed by a One Health approach, a harmonized, collaborative effort among human, 
animal, and environmental stakeholders.  
The objective of this thesis research was to apply the One Health framework as a 
systems-thinking approach to understand collaboration at the macro-level (multi-
stakeholder engagement and contributions to implementation practices) and the micro-
level (the shared microbial communities between AAI participants). Through this all-
encompassing viewpoint, this work has focused on identifying modifiable factors to 
address infection control and safety in hospital AAI for all individuals involved; the 
patients, healthcare workers, therapy dogs and their handlers, and the hospital 
environment. This thesis has approached infection control in hospital AAI programs 
through multiple angles - from understanding its effectiveness and unintended 
consequences on the microbial scale, to understanding compliance and potential 
improvements from individuals who are managing or participating in these programs. 
Taken together, this work advocates for the sustainability of these valuable programs by 
identifying areas for potential improvement in implementation. 
Chapter 2 reviewed the literature surrounding hospital-associated pathogens and argued 
for the utilization of a One Health approach to control hospital-acquired infections. 
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Chapter 3 identified knowledge gaps in current research on hazards associated with 
hospital AAI programs, specifically infectious disease risks. Both of these literature 
review chapters set the foundation for our original research. Chapter 4 used in-depth 
interviews with key stakeholders in AAI programs (healthcare workers and AAI workers) 
to identify barriers and facilitators to program use for healthcare worker benefit, and 
determine knowledge, beliefs, and practices regarding infectious disease risk and control 
policies, in order to understand the contextual parameters for enhanced program 
implementation. Chapter 5 uses this data to create a conceptual framework to improve 
program implementation targeted to hospital administrators and hospital infection 
control specialists. 
Chapters 6 and 7 used targeted amplicon metagenomics of samples from patients and 
therapy dogs to understand AAI’s collective positive and negative dynamism on the 
microscopic scale. Explicitly, the microbial community alterations and sharing that occur 
between individuals during an AAI session, and the impact of an infection control 
intervention (dog decolonization) on the burden and sharing of not just pathogens, but 
all microbiota (the microbiome). Chapter 6 specifically looks at the impact of the 
decolonization intervention on therapy dog microbiota to identify both effectiveness and 
safety to minimize unintended consequences and therefore enhance sustainability of this 
intervention modality for both human and animal health. Chapter 7 further unpacked 
microbiome changes in child patients as a result of microbial sharing with the therapy 
dog, and how patient-dog contact level and the dog decolonization intervention modifies 
this sharing.    
Research within this dissertation is significant to inform intervention strategies that 
target risk reductions of bacterial contamination during AAI programs and provide the 
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groundwork for further research. The main key findings from this dissertation research, 
to be used for further study design, are: 
1. The lack of data on infectious disease risks to participants in hospital AAI leads to 
hesitancy in program adoption and underutilization of these beneficial programs. 
The lack of data was identified in Chapter 3 and confirmed from on-the-ground 
stakeholders in Chapter 4. This lack of data also relates to a lack of understanding 
and lowered concern regarding infectious disease risk, also identified in Chapter 
4, which could be a barrier to the adoption of control measures and program 
improvement.  
2. This lack of information and program hesitancy is best addressed by multi-
stakeholder collaboration, in the form of program advocates across and outside 
the hospital to design practical risk mitigation strategies, and impactful 
leadership to direct implementation and train individuals on these appropriate 
risk mitigation strategies. This concept of holistic engagement was argued in 
Chapter 2, reported by stakeholders in Chapter 4, and hallmark recommendation 
in Chapter 5.  
3. This holistic outlook, backed by multi-stakeholder collaboration, can be used to 
design risk mitigation strategies, namely infection control intervention, to 
improve the safety of these programs. This includes conducting an individual risk 
assessment within a hospital’s AAI program (Chapter 4), but it also deals with 
understanding collaboration at the microscopic level, namely acknowledging 
microbial transmission, including pathogens, as a function of the entire microbial 
community. Control interventions may impact the microbiome, which may have 
downstream implications for the effectiveness of reducing pathogen transmission 
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(Chapter 7). Understanding microbial transmissions, within the context of all 
possible transmission pathways and exposure routes, allowed this research to 
determine that the therapy dog is only one potential pathway and may not 
contribute substantially to the infectious disease risk during these AAI programs.   
4. In addition to understanding all potential routes of transmission, a holistic 
outlook will, more importantly, allow for the determination of any unintended 
consequences from risk mitigation strategies. This was first identified in Chapter 
4, where therapy animal handlers reported concerns for the dogs’ health as a 
result of control measures, and was further explored in Chapters 6 and 7. Our 
decolonization intervention had the unintended consequence of being associated 
with a reduction in dog-specific microbiota, and sharing of dog-specific 
phylogenetically rare microbiota to and between patients. This could have 
secondary health impacts—both beneficial (reduction of dog pathogens) and 
detrimental (reduction of commensal flora). It is critically important to ensure 
the safety of all individuals involved in these programs, including the therapy dog 
teams. As the low number of therapy dog teams was reported to be a limited 
resource and a barrier to program implementation, any risk mitigation shown to 
have negative health consequences in the dog would further lower this critical 
resource and hinder program implementation.   
As evidenced by our key findings, this dissertation is a complete and comprehensive 
body of research that marks the first body of work to connect qualitative and quantitative 
study designs to understand how beliefs and practices overlap with microbial 
transmission dynamics and program safety in hospital AAI. In addition to the novelty of 
this thesis as a whole, each chapter advances the state of current knowledge on AAI 
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program implementation, as identified by our literature review chapters. By applying a 
One Health framework to AAI program safety, this research highlighted the importance 
of considering all potential stakeholders. This is in terms of gaining program support and 
understanding barriers to program safety, as well as beginning to understand the 
multiple pathways of microbial sharing. Previous research has focused on microbial 
carriage on just the therapy animal (Dalton et al., 2020), while our research extends that 
to explore sharing between therapy dogs and patients. Furthermore, while previous 
studies have commented on the importance of stakeholder buy-in for hospital infection 
control (Seibert et al., 2014; Yiwen et al., 2010), none have explored knowledge, belief, 
and practices in the context of AAI programs. A hallmark of this dissertation, and the 
One Health framework, is stakeholder collaboration. In addition to collecting perspective 
from those individuals on the ground, it was essential to translate the research to reach 
stakeholders involved in hospital leadership. While guidelines directed towards this 
critical population have been previously published (Lefebvre et al., 2008; Murthy et al., 
2015), our Chapter 5 commentary backs those recommendations with novel findings 
from a mixed-methods study design. Overall, this dissertation research achieved its 







8.2 Implications for Public Health and Policy 
 
The findings from this dissertation can be used to advance the knowledge of program 
safety and implementation for hospital AAI programs, which has public health and 
policy implications. The findings are perhaps most relevant for hospital administrators 
and hospital infection control epidemiologists who are in charge of these programs. Our 
Chapter 5 commentary directly translate the research findings from our qualitative work 
into actionable guidelines for this population, while Chapter 7 makes recommendations 
based on microbial pathways, that all microbial transmission pathways must be 
considering in the design of infection control programs in order to be effective and safe.  
However, these results will also be applicable to individuals directly involved in these 
programs, including healthcare workers and therapy animal handlers. Therapy animal 
handlers, and other individuals involved in the care of the therapy animals such as 
veterinarians and certification organizations, will also benefit from these safety 
guidelines, particularly recommendations from Chapter 6 on unintended consequences 
of infection control measures to the therapy dogs, to protect this valuable, limited 
resource. The findings overall from this dissertation can be used to improve hospital 
infection control policies. 
In addition to infection control policies, this research strongly advocates for the adoption 
of a One Health framework in research studies at the human-animal interface. A 
hallmark of the One Health approach is the importance of collaboration across 
disciplines. This research significantly benefitted from the inclusion of a mixed-methods 
study design and the incorporation of perspective from multiple individuals with diverse 
backgrounds. This stresses the need for future studies in the field of AAI and other 
human-animal public health areas to work with specialists with varied experiences. This 
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includes human-animal interaction specialists, microbiologists, human and animal 
medical professionals, environmental exposure scientists, and quantitative and 
qualitative researchers. Working together with these multiple disciplines will create 
more comprehensive study designs that translate into accurate and practical findings.    
 






8.3 Future Directions 
 
This thesis lays the groundwork for future research intended to support and extend 
hospital-based AAI programs. While the studies within this dissertation are exploratory 
and focused in scope, their preliminary results suggest the appropriateness of the study 
designs and inclusion of the One Health framework. Additional research, using the same 
rigorous study designs, would benefit the field of AAI as a whole and all participants 
involved. As a result of this thesis, it is recommended that two major avenues of research 
be pursued.  
The first is additional qualitative analysis, focusing on program implementation in a 
wide-ranging variety of hospitals, departments, and patient populations. We discovered 
in our data that there is significant heterogeneity in program adoption, implementation, 
and adherence. This finding is also confirmed with quantitative survey results from other 
studies (Linder et al., 2017). As such, perspectives on barriers and facilitators may be 
fundamentally different across different programs, and our recommendations may not 
hold true for all AAI programs. Reaching out to new stakeholder groups, both in 
different geographic locations and job roles, will improve the generalizability and 
strength of our recommendations. It became apparent in our data that concerns 
regarding infection are directly related to program leadership and hospital buy-in, so 
understanding the unique circumstances regarding program implementation across a 
broader array of settings will have important implications for best practices and program 
safety. A benefit to qualitative data is that it can be used to create targeted, practical, and 
relevant quantitative studies, such as survey questionnaires. This could be a potential 
avenue to capture a greater participant population across a diverse background of 
experiences and opinions. Combined with qualitative interviews of a subset of 
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participants, this mixed-methods design can improve the validity of our findings and 
subsequent policy recommendations for best practices of program implementation to 
improve AAI benefits and minimize risks.  
The second recommended future research area is to explore further microbial 
transmission that occurs during AAI programs. In addition to the limitation of a fixed 
sample size in our quantitative microbial studies, our results reflect only microbial 
carriage at one timepoint. Future research would benefit from understanding the 
temporal stability of the observed microbiome and pathogen changes during these 
programs. Likewise, this research highlighted the importance of other potential 
microbial pathways, such as between patients and healthcare workers or therapy animal 
handlers — this could be another avenue for future exploration. This research showed 
how infection control interventions could impact the microbiome of both patients and 
therapy dogs, and alter microbial sharing, yet we tested only one intervention strategy. 
Other possible infection control strategies, particularly those identified from our 
qualitative research, could be examined to understand the unique microbial impacts of 
different interventions. Finally, distinguishing the clinical significance of these microbial 
shifts in both patients and therapy dogs will have a critical influence on engaging 
hospital administrators in program implementation. If these observed microbial shifts 
lead to differential health outcomes, either negative or positive, this will have significant 
implications for the safety, effectiveness, and overall use of AAI programs in hospitals. 
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8.4 Final Remarks 
 
While undertaking this dissertation, it became profoundly clear how important animal-
assisted intervention programs are to the patients, the healthcare workers, and the 
therapy dog teams. These programs are a vital part of holistic patient health, directly 
observed from the impacts the therapy dog had on patients and healthcare workers, even 
with brief interactions. It is perhaps the most compelling example of the unequivocal 
power of the human-animal bond. The need for alternative holistic social support 
systems has never been more critical than during this time of a worldwide pandemic. The 
driving force behind all study goals within this thesis is the preservation and proliferative 
uptake of these indispensable programs. This can only be achieved through the 
recognition and minimization of barriers to program implementation, including 
infection risks to all individuals. By understanding and addressing these risks, we can 
enrich these programs and enhance their use across healthcare facilities. A holistic 
understanding of the risks and barriers, appreciated through a One Health framework, 
can best capture the minute and multi-faceted complexities within AAI programs. It is 
the hope with this dissertation, and the subsequent research that follows, that we can 
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